Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Vaccine

Retrieve available abstracts of 3496 articles:
HTML format

Single Articles

    July 2021
  1. SCHEIBLHOFER S, Drothler S, Braun W, Braun R, et al
    Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding.
    Vaccine. 2021;39:4399-4403.
    PubMed     Abstract available

  2. HANLY M, Churches T, Fitzgerald O, MacIntyre CR, et al
    Vaccinating Australia: How long will it take?
    Vaccine. 2021 Jul 17. pii: S0264-410X(21)00865.
    PubMed     Abstract available

  3. SHILLING H, Garland SM, Atchison S, Cornall AM, et al
    Human papillomavirus prevalence and risk factors among Australian women 9-12 years after vaccine program introduction.
    Vaccine. 2021 Jul 16. pii: S0264-410X(21)00864.
    PubMed     Abstract available

  4. PATHIRANA J, Kwatra G, Maposa I, Groome MJ, et al
    Effect of cytomegalovirus infection on humoral immune responses to select vaccines administered during infancy.
    Vaccine. 2021 Jul 15. pii: S0264-410X(21)00661.
    PubMed     Abstract available

  5. LAMONTAGNE DS, Manangazira P, Marembo J, Chigodo C, et al
    HPV vaccination coverage in three districts in ZIMBABWE following national introduction of 0,12 month schedule among 10 to 14 year old girls.
    Vaccine. 2021 Jul 15. pii: S0264-410X(21)00871.
    PubMed     Abstract available

  6. ELAS M, Villatoro N, Pezzoli L
    Disproportionality analysis of reported drug adverse events to assess a potential safety signal for pentavalent vaccine in 2019 in El Salvador.
    Vaccine. 2021 Jul 15. pii: S0264-410X(21)00869.
    PubMed     Abstract available

    Marketing the COVID-19 vaccine and the implications for public health.
    Vaccine. 2021 Jul 13. pii: S0264-410X(21)00874.
    PubMed     Abstract available

  8. O'DELL FJ, Williams AN, Poland A
    The contributions of William Money MRCS to smallpox vaccination and control - A little-known story.
    Vaccine. 2021 Jul 13. pii: S0264-410X(21)00844.
    PubMed     Abstract available

  9. CLARKE M, Goodchild LM, Evans S, Giles LC, et al
    Body mass index and vaccine responses following influenza vaccination during pregnancy.
    Vaccine. 2021 Jul 12. pii: S0264-410X(21)00826.
    PubMed     Abstract available

  10. GOMEZ M, McCollum J, Wang H, Bachchhav S, et al
    Evaluation of the stability of a spray-dried tuberculosis vaccine candidate designed for dry powder respiratory delivery.
    Vaccine. 2021 Jul 10. pii: S0264-410X(21)00861.
    PubMed     Abstract available

  11. MACINTYRE CR, Veness B, Berger D, Hamad N, et al
    Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia.
    Vaccine. 2021 Jul 10. pii: S0264-410X(21)00872.
    PubMed     Abstract available

  12. GUKTUR RE, Nep EI, Asala O, Olorunfemi PO, et al
    Carboxymethylated and acetylated xerogel derivatives of Plectranthus esculentus starch protect Newcastle disease vaccines against cold chain failure.
    Vaccine. 2021 Jul 9. pii: S0264-410X(21)00812.
    PubMed     Abstract available

  13. ZHANG T, Zhang J, Shao X, Feng S, et al
    Effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China, an observational cohort study.
    Vaccine. 2021 Jul 9. pii: S0264-410X(21)00836.
    PubMed     Abstract available

  14. FONGWEN N, Delrieu I, Ham LH, Gubler DJ, et al
    Implementation strategies for the first licensed dengue vaccine: A meeting report.
    Vaccine. 2021 Jul 9. pii: S0264-410X(21)00845.
    PubMed     Abstract available

  15. TERNA RICHARD M, Taiwo L, Jean Baptiste AE, Bawa S, et al
    Planning for supplemental immunization activities using the readiness assessment dashboard: Experience from 2017/2018 Measles vaccination campaign, Nigeria.
    Vaccine. 2021 Jul 8. pii: S0264-410X(21)00831.
    PubMed     Abstract available

  16. MATEO-URDIALES A, Del Manso M, Andrianou X, Spuri M, et al
    Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy- Update on the 28th of March 2021.
    Vaccine. 2021 Jul 7. pii: S0264-410X(21)00862.
    PubMed     Abstract available

  17. DING Y, Luo L, Luo Y, Zhao D, et al
    A novel combined vaccine against classical swine fever and porcine epidemic diarrhea viruses elicits a significant Th2-favored humoral response in mice.
    Vaccine. 2021 Jul 7. pii: S0264-410X(21)00846.
    PubMed     Abstract available

  18. AT THOBARI J, Damayanti W, Haposan JH, Nirwati H, et al
    Safety and immunogenicity of human neonatal RV3 rotavirus vaccine (Bio Farma) in adults, children, and neonates in Indonesia: Phase I Trial.
    Vaccine. 2021 Jul 6. pii: S0264-410X(21)00832.
    PubMed     Abstract available

  19. GESSNER BD, Theilacker C, Mendez C, Jodar L, et al
    Comment on "Vila-Corcoles et al., Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016."
    Vaccine. 2021;39:4032-4033.

  20. BELLIER L, Petitjean A, Sarazu T, Tresierra J, et al
    Cost-effectiveness analysis of switching from a trivalent to a quadrivalent inactivated influenza vaccine in the Peruvian immunisation programme.
    Vaccine. 2021;39:4144-4152.
    PubMed     Abstract available

  21. OZAWA S, Yemeke TT, Mitgang E, Wedlock PT, et al
    Systematic review of the costs for vaccinators to reach vaccination sites: Incremental costs of reaching hard-to-reach populations.
    Vaccine. 2021 Jul 5. pii: S0264-410X(21)00581.
    PubMed     Abstract available

  22. GENTILE A, Pacchiotti AC, Giglio N, Nolte MF, et al
    Vaccine hesitancy in Argentina: Validation of WHO scale for parents.
    Vaccine. 2021 Jul 5. pii: S0264-410X(21)00842.
    PubMed     Abstract available

  23. MARTIN C, Marinova D, Aguilo N, Gonzalo-Asensio J, et al
    MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG.
    Vaccine. 2021 Jul 5. pii: S0264-410X(21)00799.
    PubMed     Abstract available

  24. GOSSET A, Diallo MY, Betsem E, Schaeffer L, et al
    Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NeoVac Study).
    Vaccine. 2021 Jul 5. pii: S0264-410X(21)00809.
    PubMed     Abstract available

  25. SIMAS C, Paterson P, Lees S, J Larson H, et al
    "From my phone, I could rule the world": Critical engagement with maternal vaccine information, vaccine confidence builders and post-Zika outbreak rumours in Brazil.
    Vaccine. 2021 Jul 3. pii: S0264-410X(21)00775.
    PubMed     Abstract available

  26. LI AJ, Manzi F, Kyesi F, Makame Y, et al
    Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019.
    Vaccine. 2021 Jul 3. pii: S0264-410X(21)00797.
    PubMed     Abstract available

  27. HUANG Y, Seaton KE, Casapia M, Polakowski L, et al
    AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period.
    Vaccine. 2021 Jul 3. pii: S0264-410X(21)00827.
    PubMed     Abstract available

  28. SCHALTZ-BUCHHOLZER F, Roth A, de Bree LCJ, Biering-Sorensen S, et al
    Neonatal Bacille Calmette-Guerin vaccination and tuberculin skin test reactions at 2- and 6-months: Effects on mortality up to 1 year of age.
    Vaccine. 2021 Jul 2. pii: S0264-410X(21)00839.
    PubMed     Abstract available

  29. LO CY, Misplon JA, Li X, Price GE, et al
    Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice.
    Vaccine. 2021 Jul 2. pii: S0264-410X(21)00833.
    PubMed     Abstract available

  30. RAHAMIMOV N, Baturov V, Shani A, Ben Zoor I, et al
    Inadequate deltoid muscle penetration and concerns of improper COVID mRNA vaccine administration can be avoided by injection technique modification.
    Vaccine. 2021 Jul 2. pii: S0264-410X(21)00843.
    PubMed     Abstract available

  31. THIEM VD, Anh DD, Ha VH, Hien ND, et al
    Safety and immunogenicity of two formulations of rotavirus vaccine in Vietnamese infants.
    Vaccine. 2021 Jul 1. pii: S0264-410X(21)00806.
    PubMed     Abstract available

  32. CHOWDHURY F, Ali Syed K, Akter A, Rahman Bhuiyan T, et al
    A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol(R), an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh.
    Vaccine. 2021 Jul 1. pii: S0264-410X(21)00830.
    PubMed     Abstract available

  33. YEMEKE TT, Mitgang E, Wedlock PT, Higgins C, et al
    Promoting, seeking, and reaching vaccination services: A systematic review of costs to immunization programs, beneficiaries, and caregivers.
    Vaccine. 2021 Jul 1. pii: S0264-410X(21)00670.
    PubMed     Abstract available

    June 2021
  34. MWABA J, Chisenga CC, Xiao S, Ng'ombe H, et al
    Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia.
    Vaccine. 2021 Jun 30. pii: S0264-410X(21)00770.
    PubMed     Abstract available

  35. SORENSEN MK, Schaltz-Buchholzer F, Jensen AM, Nielsen S, et al
    Retesting the hypothesis that early Diphtheria-Tetanus-Pertussis vaccination increases female mortality: An observational study within a randomised trial.
    Vaccine. 2021 Jun 30. pii: S0264-410X(21)00720.
    PubMed     Abstract available

  36. HINES AM, Murphy N, Mullin C, Barillas J, et al
    Henoch-Schonlein purpura presenting post COVID-19 vaccination.
    Vaccine. 2021 Jun 30. pii: S0264-410X(21)00841.

  37. FISCHER P, Pawlowski A, Cao D, Bell D, et al
    Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women.
    Vaccine. 2021 Jun 29. pii: S0264-410X(21)00796.
    PubMed     Abstract available

  38. OSTERGAARD L, Vesikari T, Senders SD, Flodmark CE, et al
    Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months.
    Vaccine. 2021 Jun 29. pii: S0264-410X(21)00717.
    PubMed     Abstract available

  39. PLUTZER E, Warner SB
    A potential new front in health communication to encourage vaccination: Health education teachers.
    Vaccine. 2021 Jun 29. pii: S0264-410X(21)00800.
    PubMed     Abstract available

  40. KAUR R, Pham M, Pichichero M
    Serum antibody levels to pneumococcal polysaccharides 22F, 33F, 19A and 6A that correlate with protection from colonization and acute otitis media in children.
    Vaccine. 2021;39:3900-3906.
    PubMed     Abstract available

  41. KELLY SM, Larsen KR, Darling R, Petersen AC, et al
    Single-dose combination nanovaccine induces both rapid and durable humoral immunity and toxin neutralizing antibody responses against Bacillus anthracis.
    Vaccine. 2021;39:3862-3870.
    PubMed     Abstract available

  42. AL-SHAIKH A, Muthu N, Aidyralieva C, Profili MC, et al
    COVID-19 vaccine roll-out in middle-income countries: Lessons learned from the Jordan experience.
    Vaccine. 2021 Jun 29. pii: S0264-410X(21)00840.

  43. VERGER P, Duale C, Lenzi N, Scronias D, et al
    Vaccine hesitancy among hospital staff physicians: A cross-sectional survey in France in 2019.
    Vaccine. 2021 Jun 28. pii: S0264-410X(21)00803.
    PubMed     Abstract available

  44. BURNETT E, Juin S, Esona MD, Desormeaux AM, et al
    Effectiveness of monovalent rotavirus vaccine against hospitalizations due to all rotavirus and equine-like G3P[8] genotypes in Haiti 2014-2019.
    Vaccine. 2021 Jun 26. pii: S0264-410X(21)00805.
    PubMed     Abstract available

  45. SARHAN AT, Bahey-El-Din M, Zaghloul TI
    Recombinant Ax21 protein is a promising subunit vaccine candidate against Stenotrophomonas maltophilia in a murine infection model.
    Vaccine. 2021 Jun 26. pii: S0264-410X(21)00801.
    PubMed     Abstract available

  46. FUJIMOTO AB, Keskinocak P, Yildirim I
    Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation.
    Vaccine. 2021 Jun 26. pii: S0264-410X(21)00828.
    PubMed     Abstract available

  47. FELIX S, Handem S, Nunes S, Paulo AC, et al
    Impact of private use of the 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal carriage among Portuguese children living in urban and rural regions.
    Vaccine. 2021 Jun 25. pii: S0264-410X(21)00771.
    PubMed     Abstract available

  48. CARNALLA M, Torres-Ibarra L, Barrientos-Gutierrez T, Cruz-Valdez A, et al
    Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes.
    Vaccine. 2021 Jun 25. pii: S0264-410X(21)00776.
    PubMed     Abstract available

  49. MYLES IA, Vinciguerra JS, Premus RT
    Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site.
    Vaccine. 2021 Jun 25. pii: S0264-410X(21)00811.
    PubMed     Abstract available

  50. TUO W, Feng X, Cao L, Vinyard B, et al
    Vaccination with Neospora caninum-cyclophilin and -profilin confers partial protection against experimental neosporosis-induced abortion in sheep.
    Vaccine. 2021 Jun 24. pii: S0264-410X(21)00768.
    PubMed     Abstract available

  51. DESAI AP, Desai AP, Loomis GJ
    Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00808.
    PubMed     Abstract available

  52. BALDOLLI A, Michon J, Appia F, Galimard C, et al
    Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease: A case control study.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00804.
    PubMed     Abstract available

  53. FURUYA-KANAMORI L, Xu C, Doi SAR, Clark J, et al
    Comparison of immunogenicity and safety of licensed Japanese encephalitis vaccines: A systematic review and network meta-analysis.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00759.
    PubMed     Abstract available

  54. DASSAH S, Adu B, Sirima SB, Mordmuller B, et al
    Extended follow-up of children in a phase2b trial of the GMZ2 malaria vaccine.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00760.
    PubMed     Abstract available

  55. MARTIN-MERINO E, Castillo-Cano B, Martin-Perez M, Llorente-Garcia A, et al
    Papillomavirus vaccination and Guillain-Barre Syndrome among girls: A cohort study in Spain.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00765.
    PubMed     Abstract available

  56. KRISTENSEN D, Giersing B, Hickling J, Kazi F, et al
    A global collaboration to advance vaccine product innovations - The Vaccine Innovation Prioritisation Strategy.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00711.

  57. PHILLIP K, Nair N, Samanta K, Azevedo JF, et al
    Maternal transfer of neutralizing antibodies to B. burgdorferi OspA after oral vaccination of the rodent reservoir.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00761.
    PubMed     Abstract available

  58. OOSTDIJK C, Van Zoonen K, Ruijs WLM, Mollema L, et al
    Household decision-making for the MenACWY vaccination: How parents and adolescents deal with an adolescent vaccination decision.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00772.
    PubMed     Abstract available

  59. TRENT M, Seale H, Chughtai AA, Salmon D, et al
    Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00798.
    PubMed     Abstract available

  60. JAYARAMAN Y, Veeraraghavan B, Girish Kumar CP, Sukumar B, et al
    Hospital-based sentinel surveillance for bacterial meningitis in under-five children prior to the introduction of the PCV13 in India.
    Vaccine. 2021;39:3737-3744.
    PubMed     Abstract available

  61. MBAEYI C, Moran T, Wadood Z, Ather F, et al
    Stopping a polio outbreak in the midst of war: Lessons from Syria.
    Vaccine. 2021;39:3717-3723.
    PubMed     Abstract available

  62. GOOCH KE, Smith TRF, Salguero FJ, Fotheringham SA, et al
    One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00807.
    PubMed     Abstract available

  63. LUNDBERG L, Bygdell M, Stukat von Feilitzen G, Woxenius S, et al
    Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study.
    Vaccine. 2021 Jun 22. pii: S0264-410X(21)00795.
    PubMed     Abstract available

  64. CHEN IH, Ahorsu DK, Ko NY, Yen CF, et al
    Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students.
    Vaccine. 2021 Jun 22. pii: S0264-410X(21)00794.
    PubMed     Abstract available

  65. WANG Z, Zhou C, Gao F, Zhu Q, et al
    Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology.
    Vaccine. 2021 Jun 21. pii: S0264-410X(21)00767.
    PubMed     Abstract available

  66. RADHAKRISHNAN L, Stein Z, DeVies J, Smith A, et al
    Syndromic surveillance of vaccine-associated adverse events in U.S. emergency departments.
    Vaccine. 2021 Jun 21. pii: S0264-410X(21)00766.
    PubMed     Abstract available

  67. SMITH KJ, Wateska AR, Nowalk MP, Lin CJ, et al
    Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis.
    Vaccine. 2021 Jun 21. pii: S0264-410X(21)00773.
    PubMed     Abstract available

  68. WEDLOCK PT, Cox SN, Bartsch SM, Randall SL, et al
    Should countries switch to using five- or ten-dose rotavirus vaccines now that they are available?
    Vaccine. 2021 Jun 19. pii: S0264-410X(21)00757.
    PubMed     Abstract available

  69. FOGEL B, Schaefer EW, Hicks SD
    Early influenza vaccination rates decline in children during the COVID-19 pandemic.
    Vaccine. 2021 Jun 17. pii: S0264-410X(21)00777.
    PubMed     Abstract available

  70. BROWN CC, Young SG, Pro GC
    COVID-19 vaccination rates vary by community vulnerability: A county-level analysis.
    Vaccine. 2021 Jun 17. pii: S0264-410X(21)00774.
    PubMed     Abstract available

  71. LILES E, Irving SA, Dandamudi P, Belongia EA, et al
    Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination.
    Vaccine. 2021;39:3614-3620.
    PubMed     Abstract available

  72. FENG Y, Yao T, Chang Y, Gao L, et al
    Immunogenicity and persistence of high-dose recombinant hepatitis B vaccine in adults infected with human immunodeficiency virus in China: A randomized, double-blind, parallel controlled trial.
    Vaccine. 2021;39:3582-3589.
    PubMed     Abstract available

  73. VAILLANT L, Oster P, McMillan B, Velin D, et al
    Gastric eosinophils are detrimental for Helicobacter pylori vaccine efficacy.
    Vaccine. 2021;39:3590-3601.
    PubMed     Abstract available

  74. JETHWA H, Wong R, Abraham S
    Covid-19 vaccine trials: Ethnic diversity and immunogenicity.
    Vaccine. 2021;39:3541-3543.

  75. PRASAD N, Read JM, Jewell C, Waite B, et al
    Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand.
    Vaccine. 2021 Jun 16. pii: S0264-410X(21)00708.
    PubMed     Abstract available

  76. FRADICO JRB, Campi-Azevedo AC, Peruhype-Magalhaes V, Coelho-Dos-Reis JGA, et al
    CCL3, CCL5, IL-15, IL-1Ra and VEGF compose a reliable algorithm to discriminate classes of adverse events following 17DD-YF primary vaccination according to cause-specific definitions.
    Vaccine. 2021 Jun 16. pii: S0264-410X(21)00709.
    PubMed     Abstract available

  77. YITBAREK K, Tilahun T, Debela T, Abdena D, et al
    Measles epidemiology and vaccination coverage in Oromia Region, Ethiopia: Evidence from surveillance, 2011-2018.
    Vaccine. 2021 Jun 16. pii: S0264-410X(21)00739.
    PubMed     Abstract available

  78. MOSS WJ, Shendale S, Lindstrand A, O'Brien KL, et al
    Feasibility assessment of measles and rubella eradication.
    Vaccine. 2021;39:3544-3559.
    PubMed     Abstract available

  79. ANDRE GO, Borges MT, Assoni L, Ferraz LFC, et al
    Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsis.
    Vaccine. 2021;39:3626-3632.
    PubMed     Abstract available

  80. GARON JR, Mukavhi A, Rupfutse M, Bright S, et al
    Multiple cohort HPV vaccination in Zimbabwe: 2018-2019 program feasibility, awareness, and acceptability among health, education, and community stakeholders.
    Vaccine. 2021 Jun 15. pii: S0264-410X(21)00669.
    PubMed     Abstract available

    Helping patients with ethical concerns about COVID-19 vaccines in light of fetal cell lines used in some COVID-19 vaccines.
    Vaccine. 2021 Jun 15. pii: S0264-410X(21)00763.
    PubMed     Abstract available

  82. SMITH LE, Hodson A, Rubin GJ
    Parental attitudes towards mandatory vaccination; a systematic review.
    Vaccine. 2021 Jun 14. pii: S0264-410X(21)00742.
    PubMed     Abstract available

  83. IVANOV V, Oomens AGP, Papin JF, Staats R, et al
    Intranasal and intrapulmonary vaccination with an M protein-deficient respiratory syncytial virus (RSV) vaccine improves clinical signs and reduces viral replication in infant baboons after an RSV challenge infection.
    Vaccine. 2021 Jun 14. pii: S0264-410X(21)00737.
    PubMed     Abstract available

  84. KOCHHAR GS, Desai A, Caldera DO F, El Hachem S, et al
    Effectiveness of recombinant zoster vaccine (RZV) in patients with inflammatory bowel disease.
    Vaccine. 2021 Jun 14. pii: S0264-410X(21)00615.
    PubMed     Abstract available

  85. POLAND GA, Ovsyannikova IG, Kennedy RB
    The need for broadly protective COVID-19 vaccines: Beyond S-only approaches.
    Vaccine. 2021 Jun 14. pii: S0264-410X(21)00764.

  86. SCHALTZ-BUCHHOLZER F, Kjaer Sorensen M, Benn CS, Aaby P, et al
    The introduction of BCG vaccination to neonates in Northern Sweden, 1927-31: Re-analysis of historical data to understand the lower mortality among BCG-vaccinated children.
    Vaccine. 2021 Jun 13. pii: S0264-410X(21)00718.
    PubMed     Abstract available

  87. LIPSITCH M, Kahn R
    Interpreting vaccine efficacy trial results for infection and transmission.
    Vaccine. 2021 Jun 12. pii: S0264-410X(21)00735.
    PubMed     Abstract available

  88. FERRARI D, Di Resta C, Tomaiuolo R, Sabetta E, et al
    Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects.
    Vaccine. 2021 Jun 12. pii: S0264-410X(21)00756.
    PubMed     Abstract available

  89. MCFADDEN K, Heywood A, Dyda A, Kaufman J, et al
    Minimising missed opportunities to promote and deliver immunization services to middle and older age adults: Can hospital-based programs be a solution?
    Vaccine. 2021;39:3467-3472.
    PubMed     Abstract available

  90. DAVIES C, Stoney T, Hutton H, Parrella A, et al
    School-based HPV vaccination positively impacts parents' attitudes toward adolescent vaccination.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00637.
    PubMed     Abstract available

  91. BEAU RENEER Z, Abreu RB, Jamal US, Corn MR, et al
    Seasonal influenza vaccination does not effectively expand H2 cross-reactive antibodies in humans.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00659.
    PubMed     Abstract available

  92. MESHER D, Thomas SL, Linley E, Edmundson C, et al
    Post-vaccination HPV seroprevalence among female sexual health clinic attenders in England.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00580.
    PubMed     Abstract available

  93. OH SH, Kim SH, Jeon JH, Kim EB, et al
    Cytoplasmic expression of a model antigen with M Cell-Targeting moiety in lactic acid bacteria and implication of the mechanism as a mucosal vaccine via oral route.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00734.
    PubMed     Abstract available

  94. HSIA J, Zhao G, Lu PJ, Town M, et al
    Estimating bias from internet non-use for a hybrid web vaccination survey - 2013-2017 Behavioral Risk Factor Surveillance System.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00675.
    PubMed     Abstract available

  95. ODITA CI, Conan A, Smith-Antony M, Battice J, et al
    Non-specific effects of rabies vaccine on the incidence of self-reported common infectious disease episodes: A randomized controlled trial.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00719.
    PubMed     Abstract available

  96. CHEN Y, Wang Y, Robertson ID, Hu C, et al
    Key issues affecting the current status of infectious diseases in Chinese cattle farms and their control through vaccination.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00673.
    PubMed     Abstract available

  97. RAHMAN T, de Gier C, Orami T, Seppanen EJ, et al
    PCV10 elicits Protein D IgG responses in Papua New Guinean children but has no impact on NTHi carriage in the first two years of life.
    Vaccine. 2021;39:3486-3492.
    PubMed     Abstract available

  98. SORG AL, Obermeier V, Liese JG, von Kries R, et al
    Incidence trends of parapneumonic pleural effusions/empyema in children 2009 to 2018 from health insurance data: Only temporal reduction after the introduction of PCV13.
    Vaccine. 2021;39:3516-3519.
    PubMed     Abstract available

  99. CHAUHAN AS, Kapoor I, Rana SK, Kumar D, et al
    Cost effectiveness of typhoid vaccination in India.
    Vaccine. 2021 Jun 10. pii: S0264-410X(21)00713.
    PubMed     Abstract available

  100. VANDERSLOTT S, Marks T
    Charting mandatory childhood vaccination policies worldwide.
    Vaccine. 2021 Jun 10. pii: S0264-410X(21)00547.
    PubMed     Abstract available

  101. LUTZ CS, Biggerstaff M, Rolfes MA, Lafond KE, et al
    Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low- and middle-income countries.
    Vaccine. 2021 Jun 9. pii: S0264-410X(21)00557.
    PubMed     Abstract available

  102. MUHI S, Stinear TP
    Systematic review of M. Bovis BCG and other candidate vaccines for Buruli ulcer prophylaxis.
    Vaccine. 2021 Jun 9. pii: S0264-410X(21)00700.
    PubMed     Abstract available

  103. GUNTUKU SC, Buttenheim AM, Sherman G, Merchant RM, et al
    Twitter discourse reveals geographical and temporal variation in concerns about COVID-19 vaccines in the United States.
    Vaccine. 2021 Jun 9. pii: S0264-410X(21)00738.
    PubMed     Abstract available

  104. HOEHL S, Ciesek S, Graf J, Wicker S, et al
    A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00736.

  105. DE VRIES LM, Kellerborg KM, Brouwer WBF, van Baal PHM, et al
    Don't forget about the future: The impact of including future costs on the cost-effectiveness of adult pneumococcal conjugate vaccination with PCV13 in the Netherlands.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00699.
    PubMed     Abstract available

  106. STOECKEL F, Carter C, Lyons BA, Reifler J, et al
    Association of vaccine hesitancy and immunization coverage rates in the European Union.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00657.
    PubMed     Abstract available

  107. SUN Y, Jackson K, Dalmon CA, Shapiro BL, et al
    Effectiveness of the recombinant zoster vaccine among Kaiser Permanente Hawaii enrollees aged 50 and older: A retrospective cohort study.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00642.
    PubMed     Abstract available

  108. DIAZ-MITOMA F, Popovic V, Spaans JN
    Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac(R), compared with Engerix-B(R) in healthy Asian adults: A phase 3 randomized clinical trial.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00662.
    PubMed     Abstract available

  109. ANDAYI F, Emukule GO, Osoro E, Ndegwa LK, et al
    Knowledge and attitude of Kenyan healthcare workers towards pandemic influenza disease and vaccination: 9 years after the last influenza pandemic.
    Vaccine. 2021 Jun 7. pii: S0264-410X(21)00643.
    PubMed     Abstract available

  110. RAZ A, Keshet Y, Popper-Giveon A, Karkabi MS, et al
    One size does not fit all: Lessons from Israel's Covid-19 vaccination drive and hesitancy.
    Vaccine. 2021 Jun 5. pii: S0264-410X(21)00714.

  111. CHUA JV, Davis C, Husson JS, Nelson A, et al
    Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00685.
    PubMed     Abstract available

  112. NOGUERA M, Vela A, Kraft C, Chevalier M, et al
    Effects of three commercial vaccines against porcine parvovirus 1 in pregnant gilts.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00614.
    PubMed     Abstract available

  113. KARAFILLAKIS E, Francis MR, Paterson P, Larson HJ, et al
    Trust, emotions and risks: Pregnant women's perceptions, confidence and decision-making practices around maternal vaccination in France.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00704.
    PubMed     Abstract available

  114. WOLFE LS, Smedley JG 3rd, Bubna N, Hussain A, et al
    Development of a platform-based approach for the clinical production of HIV gp120 envelope glycoprotein vaccine candidates.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00668.
    PubMed     Abstract available

  115. DAL-RE R, Launay O
    Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00703.

  116. ITO N, Okamoto T, Sasaki M, Miyamoto S, et al
    Safety enhancement of a genetically modified live rabies vaccine strain by introducing an attenuating Leu residue at position 333 in the glycoprotein.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00553.
    PubMed     Abstract available

  117. CHANDRA D, Vipin B
    On the vaccine supply chain coordination under subsidy contract.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00676.
    PubMed     Abstract available

  118. STUURMAN AL, Biccler J, Carmona A, Descamps A, et al
    Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe - Results from the DRIVE EU study platform.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00654.
    PubMed     Abstract available

  119. UWINS C, Cyriac S, Bhandoria G
    HPV vaccine: Expanding indications and global disparity.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00677.

  120. GATES A, Rahman S, Sim S, Pillay J, et al
    Health inequities related to vaccination: An evidence map of potentially influential factors and systematic review of interventions.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00640.
    PubMed     Abstract available

  121. FERDINANDS JM, Thompson MG, Blanton L, Spencer S, et al
    Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research.
    Vaccine. 2021 Jun 2. pii: S0264-410X(21)00562.
    PubMed     Abstract available

  122. LASKY T, McMahon AW, Hua W, Forshee R, et al
    Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review.
    Vaccine. 2021 Jun 2. pii: S0264-410X(21)00666.
    PubMed     Abstract available

  123. SHINGAI M, Nomura N, Sekiya T, Ohno M, et al
    Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells.
    Vaccine. 2021 Jun 2. pii: S0264-410X(21)00660.
    PubMed     Abstract available

  124. YANG T, Liu B, Yue L, Xie T, et al
    Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00653.
    PubMed     Abstract available

  125. JOHM P, Nkoum N, Ceesay A, Mbaye EH, et al
    Factors influencing acceptance of vaccination during pregnancy in The Gambia and Senegal.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00663.
    PubMed     Abstract available

  126. SHI M, Chen X, Sun Y, Kim HK, et al
    A protein A based Staphylococcus aureus vaccine with improved safety.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00667.
    PubMed     Abstract available

  127. CHYDERIOTIS S, Sicsic J, Raude J, Bonmarin I, et al
    Optimising HPV vaccination communication to adolescents: A discrete choice experiment.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00656.
    PubMed     Abstract available

  128. WANG Y, Zhang Y, Wu H, Huang L, et al
    Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00665.
    PubMed     Abstract available

  129. DEY A, Chozhavel Rajanathan TM, Chandra H, Pericherla HPR, et al
    Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00706.
    PubMed     Abstract available

  130. PATEL MK, Bergeri I, Bresee JS, Cowling BJ, et al
    Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00707.
    PubMed     Abstract available

    May 2021
  131. BREWER NT, Mitchell CG, Alton Dailey S, Hora L, et al
    HPV vaccine communication training in healthcare systems: Evaluating a train-the-trainer model.
    Vaccine. 2021 May 30. pii: S0264-410X(21)00610.
    PubMed     Abstract available

  132. ZIPFEL CM, Colizza V, Bansal S
    The missing season: The impacts of the COVID-19 pandemic on influenza.
    Vaccine. 2021 May 30. pii: S0264-410X(21)00635.
    PubMed     Abstract available

  133. LEWIS NS, Banyard AC, Essen S, Whittard E, et al
    Antigenic evolution of contemporary clade HPAI H5 influenza A viruses and impact on vaccine use for mitigation and control.
    Vaccine. 2021 May 29. pii: S0264-410X(21)00655.
    PubMed     Abstract available

  134. GREWAL R, Deeks SL, Hart TA, Cox J, et al
    Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019.
    Vaccine. 2021 May 29. pii: S0264-410X(21)00603.
    PubMed     Abstract available

  135. MCGUINNESS D, Kaufhold RM, McHugh PM, Winters MA, et al
    Immunogenicity of PCV24, an expanded pneumococcal conjugate vaccine, in adult monkeys and protection in mice.
    Vaccine. 2021 May 29. pii: S0264-410X(21)00549.
    PubMed     Abstract available

  136. BARDENHEIER BH, Gravenstein S, Blackman C, Gutman R, et al
    Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents.
    Vaccine. 2021 May 28. pii: S0264-410X(21)00683.
    PubMed     Abstract available

  137. ABU MOUCH S, Roguin A, Hellou E, Ishai A, et al
    Myocarditis following COVID-19 mRNA vaccination.
    Vaccine. 2021 May 28. pii: S0264-410X(21)00682.
    PubMed     Abstract available

  138. WAGNER NM, Dempsey AF, Narwaney KJ, Gleason KS, et al
    Addressing logistical barriers to childhood vaccination using an automated reminder system and online resource intervention: A randomized controlled trial.
    Vaccine. 2021 May 28. pii: S0264-410X(21)00639.
    PubMed     Abstract available

  139. SULLIVAN E, Lecollinet S, Kerviel A, Hue E, et al
    Entry-competent-replication-abortive African horse sickness virus strains elicit robust immunity in ponies against all serotypes.
    Vaccine. 2021;39:3161-3168.
    PubMed     Abstract available

  140. BRANDILEONE MC, Almeida SCG, Bokermann S, Minamisava R, et al
    Dynamics of antimicrobial resistance of Streptococcus pneumoniae following PCV10 introduction in Brazil: Nationwide surveillance from 2007 to 2019.
    Vaccine. 2021;39:3207-3215.
    PubMed     Abstract available

  141. GURWITZ D
    COVID-19 vaccine hesitancy: Lessons from Israel.
    Vaccine. 2021 May 27. pii: S0264-410X(21)00680.

  142. CHU H, Ko LK, Ibrahim A, Bille Mohamed F, et al
    The impact of an educational forum intervention on East African mothers' HPV vaccine-related knowledge, attitudes, and intentions to vaccinate their adolescent children.
    Vaccine. 2021 May 27. pii: S0264-410X(21)00593.
    PubMed     Abstract available

  143. VUJOVICH-DUNN C, Kaufman J, King C, Skinner SR, et al
    A systematic review and meta-analysis of effectiveness of decision aids for vaccination decision-making.
    Vaccine. 2021 May 26. pii: S0264-410X(21)00583.
    PubMed     Abstract available

  144. KESSELS R, Luyten J, Tubeuf S
    Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general.
    Vaccine. 2021 May 26. pii: S0264-410X(21)00664.
    PubMed     Abstract available

  145. SATTLER C, Hoffmann P, Herzberg PY, Weber D, et al
    Primary vaccination in adult patients after allogeneic hematopoietic stem cell transplantation - A single center retrospective efficacy analysis.
    Vaccine. 2021 May 25. pii: S0264-410X(21)00511.
    PubMed     Abstract available

  146. WATESKA AR, Nowalk MP, Jalal H, Lin CJ, et al
    Is further research on adult pneumococcal vaccine uptake improvement programs worthwhile? Alpha value of information analysis.
    Vaccine. 2021 May 24. pii: S0264-410X(21)00609.
    PubMed     Abstract available

  147. COX SN, Wedlock PT, Pallas SW, Mitgang EA, et al
    A systems map of the economic considerations for vaccination: Application to hard-to-reach populations.
    Vaccine. 2021 May 24. pii: S0264-410X(21)00605.
    PubMed     Abstract available

  148. VANHEMS P
    A breath of humanity in the era of Covid-19 vaccine.
    Vaccine. 2021 May 24. pii: S0264-410X(21)00638.

  149. EARLE KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, et al
    Evidence for antibody as a protective correlate for COVID-19 vaccines.
    Vaccine. 2021 May 24. pii: S0264-410X(21)00658.
    PubMed     Abstract available

  150. GIDENGIL C, Goetz MB, Newberry S, Maglione M, et al
    Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis.
    Vaccine. 2021 May 23. pii: S0264-410X(21)00385.
    PubMed     Abstract available

  151. NADARZYNSKI T, Frost M, Miller D, Wheldon CW, et al
    Vaccine acceptability, uptake and completion amongst men who have sex with men: A systematic review, meta-analysis and theoretical framework.
    Vaccine. 2021 May 22. pii: S0264-410X(21)00564.
    PubMed     Abstract available

  152. HIRST A, Hyer RN, Janssen RS
    Comparative cost-effectiveness of a 2-dose versus 3-dose vaccine for hepatitis B prevention in selected adult populations.
    Vaccine. 2021 May 21. pii: S0264-410X(21)00582.
    PubMed     Abstract available

  153. TUFAIL S, Shah MA, Zafar M, Asif TA, et al
    Identification of potent epitopes on hexon capsid protein and their evaluation as vaccine candidates against infections caused by members of Adenoviridae family.
    Vaccine. 2021 May 21. pii: S0264-410X(21)00585.
    PubMed     Abstract available

  154. ARDURA-GARCIA C, Kreis C, Rakic M, Jaboyedoff M, et al
    Rotavirus disease and health care utilisation among children under 5 years of age in highly developed countries: A systematic review and meta-analysis.
    Vaccine. 2021;39:2917-2928.
    PubMed     Abstract available

  155. BIANCHI FP, Larocca AMV, Bozzi A, Spinelli G, et al
    Long-term persistence of poliovirus neutralizing antibodies in the era of polio elimination: An Italian retrospective cohort study.
    Vaccine. 2021;39:2989-2994.
    PubMed     Abstract available

  156. VOGEL TP, Top KA, Karatzios C, Hilmers DC, et al
    Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Vaccine. 2021;39:3037-3049.
    PubMed     Abstract available

  157. SERAZIN NA, Edem B, Williams SR, Ortiz JR, et al
    Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Vaccine. 2021;39:3028-3036.
    PubMed     Abstract available

  158. AIZAWA Y, Katsuta T, Sakiyama H, Tanaka-Taya K, et al
    Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan.
    Vaccine. 2021 May 21. pii: S0264-410X(21)00636.
    PubMed     Abstract available

  159. OKORONKWO C, Taiwo LA, Asolo JA, Baptiste AEJ, et al
    Leveraging on the 2017/2018 measles vaccination campaign to improve health workers knowledge and practice on injection safety: A case study of north-central states, Nigeria.
    Vaccine. 2021 May 20. pii: S0264-410X(21)00565.
    PubMed     Abstract available

  160. SON HJ, Lee E, Park SY, Lee S, et al
    Promotion of healthcare personnel vaccinations among newly employed doctors and nurses: Evidence-guided strategy.
    Vaccine. 2021 May 20. pii: S0264-410X(21)00589.
    PubMed     Abstract available

  161. BLANCHARD-ROHNER G, Enriquez N, Lemaitre B, Cadau G, et al
    Pneumococcal immunity and PCV13 vaccine response in SOT-candidates and recipients.
    Vaccine. 2021 May 20. pii: S0264-410X(21)00594.
    PubMed     Abstract available

  162. NICHOLLS LAB, Gallant AJ, Cogan N, Rasmussen S, et al
    Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake.
    Vaccine. 2021 May 19. pii: S0264-410X(21)00544.
    PubMed     Abstract available

  163. DANG JHT, Stewart SL, Blumberg DA, Rodriguez HP, et al
    Patient and clinician factors associated with uptake of the human papillomavirus (HPV) vaccine among adolescent patients of a primary care network.
    Vaccine. 2021 May 19. pii: S0264-410X(21)00525.
    PubMed     Abstract available

  164. KIM S, Williams TC, Viboud C, Campbell H, et al
    RSV genomic diversity and the development of a globally effective RSV intervention.
    Vaccine. 2021;39:2811-2820.
    PubMed     Abstract available

  165. NAG K, Chandra Baray J, Rahman Khan M, Mahmud A, et al
    An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose.
    Vaccine. 2021 May 18. pii: S0264-410X(21)00607.
    PubMed     Abstract available

  166. LUK TT, Zhao S, Wu Y, Wong JY, et al
    Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey.
    Vaccine. 2021 May 18. pii: S0264-410X(21)00608.
    PubMed     Abstract available

  167. MENKIR TF, Jbaily A, Verguet S
    Incorporating equity in infectious disease modeling: Case study of a distributional impact framework for measles transmission.
    Vaccine. 2021;39:2894-2900.
    PubMed     Abstract available

  168. GULLA K, Cibelli N, Cooper JW, Fuller HC, et al
    A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation.
    Vaccine. 2021 May 18. pii: S0264-410X(21)00545.
    PubMed     Abstract available

  169. FUKUDA M, Nakamura J, Ito S, Kawazoe K, et al
    Vaccination inhibits the human adenoviral transduction in a mouse keratoconjunctivitis model.
    Vaccine. 2021 May 17. pii: S0264-410X(21)00561.
    PubMed     Abstract available

  170. NAKAHASHI-OUCHIDA R, Uchida Y, Yuki Y, Katakai Y, et al
    A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci.
    Vaccine. 2021 May 17. pii: S0264-410X(21)00552.
    PubMed     Abstract available

  171. CHAN YW, Wong ML, Kwok FY, Au AK, et al
    The effect of seasonal influenza vaccine on medically-attended influenza and non-influenza respiratory viruses infections at primary care level, Hong Kong SAR, 2017/18 to 2019/20.
    Vaccine. 2021 May 17. pii: S0264-410X(21)00541.
    PubMed     Abstract available

  172. MCGIRR A, Bourgoin T, Wortzman M, Millson B, et al
    An early look at the second dose completion of the recombinant zoster vaccine in Canadian adults: A retrospective database study.
    Vaccine. 2021 May 14. pii: S0264-410X(21)00523.
    PubMed     Abstract available

  173. AWAD AM, Ntoso A, Connaire JJ, Hernandez GT, et al
    An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B(R)) in adults receiving hemodialysis.
    Vaccine. 2021 May 14. pii: S0264-410X(21)00554.
    PubMed     Abstract available

  174. WOOD RM, Murch BJ, Moss SJ, Tyler JMB, et al
    Operational research for the safe and effective design of COVID-19 mass vaccination centres.
    Vaccine. 2021 May 14. pii: S0264-410X(21)00588.

  175. GUBERNOT D, Jazwa A, Niu M, Baumblatt J, et al
    U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines.
    Vaccine. 2021 May 14. pii: S0264-410X(21)00578.
    PubMed     Abstract available

  176. CHUNG JR, Flannery B, Kim SS, Gaglani M, et al
    Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United States.
    Vaccine. 2021 May 13. pii: S0264-410X(21)00555.
    PubMed     Abstract available

  177. WANG J, Jiang L, Zhang C, He W, et al
    The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine.
    Vaccine. 2021 May 13. pii: S0264-410X(21)00560.
    PubMed     Abstract available

  178. LIU Y, Xiong Y, Liang Y, Deng X, et al
    Waning immunity and potential asymptomatic infection in 3-7 years old children who received one dose of measles-mumps-rubella vaccine: A 4-year prospective study.
    Vaccine. 2021 May 13. pii: S0264-410X(21)00559.
    PubMed     Abstract available

  179. KALKOWSKA DA, Pallansch MA, Wassilak SGF, Cochi SL, et al
    Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response.
    Vaccine. 2021 May 13. pii: S0264-410X(21)00543.
    PubMed     Abstract available

  180. BANNISTER S, Sudbury E, Villanueva P, Perrett K, et al
    The safety of BCG revaccination: A systematic review.
    Vaccine. 2021;39:2736-2745.
    PubMed     Abstract available

  181. LONGCHAMPS C, Ducarroz S, Crouzet L, Vignier N, et al
    COVID-19 vaccine hesitancy among persons living in homeless shelters in France.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00563.
    PubMed     Abstract available

  182. GROENEWEG L, Loeffen YGT, Versluys AB, Wolfs TFW, et al
    Safety and efficacy of early vaccination with live attenuated measles vaccine for hematopoietic stem cell transplant recipients and solid organ transplant recipients.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00508.
    PubMed     Abstract available

  183. HAN B, Liu W, Du J, Liu H, et al
    Immunogenicity and safety of hepatitis B vaccination in patients with type 2 diabetes in China: An open-label randomized controlled trial.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00540.
    PubMed     Abstract available

  184. KIM TH, Choi JH, Park SH, Yoo JH, et al
    Safety and immunogenicity of a seasonal quadrivalent influenza vaccine (GC3110A) in healthy participants aged >/= 65 years.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00551.
    PubMed     Abstract available

  185. UWABOR E, Chau V, Romanin C, Loh LC, et al
    Digital tools for vaccine reporting: A perspective from the province of Ontario.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00558.

  186. ARREDONDO JL, Villagomez Martinez SM, Concepcion Morales M, Meyer S, et al
    Immunogenicity and safety of a tetravalent dengue vaccine and a bivalent HPV vaccine given concomitantly or sequentially in girls aged 9 to 14 years in Mexico.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00546.
    PubMed     Abstract available

  187. KRAIGSLEY AM, Moore KA, Bolster A, Peters M, et al
    Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00502.
    PubMed     Abstract available

  188. CHILENGI R, Mwila-Kazimbaya K, Chirwa M, Sukwa N, et al
    Immunogenicity and safety of two monovalent rotavirus vaccine, ROTAVAC(R) and ROTAVAC 5D(R) in Zambian infants.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00542.
    PubMed     Abstract available

  189. GLENN BA, Nonzee NJ, Tieu L, Pedone B, et al
    Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00454.
    PubMed     Abstract available

  190. AFIFI TO, Salmon S, Taillieu T, Stewart-Tufescu A, et al
    Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00590.
    PubMed     Abstract available

  191. LEUNG VKY, Fox A, Carolan LA, Aban M, et al
    Impact of prior vaccination on antibody response and influenza-like illness among Australian healthcare workers after influenza vaccination in 2016.
    Vaccine. 2021 May 10. pii: S0264-410X(21)00483.
    PubMed     Abstract available

  192. POWELL H, Liu H, Pekosz A
    Changes in sialic acid binding associated with egg adaptation decrease live attenuated influenza virus replication in human nasal epithelial cell cultures.
    Vaccine. 2021 May 10. pii: S0264-410X(21)00535.
    PubMed     Abstract available

  193. DU QQ, Zeng HL, Yuan L, Tang P, et al
    One cross-sectional investigation revealed that non-vaccine serotypes of Streptococcus pneumoniae could be identified more frequently in elderly Chinese people.
    Vaccine. 2021 May 9. pii: S0264-410X(21)00233.
    PubMed     Abstract available

  194. PASTORINO R, Villani L, La Milia DI, Ieraci R, et al
    Influenza and pneumococcal vaccinations are not associated to COVID-19 outcomes among patients admitted to a university hospital.
    Vaccine. 2021 May 9. pii: S0264-410X(21)00566.
    PubMed     Abstract available

  195. HUANG JM, Wang SY, Lai MR, Tseng YK, et al
    Development of a respiratory syncytial virus vaccine using human hepatitis B core-based virus-like particles to induce mucosal immunity.
    Vaccine. 2021 May 7. pii: S0264-410X(21)00485.
    PubMed     Abstract available

  196. STABEL JR, Bannantine JP
    Reduced tissue colonization of Mycobacterium avium subsp. paratuberculosis in neonatal calves vaccinated with a cocktail of recombinant proteins.
    Vaccine. 2021 May 6. pii: S0264-410X(21)00510.
    PubMed     Abstract available

  197. TANG XY, Yan XX, Wei X, Qin QL, et al
    Timeliness, completeness, and timeliness-and-completeness of serial routine vaccinations among rural children in Southwest China: A multi-stage stratified cluster sampling survey.
    Vaccine. 2021 May 6. pii: S0264-410X(21)00507.
    PubMed     Abstract available

  198. KHALIL I, Walker R, Porter CK, Muhib F, et al
    Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access.
    Vaccine. 2021 May 6. pii: S0264-410X(21)00453.
    PubMed     Abstract available

  199. SOMIYA M, Mine S, Yasukawa K, Ikeda S, et al
    Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines.
    Vaccine. 2021 May 6. pii: S0264-410X(21)00548.

  200. SATOH C, Toizumi M, Nguyen HAT, Hara M, et al
    Prevalence and characteristics of children with otitis media with effusion in Vietnam.
    Vaccine. 2021;39:2613-2619.
    PubMed     Abstract available

  201. MANCA TA, Graham JE, MacDonald NE, Top KA, et al
    Healthcare providers' interpretations of product labelling information developed through a consensus stakeholder approach.
    Vaccine. 2021;39:2652-2659.
    PubMed     Abstract available

  202. CORREIA R, Meneses L, Richheimer C, Alves PM, et al
    Improved storage of influenza HA-VLPs using a trehalose-glycerol natural deep eutectic solvent system.
    Vaccine. 2021 May 6. pii: S0264-410X(21)00480.
    PubMed     Abstract available

  203. FAIRMAN J, Agarwal P, Barbanel S, Behrens C, et al
    Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current standard of care (PCV13 and PPV23).
    Vaccine. 2021 May 5. pii: S0264-410X(21)00374.
    PubMed     Abstract available

  204. JO CL, Burchett H, Bastias M, Campbell P, et al
    Using existing systematic reviews for developing vaccination recommendations: Results of an international expert workshop.
    Vaccine. 2021 May 5. pii: S0264-410X(21)00504.
    PubMed     Abstract available

  205. WANG J, Bai S, Zhou S, Zhao W, et al
    Immunogenicity and safety of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 2-5 years in China.
    Vaccine. 2021 May 5. pii: S0264-410X(21)00484.
    PubMed     Abstract available

  206. BITENCOURT J, Sarno A, Oliveira C, Souza RA, et al
    Comparing cytokine production and clinical response following vaccination with BCG Moreau and BCG Russia strains in a Brazilian infant population.
    Vaccine. 2021 May 5. pii: S0264-410X(21)00475.
    PubMed     Abstract available

  207. MILLAR EV, Bennett JW, Barin B, Carey PM, et al
    Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees.
    Vaccine. 2021 May 4. pii: S0264-410X(21)00478.
    PubMed     Abstract available

  208. HALL GC, Douglas I, Heath PT, Prabhakar P, et al
    Post-licensure observational safety study after meningococcal B vaccine 4CMenB (Bexsero) vaccination within the routine UK immunisation program.
    Vaccine. 2021 May 4. pii: S0264-410X(21)00256.
    PubMed     Abstract available

  209. MPHURU A, Li AJ, Kyesi F, Mwengee W, et al
    National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation.
    Vaccine. 2021 May 4. pii: S0264-410X(21)00472.
    PubMed     Abstract available

  210. OTERI AJ, Adamu U, Dieng B, Bawa S, et al
    Nigeria experience on the use of polio assets for the 2017/18 measles vaccination campaign follow-up.
    Vaccine. 2021 May 4. pii: S0264-410X(21)00497.
    PubMed     Abstract available

  211. LAURENZ M, von Eiff C, Borchert K, Jacob C, et al
    Vaccination rates and adherence in pneumococcal conjugate vaccination in mature born infants before and after vaccination schedule change - A claims database analysis.
    Vaccine. 2021 May 4. pii: S0264-410X(21)00476.
    PubMed     Abstract available

  212. TAMANDJOU TCHUEM CR, Andersson MI, Wiysonge CS, Mufenda J, et al
    Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis.
    Vaccine. 2021 May 4. pii: S0264-410X(21)00498.
    PubMed     Abstract available

  213. MANDOMANDO I, Mumba M, Nsiari-Muzeyi Biey J, Kipese Paluku G, et al
    Implementation of the World Health Organization recommendation on the use of rotavirus vaccine without age restriction by African countries.
    Vaccine. 2021 May 3. pii: S0264-410X(21)00289.
    PubMed     Abstract available

  214. YOSHIMURA M, Shinmura Y, Shishido T, Takagi S, et al
    Persistence of neutralizing antibody and its protective efficacy induced by a live attenuated tetravalent dengue vaccine, KD-382, in cynomolgus monkeys.
    Vaccine. 2021 May 1. pii: S0264-410X(21)00477.
    PubMed     Abstract available

    April 2021
  215. WELSH KJ, Baumblatt J, Chege W, Goud R, et al
    Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
    Vaccine. 2021 Apr 30. pii: S0264-410X(21)00524.
    PubMed     Abstract available

  216. EYAL N, Gerhard T, Strom BL
    Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests.
    Vaccine. 2021 Apr 30. pii: S0264-410X(21)00526.

  217. ITO S, Nakamura J, Fukuta M, Ura T, et al
    Prophylactic and therapeutic vaccine against Pseudomonas aeruginosa keratitis using bacterial membrane vesicles.
    Vaccine. 2021 Apr 29. pii: S0264-410X(21)00482.
    PubMed     Abstract available

  218. WILKINSON K, Righolt CH, Elliott LJ, Fanella S, et al
    Pertussis vaccine effectiveness and duration of protection - A systematic review and meta-analysis.
    Vaccine. 2021 Apr 29. pii: S0264-410X(21)00479.
    PubMed     Abstract available

  219. POLKOWSKA A, Rinta-Kokko H, Toropainen M, Palmu AA, et al
    Long-term population effects of infant 10-valent pneumococcal conjugate vaccination on pneumococcal meningitis in Finland.
    Vaccine. 2021 Apr 29. pii: S0264-410X(21)00186.
    PubMed     Abstract available

  220. KINI A, Morgan R, Kuo H, Shea P, et al
    Differences and disparities in seasonal influenza vaccine, acceptance, adverse reactions, and coverage by age, sex, gender, and race.
    Vaccine. 2021 Apr 28. pii: S0264-410X(21)00448.
    PubMed     Abstract available

  221. DIAS HF, Kuhtreiber WM, Nelson KJ, Ng NC, et al
    Epigenetic changes related to glucose metabolism in type 1 diabetes after BCG vaccinations: A vital role for KDM2B.
    Vaccine. 2021 Apr 28. pii: S0264-410X(21)00446.
    PubMed     Abstract available

  222. VEKEMANS J, Schellenberg D, Benns S, O'Brien K, et al
    Meeting report: WHO consultation on malaria vaccine development, Geneva, 15-16 July 2019.
    Vaccine. 2021 Apr 27. pii: S0264-410X(21)00409.
    PubMed     Abstract available

  223. SAITOH A, Okabe N
    Changes and remaining challenges for the Japanese immunization program: Closing the vaccine gap.
    Vaccine. 2021 Apr 27. pii: S0264-410X(21)00460.
    PubMed     Abstract available

  224. XU J, Doyon-Plourde P, Tunis M, Quach C, et al
    Effect of early measles vaccination on long-term protection: A systematic review.
    Vaccine. 2021 Apr 26. pii: S0264-410X(21)00447.
    PubMed     Abstract available

  225. KWON JH, Criado MF, Killmaster L, Ali MZ, et al
    Efficacy of two vaccines against recent emergent antigenic variants of clade highly pathogenic avian influenza viruses in Bangladesh.
    Vaccine. 2021 Apr 25. pii: S0264-410X(21)00459.
    PubMed     Abstract available

  226. MACINTYRE CR, Costantino V, Trent M
    Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia.
    Vaccine. 2021 Apr 24. pii: S0264-410X(21)00501.
    PubMed     Abstract available

  227. KREPS SE, Kriner DL
    Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: Evidence from a conjoint experiment.
    Vaccine. 2021 Apr 24. pii: S0264-410X(21)00503.
    PubMed     Abstract available

  228. PARK MA, Jenkins SM, Smith CY, Pyle RC, et al
    Pneumococcal serotype-specific cut-offs based on antibody responses to pneumococcal polysaccharide vaccination in healthy adults.
    Vaccine. 2021 Apr 22. pii: S0264-410X(21)00450.
    PubMed     Abstract available

  229. XIRIDOU M, Visser M, Urbanus A, Matser A, et al
    Ending risk-group HBV vaccination for MSM after the introduction of universal infant HBV vaccination: A mathematical modelling study.
    Vaccine. 2021 Apr 22. pii: S0264-410X(21)00433.
    PubMed     Abstract available

  230. OLATUNJI EA, Ogunsola AS, Khodakarami N, Callaghan T, et al
    Who receives influenza vaccinations at the Pharmacy? An analysis of the Texas Behavioral Risk Factor Surveillance System.
    Vaccine. 2021 Apr 22. pii: S0264-410X(21)00451.
    PubMed     Abstract available

  231. SOLANS L, Debrie AS, Coutte L, Locht C, et al
    Construction and evaluation of a pertactin-deficient live attenuated pertussis vaccine candidate BPZE1 derivative.
    Vaccine. 2021 Apr 22. pii: S0264-410X(21)00449.
    PubMed     Abstract available

  232. ROY CHOUDHURY A, Polachek SW
    The impact of paid family leave on the timely vaccination of infants.
    Vaccine. 2021 Apr 22. pii: S0264-410X(21)00403.
    PubMed     Abstract available

  233. KAWAMURA Y, Hattori F, Higashimoto Y, Kozawa K, et al
    Evaluation of varicella vaccine effectiveness during outbreaks in schools or nurseries by cross-sectional study.
    Vaccine. 2021 Apr 21. pii: S0264-410X(21)00434.
    PubMed     Abstract available

  234. STEVENS NE, van Wolfswinkel M, Bao W, Ryan FJ, et al
    Immunisation with the BCG and DTPw vaccines induces different programs of trained immunity in mice.
    Vaccine. 2021 Apr 21. pii: S0264-410X(21)00400.
    PubMed     Abstract available

  235. HAMISU M, Dieng B, Taiwo L, Jean Baptiste AE, et al
    Microplanning verification and 2017/2018 measles vaccination campaign in Nigeria: Lessons learnt.
    Vaccine. 2021 Apr 20. pii: S0264-410X(21)00432.
    PubMed     Abstract available

  236. PIERSON BC, Cardile AP, Okwesili AC, Downs IL, et al
    Safety and immunogenicity of an inactivated eastern equine encephalitis virus vaccine.
    Vaccine. 2021 Apr 19. pii: S0264-410X(21)00309.
    PubMed     Abstract available

  237. JEAN BAPTISTE AE, Masresha B, Wagai J, Luce R, et al
    Trends in measles incidence and measles vaccination coverage in Nigeria, 2008-2018.
    Vaccine. 2021 Apr 17. pii: S0264-410X(21)00424.
    PubMed     Abstract available

  238. SAVAGE RD, Bell CA, Righolt CH, Wilkinson K, et al
    A multisite study of pertussis vaccine effectiveness by time since last vaccine dose from three Canadian provinces: A Canadian Immunization Research Network study.
    Vaccine. 2021 Apr 16. pii: S0264-410X(21)00310.
    PubMed     Abstract available

  239. OSTOLIN TLVDP, Gusmao MR, Mathias FAS, Cardoso JMO, et al
    A chimeric vaccine combined with adjuvant system induces immunogenicity and protection against visceral leishmaniasis in BALB/c mice.
    Vaccine. 2021 Apr 16. pii: S0264-410X(21)00429.
    PubMed     Abstract available

  240. MARTIN JC, Petrecz ML, Stek JE, Simon JK, et al
    Using the power law model to predict the long-term persistence and duration of detectable hepatitis A antibody after receipt of hepatitis A vaccine (VAQTA).
    Vaccine. 2021 Apr 15. pii: S0264-410X(21)00345.
    PubMed     Abstract available

  241. GUZMAN-HOLST A, Luna-Casas G, Cervantes-Apolinar MY, Huerta-Garcia GC, et al
    Pertussis infant morbidity and mortality trends after universal maternal immunisation in Mexico: An ecological database study with time-series analysis.
    Vaccine. 2021;39:2311-2318.
    PubMed     Abstract available

  242. YAMADA M, Li M, Iino T
    Pneumococcal vaccine coverage in Japan among patients with a history of splenectomy: Results of a retrospective administrative database study.
    Vaccine. 2021 Apr 14. pii: S0264-410X(21)00338.
    PubMed     Abstract available

  243. DANIEL M, Liang B, Luo M
    Assessment of the population coverage of an HIV-1 vaccine targeting sequences surrounding the viral protease cleavage sites in Gag, Pol, or all 12 protease cleavage sites.
    Vaccine. 2021 Apr 13. pii: S0264-410X(21)00372.
    PubMed     Abstract available

  244. BROOK B, Schaltz-Buchholzer F, Ben-Othman R, Kollmann T, et al
    A place for neutrophils in the beneficial pathogen-agnostic effects of the BCG vaccine.
    Vaccine. 2021 Apr 13. pii: S0264-410X(21)00408.
    PubMed     Abstract available

  245. LEVIN Y, Balakirski NM, Caraco Y, Ben-Ami E, et al
    Ethics and execution of developing a 2nd wave COVID vaccine - Our interim phase I/II VSV-SARS-CoV2 vaccine experience.
    Vaccine. 2021 Apr 13. pii: S0264-410X(21)00452.

  246. WANG C, Han B, Zhao T, Liu H, et al
    Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study.
    Vaccine. 2021 Apr 13. pii: S0264-410X(21)00455.
    PubMed     Abstract available

  247. YU Q, Li X, Fan M, Qiu H, et al
    The impact of childhood pneumococcal conjugate vaccine immunisation on all-cause pneumonia admissions in Hong Kong: A 14-year population-based interrupted time series analysis.
    Vaccine. 2021 Apr 12. pii: S0264-410X(21)00406.
    PubMed     Abstract available

  248. PRYMULA R, Povey M, Brzostek J, Cabrnochova H, et al
    Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries.
    Vaccine. 2021 Apr 12. pii: S0264-410X(21)00401.
    PubMed     Abstract available

  249. CHOI SK, Baik YO, Kim CW, Kim SK, et al
    An open-label, comparative, single dose, clinical Phase study to assess the safety and immunogenicity of typhoid conjugate vaccine (Vi-CRM197) in healthy Filipino adults.
    Vaccine. 2021 Apr 10. pii: S0264-410X(21)00405.
    PubMed     Abstract available

  250. LA EM, Garbinsky D, Hunter S, Poston S, et al
    Meningococcal B vaccination coverage among older adolescents in the United States.
    Vaccine. 2021 Apr 10. pii: S0264-410X(21)00375.
    PubMed     Abstract available

  251. HAMILTON RA, Krockow EM, Vekria P
    Attitudes towards influenza and uptake of the flu vaccine: A survey of pharmacy staff working in English hospitals.
    Vaccine. 2021 Apr 9. pii: S0264-410X(21)00407.
    PubMed     Abstract available

  252. JENSEN KJ, Tolstrup LK, Knobel DL, Aaby P, et al
    Non-specific effects of maternal and offspring rabies vaccination on mortality and antibiotic use in a Danish pig herd: A randomized trial.
    Vaccine. 2021 Apr 9. pii: S0264-410X(21)00399.
    PubMed     Abstract available

  253. PU J, Yu Q, Yin Z, Zhang Y, et al
    The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial.
    Vaccine. 2021 Apr 9. pii: S0264-410X(21)00431.
    PubMed     Abstract available

  254. DE SL, May S, Shah K, Slawinski M, et al
    Variable immunogenicity of a vivax malaria blood-stage vaccine candidate.
    Vaccine. 2021 Apr 8. pii: S0264-410X(21)00376.
    PubMed     Abstract available

  255. HOGAN AB, Winskill P, Watson OJ, Walker PGT, et al
    Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis.
    Vaccine. 2021 Apr 8. pii: S0264-410X(21)00427.
    PubMed     Abstract available

  256. CEYHAN M, Karadag-Oncel E, Hascelik G, Ustundag G, et al
    Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children aged less than five years.
    Vaccine. 2021;39:2041-2047.
    PubMed     Abstract available

  257. PAGLIUSI S, Hayman B, Jarrett S
    Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report.
    Vaccine. 2021 Apr 7. pii: S0264-410X(21)00293.
    PubMed     Abstract available

  258. GRAMACHO WG, Turgeon M
    When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil.
    Vaccine. 2021 Apr 6. pii: S0264-410X(21)00396.
    PubMed     Abstract available

  259. HATZIANTONIOU S, Maltezou HC, Tsakris A, Poland GA, et al
    Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study.
    Vaccine. 2021 Apr 6. pii: S0264-410X(21)00377.

  260. DANIELS V, Saxena K, Roberts C, Kothari S, et al
    Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis.
    Vaccine. 2021 Apr 6. pii: S0264-410X(21)00428.
    PubMed     Abstract available

  261. SMITH TG, Fooks AR, Moore SM, Freuling CM, et al
    Negligible risk of rabies importation in dogs thirty days after demonstration of adequate serum antibody titer.
    Vaccine. 2021 Apr 4. pii: S0264-410X(21)00368.

  262. DION SB, Major M, Gabriela Grajales A, Nepal RM, et al
    Invasive pneumococcal disease in Canada 2010-2017: The role of current and next-generation higher-valent pneumococcal conjugate vaccines.
    Vaccine. 2021 Apr 3. pii: S0264-410X(21)00260.
    PubMed     Abstract available

  263. DONG TQ, Wakefield J
    Modeling and presentation of vaccination coverage estimates using data from household surveys.
    Vaccine. 2021 Apr 3. pii: S0264-410X(21)00275.
    PubMed     Abstract available

  264. STALPERS CAL, Retmana IA, Pennings JLA, Vandebriel RJ, et al
    Variability of in vivo potency tests of Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccines.
    Vaccine. 2021 Apr 3. pii: S0264-410X(21)00384.
    PubMed     Abstract available

  265. YAO T, Shao Z, Wu L, Dong S, et al
    Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China.
    Vaccine. 2021 Apr 2. pii: S0264-410X(21)00378.
    PubMed     Abstract available

  266. BEZERRA FSB, Silva MTO, Rezende AFS, Lopes AS, et al
    Saponin-adjuvanted recombinant vaccines containing rCP00660, rCP09720 or rCP01850 proteins against Corynebacterium pseudotuberculosis infection in mice.
    Vaccine. 2021 Apr 1. pii: S0264-410X(21)00366.
    PubMed     Abstract available

  267. DE MIRANDA LOPES KA, Baptista PN, de Medeiros Nascimento R, Pimentel A, et al
    Clinical repercussions in pertussis infants post-Tdpa vaccination of pregnant woman: An immunization success?
    Vaccine. 2021 Apr 1. pii: S0264-410X(21)00373.
    PubMed     Abstract available

  268. SUH J, Lee T, Choi JK, Lee J, et al
    The impact of two-dose varicella vaccination on varicella and herpes zoster incidence in South Korea using a mathematical model with changing population demographics.
    Vaccine. 2021 Apr 1. pii: S0264-410X(21)00349.
    PubMed     Abstract available

  269. CARR DJJ, Berube AN, Filiberti A, Gmyrek GB, et al
    Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0DeltaNLS vaccine against ocular HSV-1 challenge.
    Vaccine. 2021 Apr 1. pii: S0264-410X(21)00379.
    PubMed     Abstract available

  270. HOFFMAN BL, Colditz JB, Shensa A, Wolynn R, et al
    #DoctorsSpeakUp: Lessons learned from a pro-vaccine Twitter event.
    Vaccine. 2021 Apr 1. pii: S0264-410X(21)00365.
    PubMed     Abstract available

  271. CROWCROFT NS, Bolotin S, Li Y, Campbell H, et al
    Infant pertussis and maternal immunity: The curious case of Canada.
    Vaccine. 2021;39:1977-1981.
    PubMed     Abstract available

  272. AMIN-CHOWDHURY Z, Groves N, Sheppard CL, Litt D, et al
    Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes.
    Vaccine. 2021;39:1997-2004.
    PubMed     Abstract available

  273. QUAN DH, Counoupas C, Nagalingam G, Pinto R, et al
    Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicity.
    Vaccine. 2021;39:1990-1996.
    PubMed     Abstract available

    March 2021
  274. ERIKSSON M, Kayhty H, Lahdenkari M, Makisalo H, et al
    A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients.
    Vaccine. 2021 Mar 31. pii: S0264-410X(21)00367.
    PubMed     Abstract available

  275. KLOUWENS MJ, Salverda MLM, Trentelman JJ, Ersoz JI, et al
    Vaccination with meningococcal outer membrane vesicles carrying Borrelia OspA protects against experimental Lyme borreliosis.
    Vaccine. 2021 Mar 31. pii: S0264-410X(21)00363.
    PubMed     Abstract available

  276. AZZI L, Focosi D, Dentali F, Baj A, et al
    Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naive BNT162b2 vaccine recipients.
    Vaccine. 2021 Mar 30. pii: S0264-410X(21)00402.

  277. CHEN H, Gao Z, Bai S, Liu X, et al
    Immunogenicity and safety of sabin-strain based inactivated poliovirus vaccine replacing salk-strain based inactivated poliovirus vaccine: An innovative application of different strain-IPVs replacement.
    Vaccine. 2021 Mar 30. pii: S0264-410X(21)00264.
    PubMed     Abstract available

  278. PELTON SI, Divino V, Postma MJ, Shah D, et al
    A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season.
    Vaccine. 2021 Mar 30. pii: S0264-410X(21)00347.
    PubMed     Abstract available

  279. GUR-ARIE R, Katz MA, Hirsch A, Greenberg D, et al
    "You Have to Die Not to Come to Work": A Mixed Methods Study of Attitudes and Behaviors regarding Presenteeism, Absenteeism and Influenza Vaccination among Healthcare Personnel with Respiratory Illness in Israel, 2016-2019.
    Vaccine. 2021 Mar 29. pii: S0264-410X(21)00361.
    PubMed     Abstract available

  280. YAMAWAKI RA, Rubio MDS, Alves LBR, de Almeida AM, et al
    Evaluation of transfer of maternal immunity to the offspring of broiler breeders vaccinated with a candidate recombinant vaccine against Salmonella Enteritidis.
    Vaccine. 2021 Mar 26. pii: S0264-410X(21)00343.
    PubMed     Abstract available

  281. BAVANANTHASIVAM J, Alizadeh M, Astill J, Alqazlan N, et al
    Effects of administration of probiotic lactobacilli on immunity conferred by the herpesvirus of turkeys vaccine against challenge with a very virulent Marek's disease virus in chickens.
    Vaccine. 2021 Mar 26. pii: S0264-410X(21)00339.
    PubMed     Abstract available

  282. WIJAYANTI KE, Schutze H, MacPhail C, Braunack-Mayer A, et al
    Parents' knowledge, beliefs, acceptance and uptake of the HPV vaccine in members of The Association of Southeast Asian Nations (ASEAN): A systematic review of quantitative and qualitative studies.
    Vaccine. 2021 Mar 26. pii: S0264-410X(21)00342.
    PubMed     Abstract available

  283. KUTER BJ, Offit PA, Poland GA
    The development of COVID-19 vaccines in the United States: Why and how so fast?
    Vaccine. 2021 Mar 26. pii: S0264-410X(21)00383.

  284. RUSSO AG, Decarli A, Valsecchi MG
    Strategy to identify priority groups for COVID-19 vaccination: A population based cohort study.
    Vaccine. 2021 Mar 26. pii: S0264-410X(21)00382.
    PubMed     Abstract available

  285. LAMPONEN T, Hetemaki I, Niemi HJ, Jarva H, et al
    Heterologous boosting of nonrelated toxoid immunity during acute Puumala hantavirus infection.
    Vaccine. 2021;39:1818-1825.
    PubMed     Abstract available

  286. VREMAN S, Rebel JMJ, McCaffrey J, Ledl K, et al
    Early immune responses in skin and lymph node after skin delivery of Toll-like receptor agonists in neonatal and adult pigs.
    Vaccine. 2021;39:1857-1869.
    PubMed     Abstract available

  287. WAN C, Gao C, Xie Q, Wang Y, et al
    Flagella hook protein FlgE is a novel vaccine candidate of Pseudomonas aeruginosa identified by a genomic approach.
    Vaccine. 2021 Mar 25. pii: S0264-410X(21)00344.
    PubMed     Abstract available

  288. NGUYEN KH, Santibanez TA, Stokley S, Lindley MC, et al
    Parental vaccine hesitancy and its association with adolescent HPV vaccination.
    Vaccine. 2021 Mar 25. pii: S0264-410X(21)00341.

  289. GKENTZI D, Aggelopoulos K, Karatza A, Sinopidis X, et al
    Influenza vaccination among caregivers and household contacts of children with asthma.
    Vaccine. 2021 Mar 25. pii: S0264-410X(21)00325.
    PubMed     Abstract available

  290. MPHAHLELE MJ, Groome MJ, Page NA, Bhagwandin N, et al
    A decade of rotavirus vaccination in Africa - Saving lives and changing the face of diarrhoeal diseases: Report of the 12(th) African Rotavirus Symposium.
    Vaccine. 2021 Mar 25. pii: S0264-410X(21)00282.
    PubMed     Abstract available

  291. SALMON DA, Dudley MZ, Brewer J, Kan L, et al
    COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization.
    Vaccine. 2021 Mar 24. pii: S0264-410X(21)00315.
    PubMed     Abstract available

  292. MURRAY SM, McKay PF
    Chlamydia trachomatis: Cell biology, immunology and vaccination.
    Vaccine. 2021 Mar 24. pii: S0264-410X(21)00326.
    PubMed     Abstract available

  293. BEISSBARTH J, Wilson N, Arrowsmith B, Binks MJ, et al
    Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines
    Vaccine. 2021 Mar 23. pii: S0264-410X(21)00311.
    PubMed     Abstract available

  294. ROSA SS, Prazeres DMF, Azevedo AM, Marques MPC, et al
    mRNA vaccines manufacturing: Challenges and bottlenecks.
    Vaccine. 2021 Mar 23. pii: S0264-410X(21)00319.
    PubMed     Abstract available

  295. HAEDER SF
    Joining the herd? U.S. public opinion and vaccination requirements across educational settings during the COVID-19 pandemic.
    Vaccine. 2021 Mar 23. pii: S0264-410X(21)00348.
    PubMed     Abstract available

  296. ANGELIS A, Darrow J
    Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines.
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00346.

  297. KOCHHAR S, Dube E, Graham J, Jee Y, et al
    COVID-19 vaccine safety questions and answers for healthcare providers (CONSIDER).
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00364.

  298. ZHANG Y, Li D, Zhao H, Wang L, et al
    The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response.
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00371.

  299. ANTONELLI INCALZI R, Trevisan C, Del Signore S, Volpato S, et al
    Are vaccines against COVID-19 tailored to the most vulnerable people?
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00370.

  300. KENDAL A
    Safety monitoring of COVID-19 vaccines - Lessons learned from the 1976 national influenza immunization program about detecting rare vaccine-related severe adverse events in emergency mass-vaccination programs.
    Vaccine. 2021 Mar 20. pii: S0264-410X(21)00283.

  301. CHEN D, Ye Z, Pi Z, Mizukami S, et al
    Cost-effectiveness of dual influenza and pneumococcal vaccination among the elderly in Shenzhen, China.
    Vaccine. 2021 Mar 20. pii: S0264-410X(21)00324.
    PubMed     Abstract available

  302. VILCHES TN, Zhang K, Van Exan R, Langley JM, et al
    Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada.
    Vaccine. 2021 Mar 20. pii: S0264-410X(21)00362.
    PubMed     Abstract available

    A half-century of meningococcal vaccines.
    Vaccine. 2021 Mar 19. pii: S0264-410X(21)00292.
    PubMed     Abstract available

  304. EL BARA A, Pivert A, Veillon P, Ng Wing Sang C, et al
    From national HBV and HDV screenings to vaccination and treatment in healthcare workers: The Mauritanian pilot study.
    Vaccine. 2021 Mar 19. pii: S0264-410X(21)00279.
    PubMed     Abstract available

  305. ZHANG Z, Pan J, Chen M, Zhang T, et al
    Seroepidemiology of pertussis in China: A population-based, cross-sectional study.
    Vaccine. 2021;39:1687-1692.
    PubMed     Abstract available

  306. RANE MS, Page LC, McVeigh E, Miller K, et al
    Improving adolescent human papillomavirus (HPV) immunization uptake in school-based health centers through awareness campaigns.
    Vaccine. 2021;39:1765-1772.
    PubMed     Abstract available

  307. KHANNA M, Rady H, Dai G, Ramsay AJ, et al
    Intranasal boosting with MVA encoding secreted mycobacterial proteins Ag85A and ESAT-6 generates strong pulmonary immune responses and protection against M. tuberculosis in mice given BCG as neonates.
    Vaccine. 2021;39:1780-1787.
    PubMed     Abstract available

  308. TEMPLE B, Nation ML, Dai VTT, Beissbarth J, et al
    Effect of a 2+1 schedule of ten-valent versus 13-valent pneumococcal conjugate vaccine on pneumococcal carriage: Results from a randomised controlled trial in Vietnam.
    Vaccine. 2021 Mar 18. pii: S0264-410X(21)00223.
    PubMed     Abstract available

  309. NWOGU IB, Jones M, Langley T
    Economic evaluation of meningococcal serogroup B (MenB) vaccines: A systematic review.
    Vaccine. 2021 Mar 18. pii: S0264-410X(21)00229.
    PubMed     Abstract available

  310. BROWN DR, Joura EA, Yen GP, Kothari S, et al
    Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence.
    Vaccine. 2021 Mar 17. pii: S0264-410X(20)31564.
    PubMed     Abstract available

  311. PHUA LC, Choi HCW, Wu J, Jit M, et al
    Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00321.
    PubMed     Abstract available

  312. AGOCS M, Ismail A, Kamande K, Tabu C, et al
    Reasons why children miss vaccinations in Western Kenya; A step in a five-point plan to improve routine immunization.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00262.
    PubMed     Abstract available

  313. CAMBOU MC, Copeland TP, Nielsen-Saines K, Macinko J, et al
    Insurance status predicts self-reported influenza vaccine coverage among pregnant women in the United States: A cross-sectional analysis of the National Health Interview Study Data from 2012 to 2018.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00294.
    PubMed     Abstract available

  314. HAMIDI A, Hoeksema F, Velthof P, Lemckert A, et al
    Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00312.
    PubMed     Abstract available

  315. UEKI S, Matsunaka E, Takao K, Kitao M, et al
    The effectiveness of vibratory stimulation in reducing pain in children receiving vaccine injection: A randomized controlled trial.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00281.
    PubMed     Abstract available

  316. SZIGETI R, Kellermayer R
    Natural unblinding of BCG vaccination trials.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00320.
    PubMed     Abstract available

  317. GRAUPENSPERGER S PHD, Abdallah DA, Lee CM
    Social norms and vaccine uptake: College students' COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00286.
    PubMed     Abstract available

  318. STEIMLE LN, Havumaki J, Eisenberg MC, Eisenberg JNS, et al
    Cost-effectiveness of pediatric norovirus vaccination in daycare settings.
    Vaccine. 2021 Mar 16. pii: S0264-410X(21)00257.
    PubMed     Abstract available

  319. SUSARLA SK, Palkar S, Sv PS, Diwan A, et al
    Safety and immunogenicity of inactivated hepatitis-A vaccine developed by Human Biologicals Institute in two age groups of healthy subjects: A phase I open label study.
    Vaccine. 2021 Mar 16. pii: S0264-410X(21)00280.
    PubMed     Abstract available

  320. DEERIN JF, Clifton R, Elmi A, Lewis PE, et al
    Hepatitis B birth dose vaccination patterns in the military health System, 2014-2018.
    Vaccine. 2021 Mar 16. pii: S0264-410X(21)00278.
    PubMed     Abstract available

  321. ALLINGTON D, McAndrew S, Moxham-Hall VL, Duffy B, et al
    Media usage predicts intention to be vaccinated against SARS-CoV-2 in the US and the UK.
    Vaccine. 2021 Mar 16. pii: S0264-410X(21)00234.
    PubMed     Abstract available

  322. CHOI UY, Kim KH, Lee KY, Kim JH, et al
    Active-controlled phase III study of an egg-cultivated quadrivalent inactivated split-virion influenza vaccine (GC3110A) in healthy Korean children aged 6-35 months.
    Vaccine. 2021 Mar 15. pii: S0264-410X(21)00273.
    PubMed     Abstract available

  323. HARRISON GBL, Heath DD, Robinson CM, Lawrence SB, et al
    Combined use of two separate but protective vaccine antigens provides protection against Taenia ovis infection in lambs in the presence of protective maternal antibody.
    Vaccine. 2021 Mar 15. pii: S0264-410X(21)00308.
    PubMed     Abstract available

  324. MOLODECKY NA, Usman A, Javaid A, Wahdan A, et al
    Quantifying movement patterns and vaccination status of high risk mobile populations in Pakistan and Afghanistan to inform poliovirus risk and vaccination strategy.
    Vaccine. 2021 Mar 15. pii: S0264-410X(21)00269.
    PubMed     Abstract available

  325. HABIB MA, Prymula R, Carryn S, Esposito S, et al
    Correlation of protection against varicella in a randomized Phase III varicella-containing vaccine efficacy trial in healthy infants.
    Vaccine. 2021 Mar 15. pii: S0264-410X(21)00265.
    PubMed     Abstract available

  326. NET P, Colrat F, Nascimento Costa M, Bianic F, et al
    Estimating public health and economic benefits along 10 years of Fluzone(R) High Dose in the United States.
    Vaccine. 2021;39 Suppl 1:A56-A69.
    PubMed     Abstract available

  327. FERREIRA MN, Netto EM, Nascimento-Carvalho CM
    The impact of 10-valent pneumococcal conjugate vaccine upon hospitalization rate of children with pneumonia in different Brazilian administrative regions.
    Vaccine. 2021 Mar 14. pii: S0264-410X(21)00231.
    PubMed     Abstract available

  328. WILLIAMSON JD, Gould KG, Brown K
    Richard Pfeiffer's typhoid vaccine and Almroth Wright's claim to priority.
    Vaccine. 2021 Mar 13. pii: S0264-410X(21)00285.
    PubMed     Abstract available

  329. RIGHOLT CH, Pabla G, Donelle J, Brna P, et al
    Vaccine coverage among children with epilepsy in two Canadian provinces: A Canadian immunization research network study.
    Vaccine. 2021 Mar 13. pii: S0264-410X(21)00277.
    PubMed     Abstract available

    Developing standard safety outcomes for COVID-19 vaccines.
    Vaccine. 2021 Mar 12. pii: S0264-410X(21)00272.

  331. THANAWASTIEN A, Joyce KE, Cartee RT, Haines LA, et al
    Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid.
    Vaccine. 2021;39:1652-1660.
    PubMed     Abstract available

  332. LEE J, Li Y, Li Y, Cino-Ozuna AG, et al
    Bat influenza vectored NS1-truncated live vaccine protects pigs against heterologous virus challenge.
    Vaccine. 2021 Mar 11. pii: S0264-410X(21)00268.
    PubMed     Abstract available

  333. BERTRAN K, Kassa A, Criado MF, Nunez IA, et al
    Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses.
    Vaccine. 2021 Mar 11. pii: S0264-410X(21)00266.
    PubMed     Abstract available

  334. EBAMA MS, Chu SY, Azziz-Baumgartner E, Lafond KE, et al
    Ancillary benefits of seasonal influenza vaccination in middle-income countries.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00228.
    PubMed     Abstract available

  335. GBENEWEI E, Nomhwange T, Taiwo L, Ayodeji I, et al
    Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00258.
    PubMed     Abstract available

  336. MOMOH J, Oteri AJ, Mogekwu F, Onwu N, et al
    Ensuring accountability in implementation of supplementary immunisation activities: A case study of the 2017/2018 measles vaccination campaign in Nigeria.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00259.
    PubMed     Abstract available

  337. REPERANT LA, Osterhaus ADME
    COVID-19 vaccination and critical care capacity: Perilous months ahead.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00316.

  338. WENTZELL E, Racila AM
    The social experience of participation in a COVID-19 vaccine trial: Subjects' motivations, others' concerns, and insights for vaccine promotion.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00317.
    PubMed     Abstract available

  339. LATKIN C, Dayton LA, Yi G, Konstantopoulos A, et al
    COVID-19 vaccine intentions in the United States, a social-ecological framework.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00238.
    PubMed     Abstract available

  340. KWAK BO, Kwon YS, Hong YJ, Shin SH, et al
    Immunogenicity and safety of the third booster dose of the inactivated Japanese encephalitis vaccine in Korean children: A prospective multicenter study.
    Vaccine. 2021 Mar 9. pii: S0264-410X(21)00267.
    PubMed     Abstract available

  341. STEFFEN CA, Henaff L, Durupt A, Omeiri NE, et al
    Evidence-informed vaccination decision-making in countries: Progress, challenges and opportunities.
    Vaccine. 2021 Mar 9. pii: S0264-410X(21)00235.
    PubMed     Abstract available

  342. GATWOOD J, Chiu CY, Shuvo S, Ramachandran S, et al
    Role of social determinants of health in pneumococcal vaccination among high-risk adults.
    Vaccine. 2021 Mar 9. pii: S0264-410X(21)00241.
    PubMed     Abstract available

  343. GUIDRY JPD, Perrin PB, Laestadius LI, Vraga EK, et al
    U.S. public support for COVID-19 vaccine donation to low- and middle-income countries during the COVID-19 pandemic.
    Vaccine. 2021 Mar 9. pii: S0264-410X(21)00306.
    PubMed     Abstract available

  344. MINTA AA, Silva MWT, Shrestha A, de Quiroz-Castro M, et al
    Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018.
    Vaccine. 2021 Mar 9. pii: S0264-410X(21)00222.
    PubMed     Abstract available

  345. SADARANGANI M, Abu Raya B, Conway JM, Iyaniwura SA, et al
    Importance of COVID-19 vaccine efficacy in older age groups.
    Vaccine. 2021 Mar 8. pii: S0264-410X(21)00288.
    PubMed     Abstract available

  346. KISZEWSKI AE, Cleary EG, Jackson MJ, Ledley FD, et al
    NIH funding for vaccine readiness before the COVID-19 pandemic.
    Vaccine. 2021 Mar 8. pii: S0264-410X(21)00290.
    PubMed     Abstract available

  347. PULLAN S, Dey M
    Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis.
    Vaccine. 2021 Mar 6. pii: S0264-410X(21)00287.
    PubMed     Abstract available

  348. DONADEL M, Panero MS, Ametewee L, Shefer AM, et al
    National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.
    Vaccine. 2021 Mar 6. pii: S0264-410X(21)00239.
    PubMed     Abstract available

  349. WILLIAMSON SL, Gadd E, Pillay T, Toldi G, et al
    Non-specific effects of BCG vaccination on neutrophil and lymphocyte counts of healthy neonates from a developed country.
    Vaccine. 2021 Mar 6. pii: S0264-410X(21)00255.
    PubMed     Abstract available

  350. HASNAN S, Tan NC
    Multi-domain narrative review of vaccine hesitancy in childhood.
    Vaccine. 2021 Mar 6. pii: S0264-410X(21)00237.
    PubMed     Abstract available

  351. BLACK SB, Law B, Chen RT, Dekker CL, et al
    The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.
    Vaccine. 2021 Mar 6. pii: S0264-410X(21)00284.
    PubMed     Abstract available

  352. PIRAS-DOUCE F, Raynal F, Raquin A, Girerd-Chambaz Y, et al
    Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models.
    Vaccine. 2021 Mar 5. pii: S0264-410X(21)00200.
    PubMed     Abstract available

  353. YOKOMICHI H, Kojima R, Horiuchi S, Ooka T, et al
    Effectiveness of influenza vaccination in infants and toddlers with and without prior infection history: The Japan Environment and Children's Study.
    Vaccine. 2021 Mar 5. pii: S0264-410X(21)00224.
    PubMed     Abstract available

  354. DU Y, Xu Y, Feng J, Hu L, et al
    Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse.
    Vaccine. 2021 Mar 5. pii: S0264-410X(21)00274.
    PubMed     Abstract available

  355. KUO H, Shapiro JR, Dhakal S, Morgan R, et al
    Sex-specific effects of age and body mass index on antibody responses to seasonal influenza vaccines in healthcare workers.
    Vaccine. 2021 Mar 4. pii: S0264-410X(21)00227.
    PubMed     Abstract available

  356. WOO EJ, Moro PL
    Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system.
    Vaccine. 2021 Mar 4. pii: S0264-410X(21)00232.
    PubMed     Abstract available

  357. STURM L, Kasting ML, Head KJ, Hartsock JA, et al
    Influenza vaccination in the time of COVID-19: A national U.S. survey of adults.
    Vaccine. 2021 Mar 4. pii: S0264-410X(21)00271.
    PubMed     Abstract available

  358. HELMKAMP LJ, Szilagyi PG, Zimet G, Saville AW, et al
    A validated modification of the vaccine hesitancy scale for childhood, influenza and HPV vaccines.
    Vaccine. 2021 Mar 3. pii: S0264-410X(21)00206.
    PubMed     Abstract available

  359. JOURA EA, Ulied A, Vandermeulen C, Rua Figueroa M, et al
    Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45years of age compared to women 16-26years of age: An open-label phase 3 study.
    Vaccine. 2021 Mar 3. pii: S0264-410X(21)00128.
    PubMed     Abstract available

  360. WENDLAND EM, Kops NL, Bessel M, Comerlato J, et al
    Effectiveness of a universal vaccination program with an HPV quadrivalent vaccine in young Brazilian women.
    Vaccine. 2021 Mar 2. pii: S0264-410X(21)00207.
    PubMed     Abstract available

  361. FELL DB, Dimitris MC, Hutcheon JA, Ortiz JR, et al
    Guidance for design and analysis of observational studies of fetal and newborn outcomes following COVID-19 vaccination during pregnancy.
    Vaccine. 2021 Mar 2. pii: S0264-410X(21)00261.
    PubMed     Abstract available

  362. CUTTS FT, Danovaro-Holliday MC, Rhoda DA
    Challenges in measuring supplemental immunization activity coverage among measles zero-dose children.
    Vaccine. 2021;39:1359-1363.

  363. WANG Y, Huang C, Tang J, Liu G, et al
    Salmonella Pullorum spiC mutant is a desirable LASV candidate with proper virulence, high immune protection and easy-to-use oral administration.
    Vaccine. 2021;39:1383-1391.
    PubMed     Abstract available

    February 2021
  364. STANLEY M, Joura E, Yen GP, Kothari S, et al
    Systematic literature review of neutralizing antibody immune responses to non-vaccine targeted high-risk HPV types induced by the bivalent and the quadrivalent vaccines.
    Vaccine. 2021 Feb 28. pii: S0264-410X(21)00099.
    PubMed     Abstract available

  365. WANG J, Lyu Y, Zhang H, Jing R, et al
    Willingness to pay and financing preferences for COVID-19 vaccination in China.
    Vaccine. 2021 Feb 27. pii: S0264-410X(21)00240.
    PubMed     Abstract available

  366. SHEN M, Zu J, Fairley CK, Pagan JA, et al
    Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use.
    Vaccine. 2021 Feb 27. pii: S0264-410X(21)00236.
    PubMed     Abstract available

  367. BERNSTEIN DN, Alokozai A, Humbyrd CJ
    Vaccinating America's children: A job for orthopaedic surgeons & other non-primary care specialists?
    Vaccine. 2021 Feb 26. pii: S0264-410X(21)00175.

  368. AYASSE M, Ahmed A, McCullum C, Espinosa ML, et al
    Vaccines do not cause atopic dermatitis: A systematic review and meta-analysis.
    Vaccine. 2021 Feb 26. pii: S0264-410X(21)00203.
    PubMed     Abstract available

  369. WON H, Kim AR, Yoo JS, Chung GT, et al
    Cross-neutralization between vaccine and circulating wild-type mumps viruses in Korea.
    Vaccine. 2021 Feb 25. pii: S0264-410X(21)00055.
    PubMed     Abstract available

  370. ANDERSEN AR, Kolmos SK, Flanagan KL, Benn CS, et al
    Systematic review and meta-analysis of the effect of pertussis vaccine in pregnancy on the risk of chorioamnionitis, non-pertussis infectious diseases and other adverse pregnancy outcomes.
    Vaccine. 2021 Feb 25. pii: S0264-410X(21)00166.
    PubMed     Abstract available

  371. SPENCER JA, Penfound T, Salehi S, Aranha MP, et al
    Cross-reactive immunogenicity of group A streptococcal vaccines designed using a recurrent neural network to identify conserved M protein linear epitopes.
    Vaccine. 2021 Feb 25. pii: S0264-410X(21)00129.
    PubMed     Abstract available

  372. SANDBRINK JB, Koblentz GD
    Biosecurity risks associated with vaccine platform technologies.
    Vaccine. 2021 Feb 25. pii: S0264-410X(21)00171.
    PubMed     Abstract available

  373. LEE MHP, Tan CW, Tee HK, Ong KC, et al
    Vaccine candidates generated by codon and codon pair deoptimization of enterovirus A71 protect against lethal challenge in mice.
    Vaccine. 2021 Feb 24. pii: S0264-410X(21)00172.
    PubMed     Abstract available

  374. SELL TK, Gastfriend D, Watson M, Watson C, et al
    Building the global vaccine manufacturing capacity needed to respond to pandemics.
    Vaccine. 2021 Feb 24. pii: S0264-410X(21)00165.

  375. MUNOZ FM, Cramer JP, Dekker CL, Dudley MZ, et al
    Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Vaccine. 2021 Feb 23. pii: S0264-410X(21)00094.
    PubMed     Abstract available

  376. ALDAKAK L, Huber VM, Ruhli F, Bender N, et al
    Sex difference in the immunogenicity of the quadrivalent Human Papilloma Virus vaccine: Systematic review and meta-analysis.
    Vaccine. 2021 Feb 23. pii: S0264-410X(21)00170.
    PubMed     Abstract available

  377. BONANNI P, Villani A, Scotti S, Biasci P, et al
    The recommended lifetime immunization schedule from the board of vaccination calendar for life in Italy: A continuing example of impact on public health policies.
    Vaccine. 2021;39:1183-1186.
    PubMed     Abstract available

  378. VERELST F, Beutels P, Hens N, Willem L, et al
    Workplace influenza vaccination to reduce employee absenteeism: An economic analysis from the employers' perspective.
    Vaccine. 2021 Feb 22. pii: S0264-410X(21)00168.
    PubMed     Abstract available

  379. SU QD, Zou YN, Yi Y, Shen LP, et al
    Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response.
    Vaccine. 2021;39:1241-1247.
    PubMed     Abstract available

  380. BLUNCK BN, Aideyan L, Ye X, Avadhanula V, et al
    A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas.
    Vaccine. 2021;39:1248-1256.
    PubMed     Abstract available

  381. CHOI UY, Kim KH, Lee J, Eun BW, et al
    Immunogenicity and safety profiles of a new MAV/06 strain varicella vaccine in healthy children: A multinational, multicenter, randomized, double-blinded, active-controlled phase III study.
    Vaccine. 2021 Feb 21. pii: S0264-410X(21)00161.
    PubMed     Abstract available

  382. REN S, Attia J, Li SC, Newby D, et al
    Pneumococcal polysaccharide vaccine is a cost saving strategy for prevention of acute coronary syndrome.
    Vaccine. 2021 Feb 21. pii: S0264-410X(21)00167.
    PubMed     Abstract available

  383. MCPHERSON AS, Whittington RJ, Hall E, Cook EJ, et al
    A comparison of multivalent and bivalent vaccination strategies for the control of virulent ovine footrot.
    Vaccine. 2021 Feb 20. pii: S0264-410X(21)00159.
    PubMed     Abstract available

  384. KABIR A, Newall AT, Randall D, Menzies R, et al
    Estimating pneumococcal vaccine coverage among Australian Indigenous children and children with medically at-risk conditions using record linkage.
    Vaccine. 2021 Feb 20. pii: S0264-410X(21)00163.
    PubMed     Abstract available

  385. DAS SC, Price JD, Gosling K, MacLennan N, et al
    Liposome engraftment and antigen combination potentiate the immune response towards conserved epitopes of the malaria vaccine candidate MSP2.
    Vaccine. 2021 Feb 20. pii: S0264-410X(21)00158.
    PubMed     Abstract available

  386. SAUER M, Vasudevan P, Meghani A, Luthra K, et al
    Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries.
    Vaccine. 2021 Feb 19. pii: S0264-410X(21)00107.
    PubMed     Abstract available

  387. CHOI J, Jo HJ, Jung SS, Choi J, et al
    Evaluation of swine protection with foot-and-mouth disease O1/Campos and O/Primorsky/2014 vaccines against the O Mya-98 lineage virus from East Asia.
    Vaccine. 2021 Feb 19. pii: S0264-410X(21)00173.
    PubMed     Abstract available

  388. ORTIZ JR, Robertson J, Hsu JS, Yu SL, et al
    The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region.
    Vaccine. 2021 Feb 19. pii: S0264-410X(21)00204.
    PubMed     Abstract available

  389. DENG L, Danchin M, Lewis G, Cheung A, et al
    Revaccination outcomes of children with vaccine proximate seizures.
    Vaccine. 2021 Feb 18. pii: S0264-410X(21)00164.
    PubMed     Abstract available

  390. MARTINON-TORRES F, Halperin SA, Nolan T, Tapiero B, et al
    Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.
    Vaccine. 2021 Feb 18. pii: S0264-410X(21)00130.
    PubMed     Abstract available

  391. CHANG LJ, Anderson EJ, Jeanfreau R, He Y, et al
    Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6months through<18years of age: A randomized controlled phase II dose-finding trial.
    Vaccine. 2021 Feb 18. pii: S0264-410X(21)00162.
    PubMed     Abstract available

  392. CONSTANTINOU CA, Ziogas DC, Venetsanopoulou A, Gamaletsou MN, et al
    A clinical audit of pneumococcal vaccination among patients with autoimmune rheumatic diseases living in Greece: The power of awareness.
    Vaccine. 2021 Feb 17. pii: S0264-410X(21)00157.
    PubMed     Abstract available

  393. PALMU AA, De Wals P, Toropainen M, Ladhani SN, et al
    Similar impact and replacement disease after pneumococcal conjugate vaccine introduction in hospitalised children with invasive pneumococcal disease in Europe and North America.
    Vaccine. 2021 Feb 17. pii: S0264-410X(21)00111.
    PubMed     Abstract available

  394. KUTER BJ, Browne S, Momplaisir FM, Feemster KA, et al
    Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia.
    Vaccine. 2021 Feb 16. pii: S0264-410X(21)00185.
    PubMed     Abstract available

  395. JUSTE RA, Geijo MV, Elguezabal N, Sevilla IA, et al
    Paratuberculosis vaccination specific and non-specific effects on cattle lifespan.
    Vaccine. 2021 Feb 15. pii: S0264-410X(21)00097.
    PubMed     Abstract available

  396. WU MJ, Chung JR, Kim SS, Jackson ML, et al
    Influenza vaccination coverage among persons seeking outpatient medical care for acute respiratory illness in five states in the United States, 2011-2012 through 2018-2019.
    Vaccine. 2021 Feb 15. pii: S0264-410X(21)00106.
    PubMed     Abstract available

  397. TZANAKAKI G, Xirogianni A, Tsitsika A, Clark SA, et al
    Estimated strain coverage of serogroup B meningococcal vaccines: A retrospective study for disease and carrier strains in Greece (2010-2017).
    Vaccine. 2021 Feb 14. pii: S0264-410X(21)00127.
    PubMed     Abstract available

  398. RID A, Shah SK, Miller FG, Danis M, et al
    Ethical trade-offs in vaccine development and distribution-Response to Gurwitz.
    Vaccine. 2021;39:1028-1029.

  399. GURWITZ D
    Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries.
    Vaccine. 2021;39:1027.

  400. MCALISTER SM, van den Biggelaar AHJ, Woodman TL, Hutton H, et al
    An observational study of antibody responses to a primary or subsequent pertussis booster vaccination in Australian healthcare workers.
    Vaccine. 2021 Feb 12. pii: S0264-410X(21)00068.
    PubMed     Abstract available

  401. NICACIO AAMF, Peracchi OAB, Yamada J, Fraga MM, et al
    Tdap booster to adolescents with juvenile idiopathic arthritis on and off anti-TNF agents is safe and immunogenic.
    Vaccine. 2021;39:1165-1172.
    PubMed     Abstract available

  402. HAI NM, Dung ND, Pho DC, Son VT, et al
    Immunogenicity, safety and reactogenicity of ROTAVAC(R) in healthy infants aged 6-8 weeks in Vietnam.
    Vaccine. 2021;39:1140-1147.
    PubMed     Abstract available

  403. DOCKRELL HM, Butkeviciute E
    Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine?
    Vaccine. 2021 Feb 11. pii: S0264-410X(21)00109.
    PubMed     Abstract available

  404. KHETSURIANI N, Zaika O, Chitadze N, Slobodianyk L, et al
    Seroprevalence of hepatitis B virus infection markers among children in Ukraine, 2017.
    Vaccine. 2021 Feb 11. pii: S0264-410X(21)00133.
    PubMed     Abstract available

  405. LIN J, Dobbins T, Wood JG, Bernardo C, et al
    Effectiveness of the live-attenuated herpes zoster vaccine 2 years after its introduction in Australia.
    Vaccine. 2021 Feb 10. pii: S0264-410X(21)00108.
    PubMed     Abstract available

  406. WARD BJ, Seguin A, Couillard J, Trepanier S, et al
    Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18-49 years of age.
    Vaccine. 2021 Feb 10. pii: S0264-410X(21)00004.
    PubMed     Abstract available

  407. POLAND CM, Matthews AKS, Poland GA
    Improving COVID-19 vaccine acceptance: Including insights from human decision-making under conditions of uncertainty and human-centered design.
    Vaccine. 2021 Feb 10. pii: S0264-410X(21)00154.

  408. BRUCE-STASKAL PJ, Woods RM, Borisov OV, Massare MJ, et al
    Corrigendum to "Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonance" [Vaccine 38(43) (2020) 6757-6765].
    Vaccine. 2021 Feb 9. pii: S0264-410X(21)00105.

  409. CHU L, McPhee R, Huang W, Bennett H, et al
    A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine.
    Vaccine. 2021 Feb 9. pii: S0264-410X(21)00153.
    PubMed     Abstract available

  410. VULPE SN, Rughinis C
    Social amplification of risk and "probable vaccine damage": A typology of vaccination beliefs in 28 European countries.
    Vaccine. 2021 Feb 8. pii: S0264-410X(21)00102.
    PubMed     Abstract available

  411. SINGH A
    Why not the 'marker' or DIVA vaccines for the control of emerging infectious diseases of humans?
    Vaccine. 2021 Feb 8. pii: S0264-410X(21)00110.

  412. ROBINSON E, Jones A, Lesser I, Daly M, et al
    International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples.
    Vaccine. 2021 Feb 6. pii: S0264-410X(21)00140.
    PubMed     Abstract available

  413. BAUER BU, Knittler MR, Prufer TL, Wolf A, et al
    Humoral immune response to Q fever vaccination of three sheep flocks naturally pre-infected with Coxiella burnetii.
    Vaccine. 2021 Feb 5. pii: S0264-410X(21)00101.
    PubMed     Abstract available

  414. DUDLEY MZ, Taitel MS, Smith-Ray R, Singh T, et al
    Effect of educational and financial incentive-based interventions on immunization attitudes, beliefs, intentions and receipt among close contacts of pregnant women.
    Vaccine. 2021;39:961-967.
    PubMed     Abstract available

  415. HODGKINSON B, Wang T, Byrnes J, Scuffham P, et al
    Modelling a cost-effective vaccination strategy for the prevention of varicella and herpes zoster infection: A systematic review.
    Vaccine. 2021 Feb 4. pii: S0264-410X(21)00100.
    PubMed     Abstract available

  416. SPANOS KE, Kraschnewski JL, Moss JL, Wong A, et al
    Parent support for social media standards combatting vaccine misinformation.
    Vaccine. 2021 Feb 4. pii: S0264-410X(21)00005.
    PubMed     Abstract available

  417. PINPATHOMRAT N, Bull N, Pasricha J, Harrington-Kandt R, et al
    Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model.
    Vaccine. 2021 Feb 3. pii: S0264-410X(21)00050.
    PubMed     Abstract available

  418. DIACO M, Chang LJ, Seet B, Robertson CA, et al
    Introductory paper: High dose influenza vaccine.
    Vaccine. 2021 Feb 3. pii: S0264-410X(20)31147.
    PubMed     Abstract available

  419. BABAKURA B, Nomhwange T, Jean Baptiste AE, Dede O, et al
    The challenges of insecurity on implementing vaccination campaign and its effect on measles elimination and control efforts: A case study of 2017/18 measles campaign in Borno state, Nigeria.
    Vaccine. 2021 Feb 2. pii: S0264-410X(21)00040.
    PubMed     Abstract available

  420. SATO R, Thompson A, Sani I, Metiboba L, et al
    Effect of Vaccine Direct Delivery (VDD) on vaccine stockouts and number of vaccinations: Case study from Bauchi State, Nigeria.
    Vaccine. 2021 Feb 1. pii: S0264-410X(21)00053.
    PubMed     Abstract available

  421. GAO J, Tang F, Wang Z, Yu J, et al
    Post-marketing safety surveillance for inactivated Enterovirus 71 vaccines in Jiangsu, China from 2017 to 2019.
    Vaccine. 2021 Feb 1. pii: S0264-410X(21)00075.
    PubMed     Abstract available

  422. WILCK MB, Jin Xu Z, Stek JE, Goveia MG, et al
    Protective immune responses against Haemophilus influenza type B elicited by a fully-liquid DTaP-IPV-Hib-HepB vaccine (VAXELIS).
    Vaccine. 2021 Feb 1. pii: S0264-410X(21)00073.
    PubMed     Abstract available

    January 2021
  423. AXELSEN PH, Poland GA
    Vaccines, masks, distancing and credibility: An urgent warning for pandemic management.
    Vaccine. 2021 Jan 31. pii: S0264-410X(21)00079.

  424. LIU Y, Li W, Dong Q, Chen M, et al
    Non-linear relationships between children age and pneumococcal vaccine coverage: Important implications for vaccine prevention strategies.
    Vaccine. 2021 Jan 30. pii: S0264-410X(21)00095.
    PubMed     Abstract available

  425. LUANGASANATIP N, Mahikul W, Poovorawan K, Cooper BS, et al
    Cost-effectiveness and budget impact analyses for the prioritisation of the four available rotavirus vaccines in the national immunisation programme in Thailand.
    Vaccine. 2021 Jan 30. pii: S0264-410X(21)00078.
    PubMed     Abstract available

  426. D'ARCO C, McCormick AA, Arnaboldi PM
    Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection.
    Vaccine. 2021 Jan 30. pii: S0264-410X(21)00067.
    PubMed     Abstract available

  427. ANDANI A, van Damme P, Bunge EM, Salgado F, et al
    One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: A systematic review.
    Vaccine. 2021 Jan 29. pii: S0264-410X(21)00054.
    PubMed     Abstract available

  428. XU W, Yang M
    Genetic variation and evolution of foot-and-mouth disease virus serotype A in relation to vaccine matching.
    Vaccine. 2021 Jan 29. pii: S0264-410X(21)00069.
    PubMed     Abstract available

  429. COLRAT F, Thommes E, Largeron N, Alvarez FP, et al
    Economic evaluation of high-dose inactivated influenza vaccine in adults aged >/=65 years: A systematic literature review.
    Vaccine. 2021 Jan 29. pii: S0264-410X(20)31603.
    PubMed     Abstract available

  430. HAMPTON LM, Aggarwal R, Evans SJW, Law B, et al
    General determination of causation between Covid-19 vaccines and possible adverse events.
    Vaccine. 2021 Jan 29. pii: S0264-410X(21)00096.

  431. KROLIK M, Csepregi L, Hartmann F, Engetschwiler C, et al
    Recombinant lymphocytic choriomeningitis virus-based vaccine vector protects type I interferon receptor deficient mice from viral challenge.
    Vaccine. 2021 Jan 28. pii: S0264-410X(21)00074.
    PubMed     Abstract available

  432. SORUP S, Englund H, Laake I, Nieminen H, et al
    Revaccination with measles-mumps-rubella vaccine and hospitalization for infection in Denmark and Sweden - An interrupted time-series analysis.
    Vaccine. 2021 Jan 28. pii: S0264-410X(21)00044.
    PubMed     Abstract available

  433. SEREMBA E, Ocama P, Ssekitoleko R, Mayanja-Kizza H, et al
    Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda.
    Vaccine. 2021 Jan 27. pii: S0264-410X(21)00070.
    PubMed     Abstract available

  434. LI AJ, Kyesi F, Mwengee W, Mphuru A, et al
    Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania's national HPV vaccine introduction.
    Vaccine. 2021 Jan 25. pii: S0264-410X(21)00052.

  435. LY TDA, Castaneda S, Hoang VT, Dao TL, et al
    Vaccine-preventable diseases other than tuberculosis, and homelessness: A scoping review of the published literature, 1980 to 2020.
    Vaccine. 2021 Jan 25. pii: S0264-410X(21)00051.
    PubMed     Abstract available

  436. JONSSON G, Hansson C, Mellhammar L, Gullstrand B, et al
    Increased serum bactericidal activity of autologous serum in C2 deficiency after vaccination against Haemophilus influenzae type b, and further support for an MBL-dependent C2 bypass mechanism.
    Vaccine. 2021 Jan 25. pii: S0264-410X(21)00007.
    PubMed     Abstract available

  437. BELCHER T, Kammoun H, Coutte L, Debrie AS, et al
    Live attenuated Bordetella pertussis vaccine candidate BPZE1 transiently protects against lethal pneumococcal disease in mice.
    Vaccine. 2021 Jan 25. pii: S0264-410X(21)00041.
    PubMed     Abstract available

  438. KIM SH, Paldurai A, Xiao S, Collins PL, et al
    Retraction notice to "Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens" [Vaccine 32(35) (2014) 4428-4435].
    Vaccine. 2021;39:775.

  439. KNOBEL DL, Arega SM, Conan A
    Sex-differential non-specific effects of rabies vaccine in dogs: An extended analysis of a randomized controlled trial in a high-mortality population.
    Vaccine. 2021 Jan 22. pii: S0264-410X(21)00045.
    PubMed     Abstract available

  440. AMANI A, Tatang CA, Bayiha CN, Woung M, et al
    A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in Cameroon.
    Vaccine. 2021 Jan 22. pii: S0264-410X(21)00021.
    PubMed     Abstract available

  441. HUTTON DW, McCullough JS, Prosser L, Ye W, et al
    Costs implications of pneumococcal vaccination of adults aged 30-60 with a recent diagnosis of diabetes.
    Vaccine. 2021 Jan 22. pii: S0264-410X(20)31535.
    PubMed     Abstract available

  442. OKOLI GN, Racovitan F, Abdulwahid T, Righolt CH, et al
    Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studie
    Vaccine. 2021 Jan 22. pii: S0264-410X(21)00048.
    PubMed     Abstract available

  443. FRIEDMAN-KLABANOFF DJ, Berry AA, Travassos MA, Cox C, et al
    Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing.
    Vaccine. 2021 Jan 22. pii: S0264-410X(20)31590.
    PubMed     Abstract available

  444. JAMROZIK E, Littler K, Bull S, Emerson C, et al
    Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.
    Vaccine. 2021;39:633-640.
    PubMed     Abstract available

  445. MENZIES R, Stein AN, Booy R, Van Buynder PG, et al
    The impact of the changing pneumococcal national immunisation program among older Australians.
    Vaccine. 2021;39:720-728.
    PubMed     Abstract available

  446. COX AD, Kuo Lee R, Ulanova M, Bruce MG, et al
    Proceedings of a workshop to discuss the epidemiology of invasive Haemophilus influenzae disease with emphasis on serotype a and b in the Americas, 2019.
    Vaccine. 2021;39:627-632.
    PubMed     Abstract available

  447. JIANG R, Liu X, Sun X, Wang J, et al
    Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase IV clinical trial for the vaccination of a large population.
    Vaccine. 2021 Jan 21. pii: S0264-410X(21)00043.
    PubMed     Abstract available

  448. KLASSEN AC, Milliron BJ, Reynolds L, Bakhtibekova Z, et al
    Formative research to address vaccine hesitancy in Tajikistan.
    Vaccine. 2021 Jan 21. pii: S0264-410X(21)00049.
    PubMed     Abstract available

  449. ALDRICH C, Leroux-Roels I, Huang KB, Bica MA, et al
    Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial.
    Vaccine. 2021 Jan 21. pii: S0264-410X(20)31667.
    PubMed     Abstract available

  450. NIYIBITEGEKA F, Riewpaiboon A, Youngkong S, Thavorncharoensap M, et al
    Economic analysis for national immunization program planning: A case of rotavirus vaccines in Burundi.
    Vaccine. 2021 Jan 21. pii: S0264-410X(21)00047.
    PubMed     Abstract available

  451. HAYMAN B, Bowles A, Evans B, Eyermann E, et al
    Advancing innovation for vaccine manufacturers from developing countries: Prioritization, barriers, opportunities.
    Vaccine. 2021 Jan 21. pii: S0264-410X(21)00009.
    PubMed     Abstract available

  452. POLAND EG, McGuire DK, Ratishvili T, Poland GA, et al
    The economics of global COVID vaccine administration during a pandemic - Why continue skin alcohol preparation as a costly but ineffective practice?
    Vaccine. 2021 Jan 20. pii: S0264-410X(20)31694.

  453. WINOKUR P, El Sahly HM, Mulligan MJ, Frey SE, et al
    Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older.
    Vaccine. 2021 Jan 20. pii: S0264-410X(20)31504.
    PubMed     Abstract available

  454. JAS D, Frances-Duvert V, Brunet S, Oberli F, et al
    Evaluation of safety and immunogenicity of feline vaccines with reduced volume.
    Vaccine. 2021 Jan 20. pii: S0264-410X(21)00042.
    PubMed     Abstract available

  455. MUGO N, Eckert LO, Odero L, Gakuo S, et al
    Antibody responses to prophylactic quadrivalent human papillomavirus vaccine at 48 months among HIV-infected girls and boys ages 9-14 in Kenya, Africa.
    Vaccine. 2021 Jan 20. pii: S0264-410X(20)31587.
    PubMed     Abstract available

  456. BALASUBRAMANI GK, Zimmerman RK, Eng H, Lyons J, et al
    Comparison of local influenza vaccine effectiveness using two methods.
    Vaccine. 2021 Jan 20. pii: S0264-410X(21)00017.
    PubMed     Abstract available

  457. DAL-RE R
    US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine.
    Vaccine. 2021 Jan 20. pii: S0264-410X(21)00077.

  458. LOIACONO MM, Pool V, van Aalst R
    DTaP combination vaccine use and adherence: A retrospective cohort study.
    Vaccine. 2021 Jan 19. pii: S0264-410X(21)00013.
    PubMed     Abstract available

  459. CAO L, Lou J, Zhao S, Chan RWY, et al
    In silico prediction of influenza vaccine effectiveness by sequence analysis.
    Vaccine. 2021 Jan 19. pii: S0264-410X(21)00006.
    PubMed     Abstract available

  460. EINARSDOTTIR S, Nicklasson M, Veje M, Bergstrom T, et al
    Vaccination against tick-borne encephalitis (TBE) after autologous and allogeneic stem cell transplantation.
    Vaccine. 2021 Jan 19. pii: S0264-410X(20)31670.
    PubMed     Abstract available

  461. BROCATO RL, Kwilas SA, Josleyn MD, Long S, et al
    Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccines.
    Vaccine. 2021 Jan 19. pii: S0264-410X(21)00002.
    PubMed     Abstract available

  462. REEMERS S, Verstegen I, Basten S, Hubers W, et al
    A broad spectrum HVT-H5 avian influenza vector vaccine which induces a rapid onset of immunity.
    Vaccine. 2021 Jan 19. pii: S0264-410X(21)00022.
    PubMed     Abstract available

  463. FATOBA AJ, Maharaj L, Adeleke VT, Okpeku M, et al
    Immunoinformatics prediction of overlapping CD8(+) T-cell, IFN-gamma and IL-4 inducer CD4(+) T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2).
    Vaccine. 2021 Jan 18. pii: S0264-410X(21)00003.
    PubMed     Abstract available

  464. SCOTT EM, Stein R, Brown MF, Hershberger J, et al
    Vaccination patterns of the northeast Ohio Amish revisited.
    Vaccine. 2021 Jan 18. pii: S0264-410X(21)00026.
    PubMed     Abstract available

  465. OTERI J, Idi Hussaini M, Bawa S, Ibizugbe S, et al
    Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria.
    Vaccine. 2021 Jan 18. pii: S0264-410X(21)00025.
    PubMed     Abstract available

  466. SOHN S, Hong K, Hwang H, Chun BC, et al
    Paradoxical health care utilization patterns among children in Korea who did not receive mandatory pneumococcal vaccination.
    Vaccine. 2021 Jan 18. pii: S0264-410X(21)00016.
    PubMed     Abstract available

  467. XU C, Lau CL, Clark J, Rafferty AC, et al
    Immunogenicity after pre- and post-exposure rabies vaccination: A systematic review and dose-response meta-analysis.
    Vaccine. 2021 Jan 18. pii: S0264-410X(21)00039.
    PubMed     Abstract available

  468. WHITAKER JA, Parikh SA, Shanafelt TD, Kay NE, et al
    The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL).
    Vaccine. 2021 Jan 15. pii: S0264-410X(21)00001.
    PubMed     Abstract available

  469. MOGEKWU FI, Oteri JA, Nsubuga P, Ezebilo O, et al
    Using data to improve outcomes of supplemental immunisation activities: 2017/2018 Nigeria measles vaccination campaign.
    Vaccine. 2021 Jan 15. pii: S0264-410X(20)31659.
    PubMed     Abstract available

  470. ZHAO X, Zeng X, Dai Q, Hou Y, et al
    Immunogenicity and protection efficacy of a Salmonella enterica serovar Typhimurium fnr, arcA and fliC mutant.
    Vaccine. 2021;39:588-595.
    PubMed     Abstract available

  471. VAN DEN BOOGAARD J, de Gier B, de Oliveira Bressane Lima P, Desai S, et al
    Immunogenicity, duration of protection, effectiveness and safety of rubella containing vaccines: A systematic literature review and meta-analysis.
    Vaccine. 2021 Jan 13. pii: S0264-410X(20)31691.
    PubMed     Abstract available

  472. WHITWORTH HS, Schiller J, Markowitz LE, Jit M, et al
    Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose schedule.
    Vaccine. 2021 Jan 13. pii: S0264-410X(20)31598.

  473. OTERI J, Bawa S, Christopher E, Nsubuga P, et al
    Potential for improving routine immunisation waste management using measles vaccination campaign 2017 in Kebbi State, Nigeria.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31654.
    PubMed     Abstract available

  474. ATSMON J, Machluf N, Yagon-Gur V, Sabbah C, et al
    Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine in healthy young adults: Results from a Phase IV study.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31630.
    PubMed     Abstract available

  475. YANG R, Liu Q, Pang W, Gao F, et al
    Two immunogenic recombinant protein vaccine candidates showed disparate protective efficacy against Zika virus infection in rhesus macaques.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31674.
    PubMed     Abstract available

  476. ARCON N, Picchio MS, Fenoy IM, Moretta RE, et al
    Synergistic effect of GRA7 and profilin proteins in vaccination against chronic Toxoplasma gondii infection.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31669.
    PubMed     Abstract available

  477. GUALANO MR, Corradi A, Voglino G, Catozzi D, et al
    Healthcare Workers' (HCWs) attitudes towards mandatory influenza vaccination: A systematic review and meta-analysis.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31655.
    PubMed     Abstract available

  478. AKMATOV MK, Holstiege J, Steffen A, Batzing J, et al
    Utilization of influenza vaccination among chronically ill individuals in Germany: A nationwide claims-based analysis.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31693.
    PubMed     Abstract available

  479. FENTON ATHR, Orefice C, Eun TJ, Biancarelli D, et al
    Effect of provider recommendation style on the length of adolescent vaccine discussions.
    Vaccine. 2021 Jan 11. pii: S0264-410X(20)31441.
    PubMed     Abstract available

  480. KORNUTA CA, Langellotti CA, Bidart JE, Soria I, et al
    A plasmid encoding the extracellular domain of CD40 ligand and Montanide GEL01 as adjuvants enhance the immunogenicity and the protection induced by a DNA vaccine against BoHV-1.
    Vaccine. 2021 Jan 11. pii: S0264-410X(20)31553.
    PubMed     Abstract available

  481. SANTANA CP, Luhm KR, Shimakura SE
    Impact of Tdap vaccine during pregnancy on the incidence of pertussis in children under one year in Brazil - A time series analysis.
    Vaccine. 2021 Jan 11. pii: S0264-410X(20)31636.
    PubMed     Abstract available

  482. ACKERSON B, Qian L, Sy LS, Bruxvoort K, et al
    Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older.
    Vaccine. 2021 Jan 11. pii: S0264-410X(20)31673.
    PubMed     Abstract available

  483. BURGER AE, Reither EN, Mamelund SE, Lim S, et al
    Black-white disparities in 2009 H1N1 vaccination among adults in the United States: A cautionary tale for the COVID-19 pandemic.
    Vaccine. 2021 Jan 11. pii: S0264-410X(20)31666.
    PubMed     Abstract available

  484. SINGH J, Malik D, Raina A
    Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
    Vaccine. 2021 Jan 9. pii: S0264-410X(21)00015.
    PubMed     Abstract available

  485. RUIZ JB, Bell RA
    Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey.
    Vaccine. 2021 Jan 9. pii: S0264-410X(21)00014.
    PubMed     Abstract available

  486. WIEMKEN TL, Rutschman AS
    Development of vaccines for influenza disease: Opportunity costs of the COVID-19 pandemic.
    Vaccine. 2021 Jan 9. pii: S0264-410X(21)00018.

  487. BEIGI RH, Krubiner C, Jamieson DJ, Lyerly AD, et al
    The need for inclusion of pregnant women in COVID-19 vaccine trials.
    Vaccine. 2021 Jan 8. pii: S0264-410X(20)31671.

  488. CHAUDHURY S, MacGill RS, Early AM, Bolton JS, et al
    Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the RTS,S malaria vaccine.
    Vaccine. 2021 Jan 8. pii: S0264-410X(20)31635.
    PubMed     Abstract available

  489. ABDI I, Gidding H, Leong RN, Moore HC, et al
    Vaccine coverage in children born to migrant mothers in Australia: A population-based cohort study.
    Vaccine. 2021 Jan 8. pii: S0264-410X(20)31638.
    PubMed     Abstract available

  490. DESMET S, Wouters I, Heirstraeten LV, Beutels P, et al
    In-depth analysis of pneumococcal serotypes in Belgian children (2015-2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease.
    Vaccine. 2021;39:372-379.
    PubMed     Abstract available

  491. MAITI S, Howlader DR, Halder P, Bhaumik U, et al
    Bivalent non-typhoidal Salmonella outer membrane vesicles immunized mice sera confer passive protection against gastroenteritis in a suckling mice model.
    Vaccine. 2021;39:380-393.
    PubMed     Abstract available

  492. WILLIAMS J, Degeling C, McVernon J, Dawson A, et al
    How should we conduct pandemic vaccination?
    Vaccine. 2021 Jan 7. pii: S0264-410X(20)31639.
    PubMed     Abstract available

  493. SHARMA H, Anil K, Parekh S, Pujari P, et al
    A phase-I, open label clinical trial to assess the safety of Tdap vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults.
    Vaccine. 2021 Jan 7. pii: S0264-410X(20)31656.
    PubMed     Abstract available

  494. CALDERA F, Mercer M, Samson SI, Pitt JM, et al
    Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity.
    Vaccine. 2021 Jan 7. pii: S0264-410X(20)31490.
    PubMed     Abstract available

  495. KELSO JM
    Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31696.

  496. SU JR, McNeil MM, Welsh KJ, Marquez PL, et al
    Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31614.
    PubMed     Abstract available

  497. NISAR MI, Ahmed S, Jehan F, Shahid S, et al
    Direct and indirect effect of 10 valent pneumococcal vaccine on nasopharyngeal carriage in children under 2 years of age in Matiari, Pakistan.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31662.
    PubMed     Abstract available

  498. SCHEPPLER L, De Clercq N, McGoldrick M, Dias J, et al
    Regulatory Harmonization and Streamlining of Clinical Trial Applications globally should lead to faster clinical development and earlier access to life-saving vaccines.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31569.
    PubMed     Abstract available

  499. KOHLI M, Maschio M, Becker D, Weinstein MC, et al
    The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31690.
    PubMed     Abstract available

  500. MIDDELDORP M, van Lier A, van der Maas N, Veldhuijzen I, et al
    Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31692.
    PubMed     Abstract available

  501. WONG MCS, Wong ELY, Huang J, Cheung AWL, et al
    Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31695.
    PubMed     Abstract available

  502. GODINOT LD, Sicsic J, Lachatre M, Bouvet E, et al
    Quantifying preferences around vaccination against frequent, mild disease with risk for vulnerable persons: A discrete choice experiment among French hospital health care workers.
    Vaccine. 2021 Jan 5. pii: S0264-410X(20)31637.
    PubMed     Abstract available

  503. SCHLEY K, Malerczyk C, Beier D, Schiffner-Rohe J, et al
    Vaccination rate and adherence of tick-borne encephalitis vaccination in Germany.
    Vaccine. 2021 Jan 4. pii: S0264-410X(20)31615.
    PubMed     Abstract available

  504. FIELDING J, Sullivan SG, Beard F, Macartney K, et al
    Constructing an ethical framework for priority allocation of pandemic vaccines.
    Vaccine. 2021 Jan 3. pii: S0264-410X(20)31633.
    PubMed     Abstract available

  505. RUSSELL LB, Kim SY, Toscano C, Cosgriff B, et al
    Comparison of static and dynamic models of maternal immunization to prevent infant pertussis in Brazil.
    Vaccine. 2021;39:158-166.
    PubMed     Abstract available

  506. BAGATTINI AM, Policena G, Minamisava R, Andrade ALS, et al
    The data used to build the models: Pertussis morbidity and mortality burden considering various Brazilian data sources.
    Vaccine. 2021;39:137-146.
    PubMed     Abstract available

  507. RUSSELL LB, Sobanjo-Ter Meulen A, Toscano CM
    Evaluating the cost-effectiveness of maternal pertussis immunization in low- and middle-income countries: A review of lessons learnt.
    Vaccine. 2021;39:121-124.
    PubMed     Abstract available

  508. MITCHELL T, Dalal W, Klosovsky A, Yen C, et al
    An immunization program for US-bound refugees: Development, challenges, and opportunities 2012-present.
    Vaccine. 2021;39:68-77.
    PubMed     Abstract available

    December 2020
  509. JIANG X, Shang X, Lin J, Zhao Y, et al
    Impacts of free vaccination policy and associated factors on influenza vaccination behavior of the elderly in China: A quasi-experimental study.
    Vaccine. 2020 Dec 31. pii: S0264-410X(20)31608.
    PubMed     Abstract available

  510. GROVES PJ, Williamson SL, Ahaduzzaman M, Diamond M, et al
    Can a combination of vaccination, probiotic and organic acid treatment in layer hens protect against early life exposure to Salmonella Typhimurium and challenge at sexual maturity?
    Vaccine. 2020 Dec 31. pii: S0264-410X(20)31612.
    PubMed     Abstract available

  511. DAMJANOVSKA S, Smith C, Sayin I, Burant CJ, et al
    Adjuvant effect of type I interferon induced by many but not all commercial influenza vaccines.
    Vaccine. 2020 Dec 31. pii: S0264-410X(20)31631.
    PubMed     Abstract available

  512. SRINIVASA REDDY Y, Narendra Babu K, Uday Kumar P, Harishankar N, et al
    Nonclinical safety evaluation of oral recombinant anti-human papilloma virus vaccine (RHPV 16 & 18): Regulatory toxicology studies in mice, rats and rabbits - An innovative approach.
    Vaccine. 2020 Dec 30. pii: S0264-410X(20)31463.
    PubMed     Abstract available

  513. PRETO C, Maron de Mello A, Cesario Pereira Maluf EM, Teixeira Krainski E, et al
    Vaccination coverage and adherence to a dengue vaccination program in the state of Parana, Brazil.
    Vaccine. 2020 Dec 29. pii: S0264-410X(20)31597.
    PubMed     Abstract available

  514. GUPTA S, Tiku VR, Gauhar M, Khatoon K, et al
    Genetic diversity of G9 rotavirus strains circulating among diarrheic children in North India: A comparison with 116E rotavirus vaccine strain.
    Vaccine. 2020 Dec 29. pii: S0264-410X(20)31604.
    PubMed     Abstract available

  515. TOMLJENOVIC M, Petrovic G, Antoljak N, Hansen L, et al
    Vaccination attitudes, beliefs and behaviours among primary health care workers in northern Croatia.
    Vaccine. 2020 Dec 29. pii: S0264-410X(20)31502.
    PubMed     Abstract available

  516. ZHONG Y, Clapham HE, Aishworiya R, Chua YX, et al
    Childhood vaccinations: Hidden impact of COVID-19 on children in Singapore.
    Vaccine. 2020 Dec 26. pii: S0264-410X(20)31634.
    PubMed     Abstract available

  517. PITTET LF, Tebruegge M, Dutta B, Donath S, et al
    Mycobacterium ulcerans-specific immune response after immunisation with bacillus Calmette-Guerin (BCG) vaccine.
    Vaccine. 2020 Dec 25. pii: S0264-410X(20)31498.
    PubMed     Abstract available

  518. SUAU R, Vidal M, Aguilar R, Ruiz-Olalla G, et al
    RTS,S/AS01E malaria vaccine induces IgA responses against CSP and vaccine-unrelated antigens in African children in the phase 3 trial.
    Vaccine. 2020 Dec 24. pii: S0264-410X(20)31606.
    PubMed     Abstract available

  519. MORO PL, Marquez P
    Reports of cell-based influenza vaccine administered during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2013-2020.
    Vaccine. 2020 Dec 24. pii: S0264-410X(20)31613.
    PubMed     Abstract available

  520. ULANOVA M, Huska B, Desbiens A, Gaultier GN, et al
    Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in 23-valent pneumococcal polysaccharide vaccine-naive and previously immunized adult patients with severe chronic kidney disease.
    Vaccine. 2020 Dec 24. pii: S0264-410X(20)31602.
    PubMed     Abstract available

  521. THANGARAJAH D, Malo JA, Field E, Andrews R, et al
    Effectiveness of quadrivalent influenza vaccination in the first year of a funded childhood program in Queensland, Australia, 2018.
    Vaccine. 2020 Dec 23. pii: S0264-410X(20)31579.
    PubMed     Abstract available

  522. KOSKAN A, Klasko-Foster L, Stecher C, Rodriguez S, et al
    Human papillomavirus vaccine guideline adherence among Arizona's Medicaid beneficiaries.
    Vaccine. 2020 Dec 23. pii: S0264-410X(20)31609.
    PubMed     Abstract available

  523. CUI YA, Folaranmi T, Buchwald UK
    The Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial: Further reflections on the design and results.
    Vaccine. 2020 Dec 22. pii: S0264-410X(20)31600.
    PubMed     Abstract available

  524. APARECIDO NUNES A, De Jesus Lopes De Abreu A, Cintra O, A C T Cintra M, et al
    Meningococcal disease epidemiology in Brazil (2005-2018) and impact of MenC vaccination.
    Vaccine. 2020 Dec 22. pii: S0264-410X(20)31542.
    PubMed     Abstract available

  525. GINI R, Dodd CN, Bollaerts K, Bartolini C, et al
    Quantifying outcome misclassification in multi-database studies: The case study of pertussis in the ADVANCE project.
    Vaccine. 2020;38 Suppl 2:B56-B64.
    PubMed     Abstract available

  526. ITTEFAQ M, Baines A, Abwao M, Shah SFA, et al
    "Does Pakistan still have polio cases?": Exploring discussions on polio and polio vaccine in online news comments in Pakistan.
    Vaccine. 2020 Dec 21. pii: S0264-410X(20)31607.
    PubMed     Abstract available

  527. MCFADDEN K, Seale H
    A review of hospital-based interventions to improve inpatient influenza vaccination uptake for high-risk adults.
    Vaccine. 2020 Dec 21. pii: S0264-410X(20)31610.
    PubMed     Abstract available

  528. RAMAKRISHNAN A, Joseph SS, Reynolds ND, Poncet D, et al
    Evaluation of the immunogenicity and protective efficacy of a recombinant CS6-based ETEC vaccine in an Aotus nancymaae CS6 + ETEC challenge model.
    Vaccine. 2020 Dec 20. pii: S0264-410X(20)31601.
    PubMed     Abstract available

  529. MARCHAL C, Belhassen M, Guiso N, Jacoud F, et al
    Vaccination coverage rates for Diphtheria, Tetanus, Poliomyelitis and Pertussis booster vaccination in France between 2013 and 2017: Learnings from an analysis of National Health System Real-World Data.
    Vaccine. 2020 Dec 20. pii: S0264-410X(20)31588.
    PubMed     Abstract available

  530. DOUGLASS N, van Diepen MT, Chapman R, Galant S, et al
    Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicity.
    Vaccine. 2020 Dec 17. pii: S0264-410X(20)31591.
    PubMed     Abstract available

  531. FAN S, Liao Y, Jiang G, Wang L, et al
    Efficacy of an inactivated bivalent vaccine for enterovirus 71 and coxsackievirus A16 in mice immunized intradermally.
    Vaccine. 2020 Dec 17. pii: S0264-410X(20)31552.
    PubMed     Abstract available

  532. GRETER H, Ivol S, Oriol Mathieu V, Erismann S, et al
    Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations.
    Vaccine. 2020 Dec 17. pii: S0264-410X(20)31566.
    PubMed     Abstract available

  533. BETLACH AM, Fano E, VanderWaal K, Pieters M, et al
    Effect of multiple vaccinations on transmission and degree of Mycoplasma hyopneumoniae infection in gilts.
    Vaccine. 2020 Dec 17. pii: S0264-410X(20)31443.
    PubMed     Abstract available

  534. KIM K, Hahn TW
    Evaluation of novel recombinant porcine circovirus type 2d (PCV2d) vaccine in pigs naturally infected with PCV2d.
    Vaccine. 2020 Dec 17. pii: S0264-410X(20)31580.
    PubMed     Abstract available

  535. SPARROW E, Wood JG, Chadwick C, Newall AT, et al
    Global production capacity of seasonal and pandemic influenza vaccines in 2019.
    Vaccine. 2020 Dec 16. pii: S0264-410X(20)31585.
    PubMed     Abstract available

  536. FULVINI AA, Tuteja A, Le J, Pokorny BA, et al
    HA1 (Hemagglutinin) quantitation for influenza A H1N1 and H3N2 high yield reassortant vaccine candidate seed viruses by RP-UPLC.
    Vaccine. 2020 Dec 16. pii: S0264-410X(20)31563.
    PubMed     Abstract available

  537. BORRIELLO A, Master D, Pellegrini A, Rose JM, et al
    Preferences for a COVID-19 vaccine in Australia.
    Vaccine. 2020 Dec 16. pii: S0264-410X(20)31599.
    PubMed     Abstract available

  538. BOKEMPER SE, Huber GA, Gerber AS, James EK, et al
    Timing of COVID-19 vaccine approval and endorsement by public figures.
    Vaccine. 2020 Dec 16. pii: S0264-410X(20)31616.
    PubMed     Abstract available

  539. MONTGOMERY VA, Lindsey CY, Smith LA, Webb RP, et al
    Development of an o-pthalaldehyde (OPA) assay to measure protein content in Ricin Vaccine E. coli (RVEc).
    Vaccine. 2020 Dec 15. pii: S0264-410X(20)31573.
    PubMed     Abstract available

  540. SANFTENBERG L, Kuehne F, Anraad C, Jung-Sievers C, et al
    Assessing the impact of shared decision making processes on influenza vaccination rates in adult patients in outpatient care: A systematic review and meta-analysis.
    Vaccine. 2020 Dec 14. pii: S0264-410X(20)31581.
    PubMed     Abstract available

  541. BROOCKMAN D, Kalla J, Guerrero A, Budolfson M, et al
    Broad cross-national public support for accelerated COVID-19 vaccine trial designs.
    Vaccine. 2020 Dec 14. pii: S0264-410X(20)31555.
    PubMed     Abstract available

  542. FLORES-VALDEZ MA, Segura-Cerda CA
    Preclinical evaluation of tuberculosis vaccine candidates: Is it time to harmonize study design and readouts for prioritizing their development?
    Vaccine. 2020 Dec 14. pii: S0264-410X(20)31556.

  543. STEVENS VW, Russo EM, Young-Xu Y, Leecaster M, et al
    Identification of patients at risk of Clostridioides difficile infection for enrollment in vaccine clinical trials.
    Vaccine. 2020 Dec 14. pii: S0264-410X(20)31583.
    PubMed     Abstract available

  544. BRAVO-GRANDE JL, Asuncion Blanco-Gonzalez M, de la Torre-Robles JM, Asmat-Inostrosa MP, et al
    Vaccination adjuvated against hepatitis B in Spanish National Healthcare System (SNS) workers typed as non-responders to conventional vaccines.
    Vaccine. 2020 Dec 14. pii: S0264-410X(20)31571.
    PubMed     Abstract available

  545. CASTANO-ZUBIETA MR, Rossetti CA, Garcia-Gonzalez DG, Maurizio E, et al
    Evaluation of the safety profile of the vaccine candidate Brucella melitensis 16MDeltavjbR strain in goats.
    Vaccine. 2020 Dec 13. pii: S0264-410X(20)31473.
    PubMed     Abstract available

  546. BOUCHEZ M, Ward JK, Bocquier A, Benamouzig D, et al
    Physicians' decision processes about the HPV vaccine: A qualitative study.
    Vaccine. 2020 Dec 13. pii: S0264-410X(20)31586.
    PubMed     Abstract available

  547. SARINHO E, Goudouris E, Sole D
    BCG vaccine: Worrying proposal for COVID-19.
    Vaccine. 2020 Dec 13. pii: S0264-410X(20)31593.
    PubMed     Abstract available

  548. DEGELING C, Williams J, Carter SM, Moss R, et al
    Priority allocation of pandemic influenza vaccines in Australia - Recommendations of 3 community juries.
    Vaccine. 2020 Dec 11. pii: S0264-410X(20)31577.
    PubMed     Abstract available

  549. ZACHARIA A, Harberts E, Valencia SM, Myers B, et al
    Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists.
    Vaccine. 2020 Dec 10. pii: S0264-410X(20)31541.
    PubMed     Abstract available

  550. DE OLIVEIRA EMERICK S, Vieira de Carvalho T, Meirelles Miranda B, Carneiro da Silva A, et al
    Lipophosphoglycan-3 protein from Leishmania infantum chagasi plus saponin adjuvant: A new promising vaccine against visceral leishmaniasis.
    Vaccine. 2020 Dec 10. pii: S0264-410X(20)31539.
    PubMed     Abstract available

  551. LIU C, Huang P, Zhao D, Xia M, et al
    Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine.
    Vaccine. 2020 Dec 10. pii: S0264-410X(20)31568.
    PubMed     Abstract available

  552. HOLM MR, Poland GA
    Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy.
    Vaccine. 2020 Dec 9. pii: S0264-410X(20)31584.

  553. CARIAS C, Pawaskar M, Nyaku M, Conway JH, et al
    Potential impact of COVID-19 pandemic on vaccination coverage in children: A case study of measles-containing vaccine administration in the United States (US).
    Vaccine. 2020 Dec 9. pii: S0264-410X(20)31557.
    PubMed     Abstract available

  554. DULIN N, Spanier A, Merino K, Hutter JN, et al
    Systematic review of Marburg virus vaccine nonhuman primate studies and human clinical trials.
    Vaccine. 2020 Dec 9. pii: S0264-410X(20)31495.
    PubMed     Abstract available

  555. GHASWALLA PK, Bengtson LGS, Marshall GS, Buikema AR, et al
    Meningococcal vaccination in patients with newly diagnosed asplenia in the United States.
    Vaccine. 2020 Dec 9. pii: S0264-410X(20)31550.
    PubMed     Abstract available

  556. RASTEGAR M, Tavana M, Meraj A, Mina H, et al
    An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic.
    Vaccine. 2020 Dec 9. pii: S0264-410X(20)31589.
    PubMed     Abstract available

  557. WILLIAMS JTB, Robinson K, Abbott E, Rojop N, et al
    Adapting and piloting a vaccine hesitancy questionnaire in rural Guatemala.
    Vaccine. 2020 Dec 8. pii: S0264-410X(20)31551.
    PubMed     Abstract available

  558. LUISI MLR
    From bad to worse II: Risk amplification of the HPV vaccine on Facebook.
    Vaccine. 2020 Dec 7. pii: S0264-410X(20)31540.
    PubMed     Abstract available

  559. GHIGA I, Richardson S, Alvarez AMR, Kato M, et al
    PIPDeploy: Development and implementation of a gamified table top simulation exercise to strengthen national pandemic vaccine preparedness and readiness.
    Vaccine. 2020 Dec 5. pii: S0264-410X(20)31500.
    PubMed     Abstract available

  560. DHAKAL S, Deshpande S, McMahon M, Strohmeier S, et al
    Female-biased effects of aging on a chimeric hemagglutinin stalk-based universal influenza virus vaccine in mice.
    Vaccine. 2020 Dec 5. pii: S0264-410X(20)31510.
    PubMed     Abstract available

  561. LENG A, Maitland E, Wang S, Nicholas S, et al
    Individual preferences for COVID-19 vaccination in China.
    Vaccine. 2020 Dec 5. pii: S0264-410X(20)31576.
    PubMed     Abstract available

  562. LLAU AF, Williams ML, Tejada CE
    National vaccine coverage trends and funding in Latin America and the Caribbean.
    Vaccine. 2020 Dec 4. pii: S0264-410X(20)31534.
    PubMed     Abstract available

  563. DOLL MK, Weitzen SD, Morrison KT
    Trends in the uptake of pediatric measles-containing vaccine in the United States: A Disneyland effect?
    Vaccine. 2020 Dec 4. pii: S0264-410X(20)31501.
    PubMed     Abstract available

  564. WENZEL NS, Atkins KE, van Leeuwen E, Halloran ME, et al
    Cost-effectiveness of live-attenuated influenza vaccination among school-age children.
    Vaccine. 2020 Dec 4. pii: S0264-410X(20)31282.
    PubMed     Abstract available

  565. MAYKIN MM, Heuser C, Feltovich H
    Pregnant people deserve the protection offered by SARS-CoV-2 vaccines.
    Vaccine. 2020 Dec 4. pii: S0264-410X(20)31572.

  566. DIMOPOULOU D, Koutsaki M, Giorgi M, Spanou M, et al
    Effects of measles-containing vaccination in children with severe underlying neurologic disease.
    Vaccine. 2020 Dec 3. pii: S0264-410X(20)31536.
    PubMed     Abstract available

  567. LEADER AE, Burke-Garcia A, Massey PM, Roark JB, et al
    Understanding the messages and motivation of vaccine hesitant or refusing social media influencers.
    Vaccine. 2020 Dec 3. pii: S0264-410X(20)31533.
    PubMed     Abstract available

  568. MOHAMMED H, Roberts CT, Grzeskowiak LE, Giles LC, et al
    Safety of maternal pertussis vaccination on pregnancy and birth outcomes: A prospective cohort study.
    Vaccine. 2020 Dec 3. pii: S0264-410X(20)31505.
    PubMed     Abstract available

  569. OCRAN-APPIAH J, Boutry C, Herve C, Soni J, et al
    Safety of the adjuvanted recombinant zoster vaccine in adults aged 50 years or older. A phase IIIB, non-randomized, multinational, open-label study in previous ZOE-50 and ZOE-70 placebo recipients.
    Vaccine. 2020 Dec 1. pii: S0264-410X(20)31323.
    PubMed     Abstract available

    November 2020
  570. EDOKA I, Kohli-Lynch C, Fraser H, Hofman K, et al
    A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme.
    Vaccine. 2020 Nov 30. pii: S0264-410X(20)31468.
    PubMed     Abstract available

  571. FOCOSI D, Maggi F, Pistello M
    Corrigendum to "Getting the most from the Ebola vaccine success" [Vaccine 33 (2015) 7141].
    Vaccine. 2020 Nov 30. pii: S0264-410X(20)31537.

  572. HABER P, Tate J, Marquez PL, Moro PL, et al
    Safety profile of rotavirus vaccines among individuals aged>/=8months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019.
    Vaccine. 2020 Nov 29. pii: S0264-410X(20)31466.
    PubMed     Abstract available

  573. MAJED L, Bresse X, El Mouaddin N, Schmidt A, et al
    Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France.
    Vaccine. 2020 Nov 28. pii: S0264-410X(20)31420.
    PubMed     Abstract available

  574. GATES A, Gates M, Rahman S, Guitard S, et al
    A systematic review of factors that influence the acceptability of vaccines among Canadians.
    Vaccine. 2020 Nov 27. pii: S0264-410X(20)31332.
    PubMed     Abstract available

  575. DE CASTRO JC, de Almeida LV, Cardoso MS, Oliveira FMS, et al
    Vaccination with chimeric protein induces protection in murine model against ascariasis.
    Vaccine. 2020 Nov 26. pii: S0264-410X(20)31499.
    PubMed     Abstract available

  576. HAVERI A, Ikonen N, Savolainen-Kopra C, Julkunen I, et al
    Long-lasting heterologous antibody responses after sequential vaccination with A/Indonesia/5/2005 and A/Vietnam/1203/2004 pre-pandemic influenza A(H5N1) virus vaccines.
    Vaccine. 2020 Nov 24. pii: S0264-410X(20)31494.
    PubMed     Abstract available

  577. VANDER STICHELE RH, Hay C, Fladvad M, Sturkenboom MCJM, et al
    How to ensure we can track and trace global use of COVID-19 vaccines?
    Vaccine. 2020 Nov 24. pii: S0264-410X(20)31508.

  578. KITANO T, Aoki H
    A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan.
    Vaccine. 2020 Nov 24. pii: S0264-410X(20)31506.
    PubMed     Abstract available

  579. URA T, Yamashita A, Mizuki N, Okuda K, et al
    New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Vaccine. 2020 Nov 24. pii: S0264-410X(20)31507.
    PubMed     Abstract available

  580. KITTIKRAISAK W, Phadungkiatwatana P, Ditsungnoen D, Kaoiean S, et al
    Comparison of influenza antibody titers among women who were vaccinated in the 2(nd) and the 3(rd) trimesters of pregnancy.
    Vaccine. 2020 Nov 23. pii: S0264-410X(20)31472.
    PubMed     Abstract available

  581. DRORI Y, Pando R, Sefty H, Rosenberg A, et al
    Influenza vaccine effectiveness against laboratory-confirmed influenza in a vaccine-mismatched influenza B-dominant season.
    Vaccine. 2020 Nov 23. pii: S0264-410X(20)31394.
    PubMed     Abstract available

  582. PECKEU L, van der Ende A, de Melker HE, Sanders EAM, et al
    Impact and effectiveness of the 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children under 5 years of age in the Netherlands.
    Vaccine. 2020 Nov 23. pii: S0264-410X(20)31456.
    PubMed     Abstract available

  583. HU S, Xu X, Zhang Y, Liu Y, et al
    A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: Implications for vaccine roll-out in mainland China.
    Vaccine. 2020 Nov 23. pii: S0264-410X(20)31469.
    PubMed     Abstract available

  584. HUANG Z, He J, Su J, Ou Z, et al
    Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in Chinese females aged 9 to 26 years: A phase 3, open-label, immunobridging study.
    Vaccine. 2020 Nov 22. pii: S0264-410X(20)31434.
    PubMed     Abstract available

  585. CLOSSON K, Karim ME, Sadarangani M, Naus M, et al
    Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: A population survey-based cross-sectional analysis.
    Vaccine. 2020 Nov 22. pii: S0264-410X(20)31327.
    PubMed     Abstract available

  586. JULIAO P, Abadia I, Welby S, Wery S, et al
    Hepatitis A antibody persistence 8 and 10 years after 1-dose and 2-dose vaccination in children from Panama.
    Vaccine. 2020 Nov 22. pii: S0264-410X(20)31470.
    PubMed     Abstract available

  587. LINDSEY NP, Perry L, Fischer M, Woolpert T, et al
    Duration of seropositivity following yellow fever vaccination in U.S. military service members.
    Vaccine. 2020 Nov 22. pii: S0264-410X(20)31462.
    PubMed     Abstract available

  588. FIX A, Kirkwood CD, Steele D, Flores J, et al
    Next-generation rotavirus vaccine developers meeting: Summary of a meeting sponsored by PATH and the bill & melinda gates foundation (19-20 June 2019, Geneva).
    Vaccine. 2020 Nov 21. pii: S0264-410X(20)31474.
    PubMed     Abstract available

  589. OHFUJI S, Okada K, Mouri Y, Mihara Y, et al
    Effectiveness of four doses of pertussis vaccine during infancy diminished in elementary school age: A test-negative case-control study in Japan.
    Vaccine. 2020 Nov 20. pii: S0264-410X(20)31475.
    PubMed     Abstract available

  590. ALLEN JC, Toapanta FR, Chen W, Tennant SM, et al
    Understanding immunosenescence and its impact on vaccination of older adults.
    Vaccine. 2020 Nov 20. pii: S0264-410X(20)31426.
    PubMed     Abstract available

  591. GANGULY M, Yeolekar L, Tyagi P, Sagar U, et al
    Evaluation of manufacturing feasibility and safety of an MDCK cell-based live attenuated influenza vaccine (LAIV) platform.
    Vaccine. 2020 Nov 20. pii: S0264-410X(20)31424.
    PubMed     Abstract available

  592. SUNDARAM ME, Wolfson J, Osterholm M, Sow S, et al
    Meningococcal vaccines and protein-energy undernutrition in children in the African meningitis belt.
    Vaccine. 2020 Nov 19. pii: S0264-410X(20)31438.
    PubMed     Abstract available

  593. HOA-TRAN TN, Dao ATH, Nguyen AT, Kataoka C, et al
    Coxsackieviruses A6 and A16 associated with hand, foot, and mouth disease in Vietnam, 2008-2017: Essential information for rational vaccine design.
    Vaccine. 2020 Nov 19. pii: S0264-410X(20)31471.
    PubMed     Abstract available

  594. ZHU S, Chang J, Hayat K, Li P, et al
    Parental preferences for HPV vaccination in junior middle school girls in China: A discrete choice experiment.
    Vaccine. 2020 Nov 19. pii: S0264-410X(20)31460.
    PubMed     Abstract available

  595. YEUNG KHT, Lin SL, Clark A, McGhee SM, et al
    Economic evaluation of the introduction of rotavirus vaccine in Hong Kong.
    Vaccine. 2020 Nov 18. pii: S0264-410X(20)31361.
    PubMed     Abstract available

  596. THANH THI LE X, Ishizumi A, Thi Thu Nguyen H, Thi Duong H, et al
    Social and behavioral determinants of attitudes towards and practices of hepatitis B vaccine birth dose in Vietnam.
    Vaccine. 2020 Nov 18. pii: S0264-410X(20)31435.
    PubMed     Abstract available

  597. KHERA A, Singh R, Shakila H, Rao V, et al
    Corrigendum to 'Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis' [Vaccine 23 (2005) 5655-5665].
    Vaccine. 2020;38:7874-7875.

  598. GRAVAGNA K, Becker A, Valeris-Chacin R, Mohammed I, et al
    Global assessment of national mandatory vaccination policies and consequences of non-compliance.
    Vaccine. 2020;38:7865-7873.
    PubMed     Abstract available

  599. XU X, Wang C, Huang Y, Zhang S, et al
    Evaluation of the vaccine efficacy of three digestive protease antigens from Dermanyssus gallinae using an in vivo rearing system.
    Vaccine. 2020;38:7842-7849.
    PubMed     Abstract available

  600. BAROUTSOU V, Zens KD, Sinniger P, Fehr J, et al
    Analysis of Tick-borne Encephalitis vaccination coverage and compliance in adults in Switzerland, 2018.
    Vaccine. 2020;38:7825-7833.
    PubMed     Abstract available

  601. PHUGARE S, Kale S, Sharma P, Kumar Goel S, et al
    Quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) using sandwich ELISA.
    Vaccine. 2020;38:7815-7824.
    PubMed     Abstract available

  602. TUCKERMAN JL, Kaufman J, Danchin M, Marshall HS, et al
    Influenza vaccination: A qualitative study of practice level barriers from medical practitioners caring for children with special risk medical conditions.
    Vaccine. 2020;38:7806-7814.
    PubMed     Abstract available

  603. GUESS AM, Nyhan B, O'Keeffe Z, Reifler J, et al
    The sources and correlates of exposure to vaccine-related (mis)information online.
    Vaccine. 2020;38:7799-7805.
    PubMed     Abstract available

  604. PHILLIPS MT, Warren JL, Givon-Lavi N, Tothpal A, et al
    Evaluating post-vaccine expansion patterns of pneumococcal serotypes.
    Vaccine. 2020;38:7756-7763.
    PubMed     Abstract available

  605. HEO JY, Seo YB, Jeong HW, Choi MJ, et al
    Epidemiology of community-acquired pneumonia in the era of extended serotype-covering multivalent pneumococcal conjugate vaccines.
    Vaccine. 2020;38:7747-7755.
    PubMed     Abstract available

  606. MOHAMED N, Simba D, Mphuru A, Lyimo D, et al
    Lessons learned in the implementation of supplementary immunization activity (SIA) field guidelines for injectable vaccines - Experiences from Tanzania.
    Vaccine. 2020;38:7741-7746.
    PubMed     Abstract available

  607. TOLL M, Li A
    Vaccine sentiments and under-vaccination: Attitudes and behaviour around Measles, Mumps, and Rubella vaccine (MMR) in an Australian cohort.
    Vaccine. 2020 Nov 17. pii: S0264-410X(20)31461.
    PubMed     Abstract available

  608. XIAOJIN S, Rodewald LE, Guomin Z, Hui Z, et al
    Long-term seropositivity, safety, and impact of inactivated and live, attenuated hepatitis a vaccines in China - A cross-sectional study.
    Vaccine. 2020 Nov 16. pii: S0264-410X(20)31457.
    PubMed     Abstract available

  609. MAGWIRA CA, Kgosana LP, Esona MD, Seheri ML, et al
    Low fecal rotavirus vaccine virus shedding is significantly associated with non-secretor histo-blood group antigen phenotype among infants in northern Pretoria, South Africa.
    Vaccine. 2020 Nov 16. pii: S0264-410X(20)31465.
    PubMed     Abstract available

  610. ROBERTS JR, Dawley E, Garbe C, Cooper T, et al
    A survey of office practice: Parents, front office staff, nurses and clinicians hold disparate views on adolescent vaccines.
    Vaccine. 2020 Nov 15. pii: S0264-410X(20)31440.
    PubMed     Abstract available

  611. SHEARER JD, Henning L, Sanford DC, Li N, et al
    Efficacy of the AV7909 anthrax vaccine candidate in guinea pigs and nonhuman primates following two immunizations two weeks apart.
    Vaccine. 2020 Nov 13. pii: S0264-410X(20)31433.
    PubMed     Abstract available

  612. ZUO XX, Zhao YH, Zhou MX, Deng BH, et al
    Live vaccine preserved at room temperature: Preparation and characterization of a freeze-dried classical swine fever virus vaccine.
    Vaccine. 2020 Nov 13. pii: S0264-410X(20)31425.
    PubMed     Abstract available

  613. JARRETT S, Wilmansyah T, Bramanti Y, Alitamsar H, et al
    The role of manufacturers in the implementation of global traceability standards in the supply chain to combat vaccine counterfeiting and enhance safety monitoring.
    Vaccine. 2020 Nov 13. pii: S0264-410X(20)31437.
    PubMed     Abstract available

  614. VYSE A, Campling J, Czudek C, Ellsbury G, et al
    The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in
    Vaccine. 2020 Nov 12. pii: S0264-410X(20)31421.

  615. CROOKE SN, Riggenbach MM, Ovsyannikova IG, Warner ND, et al
    Durability of humoral immune responses to rubella following MMR vaccination.
    Vaccine. 2020 Nov 12. pii: S0264-410X(20)31396.
    PubMed     Abstract available

  616. WANG Q, Zhang W, Cai H, Cao Y, et al
    Understanding the perceptions of Chinese women of the commercially available domestic and imported HPV vaccine: A semantic network analysis.
    Vaccine. 2020 Nov 12. pii: S0264-410X(20)31442.
    PubMed     Abstract available

  617. MASHININI DP, Fogarty KJ, Potter RC, Berles JD, et al
    Geographic hot spot analysis of vaccine exemption clustering patterns in Michigan from 2008 to 2017.
    Vaccine. 2020 Nov 12. pii: S0264-410X(20)31422.
    PubMed     Abstract available

  618. KWON WJ, Choi JC, Hong S, Kim YC, et al
    Development of a high-dose vaccine formulation for prevention of megalocytivirus infection in rock bream (Oplegnathus fasciatus).
    Vaccine. 2020 Nov 11. pii: S0264-410X(20)31423.
    PubMed     Abstract available

  619. HALL LM, Ediriweera Y, Banks J, Nambiar A, et al
    Cooling to reduce the pain associated with vaccination: A systematic review.
    Vaccine. 2020 Nov 11. pii: S0264-410X(20)31429.
    PubMed     Abstract available

  620. GARCIA LY, Cerda AA
    Acceptance of a COVID-19 vaccine: A multifactorial consideration.
    Vaccine. 2020;38:7587.

  621. GRAFFIGNA G, Palamenghi L, Barello S, Stefania B, et al
    "Cultivating" acceptance of a COVID-19 vaccination program: Lessons from Italy.
    Vaccine. 2020;38:7585-7586.

  622. COUDEVILLE L, Gomez GB, Jollivet O, Harris RC, et al
    Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.
    Vaccine. 2020;38:7588-7595.

  623. DOUBOVETZKY M, Ataman-Onal Y, Chousterman B, Feroldi E, et al
    Safety biomarkers for development of vaccines and biologics: Report from the safety biomarkers symposium held on November 28-29, 2017, Marcy l'Etoile, France.
    Vaccine. 2020 Nov 10. pii: S0264-410X(20)31306.
    PubMed     Abstract available

  624. JUSTHY DP
    Vaccine as a Platform (VaaP): Why the future of disease eradication needs to be data driven.
    Vaccine. 2020 Nov 10. pii: S0264-410X(20)31403.

  625. NAVIN MC, Danchin M
    Vaccine mandates in the US and Australia: balancing benefits and burdens for children and physicians.
    Vaccine. 2020 Nov 9. pii: S0264-410X(20)31400.

  626. ZHANG W, Gao J, Chen L, Tian J, et al
    Estimated influenza illnesses and hospitalizations averted by influenza vaccination among children aged 6-59 months in Suzhou, China, 2011/12 to 2015/16 influenza seasons.
    Vaccine. 2020 Nov 8. pii: S0264-410X(20)31389.
    PubMed     Abstract available

  627. FORTUNA L, Chaithongwongwatthana S, Soonthornworasiri N, Spiegel J, et al
    Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen(R)) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen(R)) vaccine for immunization of adolescents and a
    Vaccine. 2020 Nov 8. pii: S0264-410X(20)31390.
    PubMed     Abstract available

  628. MAUBRIGADES LR, Santos FDS, Goncalves VS, Rodrigues PRC, et al
    Association of Bacillus toyonensis spores with alum improves bovine herpesvirus 5 subunit vaccine immune response in mice.
    Vaccine. 2020 Nov 7. pii: S0264-410X(20)31386.
    PubMed     Abstract available

  629. MURALL CL, Reyne B, Selinger C, Bernat C, et al
    HPV cervical infections and serological status in vaccinated and unvaccinated women.
    Vaccine. 2020 Nov 6. pii: S0264-410X(20)31398.
    PubMed     Abstract available

  630. CHIU SS, Chua H, Kwan MYW, Chan ELY, et al
    Influenza vaccination effectiveness in preventing influenza hospitalization in children, Hong Kong, winter 2019/20.
    Vaccine. 2020 Nov 6. pii: S0264-410X(20)31401.
    PubMed     Abstract available

  631. GIRISH KUMAR CP, Giri S, Chawla-Sarkar M, Gopalkrishna V, et al
    Epidemiology of rotavirus diarrhea among children less than 5 years hospitalized with acute gastroenteritis prior to rotavirus vaccine introduction in India.
    Vaccine. 2020 Nov 6. pii: S0264-410X(20)31404.
    PubMed     Abstract available

  632. CHEN RT, Kochhar S, Condit R
    The Brighton Collaboration standardized templates for collection of key information for benefit-risk assessment of vaccines by technology (BRAVATO; formerly V3SWG).
    Vaccine. 2020 Nov 6. pii: S0264-410X(20)31392.

  633. SARASTY O, Carpio CE, Hudson D, Guerrero-Ochoa PA, et al
    The demand for a COVID-19 vaccine in Ecuador.
    Vaccine. 2020 Nov 6. pii: S0264-410X(20)31439.
    PubMed     Abstract available

  634. BULULA N, Mwiru DP, Swalehe O, Thomas Mori A, et al
    Vaccine storage and distribution between expanded program on immunization and medical store department in Tanzania: a cost-minimization analysis.
    Vaccine. 2020 Nov 5. pii: S0264-410X(20)31419.
    PubMed     Abstract available

  635. SIKORA AE, Gomez C, Le Van A, Baarda BI, et al
    A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection.
    Vaccine. 2020 Nov 5. pii: S0264-410X(20)31397.
    PubMed     Abstract available

  636. HITCHINGS MDT, Cummings DAT, Grais RF, Isanaka S, et al
    A mixture model to assess the the immunogenicity of an oral rotavirus vaccine among healthy infants in Niger.
    Vaccine. 2020 Nov 5. pii: S0264-410X(20)31399.
    PubMed     Abstract available

  637. KESKE S, Mutters NT, Tsioutis C, Ergonul O, et al
    Influenza vaccination among infection control teams: A EUCIC survey prior to COVID-19 pandemic.
    Vaccine. 2020 Nov 5. pii: S0264-410X(20)31427.
    PubMed     Abstract available

  638. ROSENTHAL EM, Hall EW, Rosenberg ES, Harris A, et al
    Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations.
    Vaccine. 2020 Nov 4. pii: S0264-410X(20)31387.
    PubMed     Abstract available

  639. SEITEL T, Cagol L, Prelog M, Frivolt K, et al
    Varicella-zoster-virus vaccination of immunosuppressed children with inflammatory bowel disease or autoimmune hepatitis: A prospective observational study.
    Vaccine. 2020 Nov 4. pii: S0264-410X(20)31322.
    PubMed     Abstract available

  640. GRIFFITH BC, Ulrich AK, Becker AB, Nederhoff D, et al
    Does education about local vaccination rates and the importance of herd immunity change US parents' concern about measles?
    Vaccine. 2020 Nov 3. pii: S0264-410X(20)31258.
    PubMed     Abstract available

  641. LOWELL JA, Dikici E, Joshi PM, Landgraf R, et al
    Vaccination against cocaine using a modifiable dendrimer nanoparticle platform.
    Vaccine. 2020 Nov 3. pii: S0264-410X(20)31335.
    PubMed     Abstract available

  642. CROOKE SN, Ovsyannikova IG, Kennedy RB, Warner ND, et al
    Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine.
    Vaccine. 2020 Nov 3. pii: S0264-410X(20)31391.
    PubMed     Abstract available

  643. CHEN WH, Tao X, Agrawal AS, Algaissi A, et al
    Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.
    Vaccine. 2020;38:7533-7541.
    PubMed     Abstract available

  644. PEUBEZ I, Margot S, Buffin S, Pion C, et al
    A novel lamprey antibody sequence to multimerize and increase the immunogenicity of recombinant viral and bacterial vaccine antigens.
    Vaccine. 2020 Nov 2. pii: S0264-410X(20)31393.
    PubMed     Abstract available

    October 2020
  645. UDDEN F, Filipe M, Slotved HC, Yamba-Yamba L, et al
    Pneumococcal carriage among children aged 4 - 12 years in Angola 4 years after the introduction of a pneumococcal conjugate vaccine.
    Vaccine. 2020 Oct 31. pii: S0264-410X(20)31369.
    PubMed     Abstract available

  646. MANGION M, Gelinas JF, Bakhshi Zadeh Gashti A, Azizi H, et al
    Evaluation of novel HIV vaccine candidates using recombinant vesicular stomatitis virus vector produced in serum-free Vero cell cultures.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31367.
    PubMed     Abstract available

  647. SHARMA T, Joshi N, Kumar Mandyal A, Nordqvist SL, et al
    Development of Hillchol(R), a low-cost inactivated single strain Hikojima oral cholera vaccine.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31337.
    PubMed     Abstract available

  648. VESIKARI T, Ramsey K, Pitisuttithum P, Capeding R, et al
    Repeated exposure to an MF-59 adjuvanted quadrivalent subunit influenza vaccine (aQIV) in children: Results of two revaccination studies.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31330.
    PubMed     Abstract available

  649. LOLI S, Carcamo CP
    Rotavirus vaccination and stunting: Secondary Data Analysis from the Peruvian Demographic and Health Survey.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31338.
    PubMed     Abstract available

  650. PALANIAPPAN PA, Mohamed Sukur S, Liow YL, Maniam S, et al
    Carriage of Haemophilus influenzae among children attending childcare centres in Kuala Lumpur, Malaysia in the post vaccination era: A cross-sectional study.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31237.
    PubMed     Abstract available

  651. SAITOH A, Saitoh A, Katsuta T, Mine M, et al
    Effect of a vaccine information statement (VIS) on immunization status and parental knowledge, attitudes, and beliefs regarding infant immunization in Japan.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31355.
    PubMed     Abstract available

  652. BONANNI P, Angelillo IF, Villani A, Biasci P, et al
    Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: Let's avoid adding epidemics to the pandemic: Appeal from the Board of the Vaccination Calendar for Life in Italy: Maintain and increase coverage also by r
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31318.
    PubMed     Abstract available

  653. CARCELEN AC, Vilajeliu A, Malik F, Gilman RH, et al
    Perceptions and attitudes towards vaccination during pregnancy in a peri urban area of Lima, Peru.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31325.
    PubMed     Abstract available

  654. GAO F, Jiang Y, Li G, Zhang Y, et al
    Immune duration of a recombinant PRRSV vaccine expressing E2 of CSFV.
    Vaccine. 2020 Oct 29. pii: S0264-410X(20)31366.
    PubMed     Abstract available

  655. SONG JY, Jeong HW, Yun JW, Lee J, et al
    Immunogenicity and safety of a modified three-dose priming and booster schedule for the Hantaan virus vaccine (Hantavax): A multi-center phase III clinical trial in healthy adults.
    Vaccine. 2020 Oct 29. pii: S0264-410X(20)31329.
    PubMed     Abstract available

  656. SCHNEIKART G, Tavarini S, Sammicheli C, Torricelli G, et al
    The respiratory syncytial virus fusion protein-specific B cell receptor repertoire reshaped by post-fusion subunit vaccination.
    Vaccine. 2020 Oct 29. pii: S0264-410X(20)31371.
    PubMed     Abstract available

  657. SCHOCH-SPANA M, Brunson EK, Long R, Ruth A, et al
    The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States.
    Vaccine. 2020 Oct 29. pii: S0264-410X(20)31368.
    PubMed     Abstract available

  658. LIU B, Shi P, Wang T, Zhao Y, et al
    Recombinant H7 hemagglutinin expressed in glycoengineered Pichia pastoris forms nanoparticles that protect mice from challenge with H7N9 influenza virus.
    Vaccine. 2020 Oct 29. pii: S0264-410X(20)31370.
    PubMed     Abstract available

  659. WOLFE DN, Espeland EM, Gao Y, Lu D, et al
    Evaluation of BioThrax(R) and AV7909 anthrax vaccines in adults 66 years of age or older.
    Vaccine. 2020 Oct 28. pii: S0264-410X(20)31362.
    PubMed     Abstract available

  660. ANDERSON MG, Ballinger EA, Benjamin D, Frenkel LD, et al
    A clinical perspective of the U.S. anti-vaccination epidemic: Considering marginal costs and benefits, CDC best practices guidelines, free riders, and herd immunity.
    Vaccine. 2020 Oct 28. pii: S0264-410X(20)31388.

  661. LIU X, Drelich A, Li W, Chen C, et al
    Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice.
    Vaccine. 2020;38:7205-7212.
    PubMed     Abstract available

  662. CHESSON HW, Meites E, Ekwueme DU, Saraiya M, et al
    Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States: Estimates from a simplified transmission model.
    Vaccine. 2020 Oct 26. pii: S0264-410X(20)31312.
    PubMed     Abstract available

  663. ORAMI T, Ford R, Kirkham LA, Thornton R, et al
    Pneumococcal conjugate vaccine primes mucosal immune responses to pneumococcal polysaccharide vaccine booster in Papua New Guinean children.
    Vaccine. 2020 Oct 26. pii: S0264-410X(20)31336.
    PubMed     Abstract available

  664. DAS R, Jobayer Chisti M, Ahshanul Haque M, Ashraful Alam M, et al
    Evaluating association of vaccine response to low serum zinc and vitamin D levels in children of a birth cohort study in Dhaka.
    Vaccine. 2020 Oct 26. pii: S0264-410X(20)31352.
    PubMed     Abstract available

  665. SPINA CI, Brewer SE, Ellingson MK, Chamberlain AT, et al
    Adapting Center for Disease Control and Prevention's immunization quality improvement program to improve maternal vaccination uptake in obstetrics.
    Vaccine. 2020 Oct 26. pii: S0264-410X(20)31360.
    PubMed     Abstract available

  666. VALENTE PINTO M, Davis K, Andrews N, Goldblatt D, et al
    Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testing.
    Vaccine. 2020 Oct 24. pii: S0264-410X(20)31316.
    PubMed     Abstract available

  667. LATIF AA, Steyn HC, Josemans AI, Marumo RD, et al
    Safety and efficacy of an attenuated heartwater (Ehrlichia ruminantium) vaccine administered by the intramuscular route in cattle, sheep and Angora goats.
    Vaccine. 2020 Oct 24. pii: S0264-410X(20)31326.
    PubMed     Abstract available

  668. GUEBRE-XABIER M, Patel N, Tian JH, Zhou B, et al
    NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge.
    Vaccine. 2020 Oct 23. pii: S0264-410X(20)31373.
    PubMed     Abstract available

  669. ALLEGRA JR, Baughman RH
    Vaccine time-temperature indicators for present and future viral threats.
    Vaccine. 2020;38:6967-6968.

  670. CHANDIR S, Siddiqi DA, Mehmood M, Setayesh H, et al
    Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: An analysis of provincial electronic immunization registry data.
    Vaccine. 2020;38:7146-7155.
    PubMed     Abstract available

  671. RUSCIO BA, Hotez P
    Expanding global and national influenza vaccine systems to match the COVID-19 pandemic response.
    Vaccine. 2020 Oct 21. pii: S0264-410X(20)31364.

  672. FREUDENBURG-DE GRAAF W, Knol MJ, van der Ende A
    Predicted coverage by 4CMenB vaccine against invasive meningococcal disease cases in the Netherlands.
    Vaccine. 2020 Oct 20. pii: S0264-410X(20)31283.
    PubMed     Abstract available

  673. CHAKRABORTY C, Agoramoorthy G
    India's cost-effective COVID-19 vaccine development initiatives.
    Vaccine. 2020 Oct 20. pii: S0264-410X(20)31365.

  674. BELL S, Clarke R, Mounier-Jack S, Walker JL, et al
    Parents' and guardians' views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England.
    Vaccine. 2020 Oct 19. pii: S0264-410X(20)31321.
    PubMed     Abstract available

  675. ROSS JC, Saidu Y, Nzuobontane D, Voukings MZ, et al
    Application of the remaining vaccine vial monitor life calculation to field temperature monitoring data to improve visibility into cold chain equipment performance.
    Vaccine. 2020 Oct 17. pii: S0264-410X(20)31260.
    PubMed     Abstract available

  676. VOLKMANN A, Williamson AL, Weidenthaler H, Meyer TPH, et al
    The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform.
    Vaccine. 2020 Oct 17. pii: S0264-410X(20)31091.
    PubMed     Abstract available

  677. MALTEZOU HC, Theodora M, Lytras T, Fotiou A, et al
    Knowledge, attitudes and practices about vaccine-preventable diseases and vaccinations of children among pregnant women in Greece.
    Vaccine. 2020 Oct 16. pii: S0264-410X(20)31278.
    PubMed     Abstract available

  678. ABU-ELYAZEED R, Klein NP, Moerman L, Povey M, et al
    Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial.
    Vaccine. 2020 Oct 16. pii: S0264-410X(20)31122.
    PubMed     Abstract available

  679. KABORE L, Meda B, Medah I, Shendale S, et al
    Assessment of missed opportunities for vaccination (MOV) in Burkina Faso using the World Health Organization's revised MOV strategy: Findings and strategic considerations to improve routine childhood immunization coverage.
    Vaccine. 2020 Oct 16. pii: S0264-410X(20)31314.
    PubMed     Abstract available

  680. ZHAI Y, Santibanez TA, Kahn KE, Srivastav A, et al
    Rural, urban, and suburban differences in influenza vaccination coverage among children.
    Vaccine. 2020 Oct 15. pii: S0264-410X(20)31324.
    PubMed     Abstract available

  681. MO AXY, Pesce J, Augustine AD, Bodmer JL, et al
    Understanding vaccine-elicited protective immunity against pre-erythrocytic stage malaria in endemic regions.
    Vaccine. 2020 Oct 15. pii: S0264-410X(20)31253.
    PubMed     Abstract available

  682. VERGKIZI S, Nikolakakis I
    Bacillus Calmette-Guerin (BCG) vaccine generates immunoregulatory cells in the cervical lymph nodes in guinea pigs injected intra dermally.
    Vaccine. 2020 Oct 15. pii: S0264-410X(20)31284.
    PubMed     Abstract available

  683. GURWITH M, Condit RC, Excler JL, Robertson JS, et al
    Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines.
    Vaccine. 2020 Oct 15. pii: S0264-410X(20)31202.
    PubMed     Abstract available

  684. GARCIA PJ, George PE, Romero C, Soto G, et al
    "The flu... is a little more complicated than a cold": Knowledge, beliefs, and practices related to influenza and influenza vaccination among at-risk populations and health professionals in Peru.
    Vaccine. 2020 Oct 15. pii: S0264-410X(20)31236.
    PubMed     Abstract available

  685. BELL H, Kamal N, Wong U
    Blistering autoimmune skin reaction following SHINGRIX vaccination in an ulcerative colitis patient: Case report and literature review.
    Vaccine. 2020 Oct 13. pii: S0264-410X(20)31255.
    PubMed     Abstract available

  686. SEO Y, Pacifici E
    Elements of Regulatory Dissonance: Examining FDA and EMA Product Labeling of New Vaccines (2006-2018).
    Vaccine. 2020 Oct 12. pii: S0264-410X(20)31249.
    PubMed     Abstract available

  687. MALTEZOU HC, Theodoridou K, Tseroni M, Raftopoulos V, et al
    Influenza vaccination policies for health workers in low-income and middle-income countries: A cross-sectional survey, January-March 2020.
    Vaccine. 2020 Oct 12. pii: S0264-410X(20)31276.
    PubMed     Abstract available

  688. MO Y, Zeng J, Xiao C, Zhang, et al
    Effectiveness and safety of pneumococcal vaccines used alone or combined with influenza vaccination in dialysis patients: A systematic review and meta-analysis.
    Vaccine. 2020 Oct 12. pii: S0264-410X(20)31262.
    PubMed     Abstract available

  689. GOLDMAN RD, Yan TD, Seiler M, Parra Cotanda C, et al
    Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey.
    Vaccine. 2020 Oct 10. pii: S0264-410X(20)31317.
    PubMed     Abstract available

  690. BEYER WEP, Osterhaus ADME
    Bivalent AS04-adjuvanted HPV vaccine provides optimal cancer prevention for HPV types not included in the vaccine.
    Vaccine. 2020 Oct 10. pii: S0264-410X(20)31157.
    PubMed     Abstract available

  691. MCCLUNG N, Burnett J, Wejnert C, Markowitz LE, et al
    Human papillomavirus vaccination coverage among men who have sex with men-National HIV Behavioral Surveillance, United States, 2017.
    Vaccine. 2020 Oct 9. pii: S0264-410X(20)31081.
    PubMed     Abstract available

  692. SAFAVI A, Kefayat A, Mahdevar E, Abiri A, et al
    Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
    Vaccine. 2020 Oct 9. pii: S0264-410X(20)31307.
    PubMed     Abstract available

  693. RONCATI L, Vadala M, Corazzari V, Palmieri B, et al
    COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
    Vaccine. 2020 Oct 9. pii: S0264-410X(20)31303.
    PubMed     Abstract available

  694. SINGH JA
    COVID-19 vaccine trials: Duty of care and standard of prevention considerations.
    Vaccine. 2020 Oct 9. pii: S0264-410X(20)31302.

  695. LATOURETTE PC 2ND, Awasthi S, Desmond A, Pardi N, et al
    Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31261.
    PubMed     Abstract available

  696. THOMPSON HA, Hogan AB, Walker PGT, White MT, et al
    Modelling the roles of antibody titre and avidity in protection from Plasmodium falciparum malaria infection following RTS,S/AS01 vaccination.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31251.
    PubMed     Abstract available

  697. AUDREY S, Farr M, Roderick M, Evans K, et al
    How acceptable is adolescent self-consent for the HPV vaccination: Findings from a qualitative study in south-west England.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31256.
    PubMed     Abstract available

  698. THIELMANN A, Puth MT, Weltermann B
    Improving knowledge on vaccine storage management in general practices: Learning effectiveness of an online-based program.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31210.
    PubMed     Abstract available

  699. ADEIKALAM S, de Champs Leger H, Vignier N, Grabar S, et al
    Utility of the Tetanos Quick Stick(R) in the vaccine catch-up of adult migrants without proof of prior vaccination.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31231.
    PubMed     Abstract available

  700. DU F, Chantler T, Francis MR, Sun FY, et al
    The determinants of vaccine hesitancy in China: A cross-sectional study following the Changchun Changsheng vaccine incident.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31257.
    PubMed     Abstract available

  701. YAO L, Wang JY, Bao LN, Fan MX, et al
    DNA adjuvant Amiloride conjunct long immunization interval promote higher antibody responses to HIV-1 gp41 and gp140 immunogens.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31259.
    PubMed     Abstract available

  702. MACIAS AE, McElhaney JE, Chaves SS, Nealon J, et al
    The disease burden of influenza beyond respiratory illness.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31209.
    PubMed     Abstract available

  703. CROOKE SN, Haralambieva IH, Grill DE, Ovsyannikova IG, et al
    Corrigendum to "Seroprevalence and durability of rubella virus antibodies in a highly immunized population". [Vaccine 37 (2019) 3876-3882].
    Vaccine. 2020;38:6858.

  704. MILLER ER, McNeil MM, Moro PL, Duffy J, et al
    The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barre syndrome.
    Vaccine. 2020 Oct 7. pii: S0264-410X(20)31254.
    PubMed     Abstract available

  705. GUILFOYLE K, Major D, Skeldon S, James H, et al
    Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model.
    Vaccine. 2020 Oct 6. pii: S0264-410X(20)31233.
    PubMed     Abstract available

  706. BIOLCHI A, De Angelis G, Moschioni M, Tomei S, et al
    Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates.
    Vaccine. 2020 Oct 6. pii: S0264-410X(20)31220.
    PubMed     Abstract available

  707. LEE JKH, Lam GKL, Shin T, Samson SI, et al
    Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis.
    Vaccine. 2020 Oct 6. pii: S0264-410X(20)31146.
    PubMed     Abstract available

  708. WOLF J, Hansen R, Hassis K, Lapps W, et al
    The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases.
    Vaccine. 2020 Oct 5. pii: S0264-410X(20)31228.

  709. CHILENGI R, Simuyandi M, Chibuye M, Chirwa M, et al
    A pilot study on use of live attenuated rotavirus vaccine (Rotarix) as an infection challenge model.
    Vaccine. 2020 Oct 5. pii: S0264-410X(20)31177.
    PubMed     Abstract available

  710. LACK A, Hiligsmann M, Bloem P, Tunnessen M, et al
    Parent, provider and vaccinee preferences for HPV vaccination: A systematic review of discrete choice experiments.
    Vaccine. 2020 Oct 3. pii: S0264-410X(20)31133.
    PubMed     Abstract available

  711. CUSTERS J, Kim D, Leyssen M, Gurwith M, et al
    Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment.
    Vaccine. 2020 Oct 3. pii: S0264-410X(20)31160.
    PubMed     Abstract available

  712. HOSHI SL, Shono A, Seposo X, Okubo I, et al
    Cost-effectiveness analysis of influenza vaccination during pregnancy in Japan.
    Vaccine. 2020 Oct 2. pii: S0264-410X(20)31180.
    PubMed     Abstract available

  713. KATALANI C, Ahmadian G, Nematzadeh G, Amani J, et al
    Immunization with oral and parenteral subunit chimeric vaccine candidate confers protection against Necrotic Enteritis in chickens.
    Vaccine. 2020 Oct 2. pii: S0264-410X(20)31208.
    PubMed     Abstract available

  714. CARRASQUILLA G, Porras A, Martinez S, DeAntonio R, et al
    Incidence and mortality of pertussis disease in infants <12 months of age following introduction of pertussis maternal universal mass vaccination in Bogota, Colombia.
    Vaccine. 2020 Oct 1. pii: S0264-410X(20)30977.
    PubMed     Abstract available

  715. EZOE S, Palacpac NMQ, Tetsutani K, Yamamoto K, et al
    First-in-human randomised trial and follow-up study of Plasmodium falciparum blood-stage malaria vaccine BK-SE36 with CpG-ODN(K3).
    Vaccine. 2020 Oct 1. pii: S0264-410X(20)31227.
    PubMed     Abstract available

  716. FAKHRI O, Devlin JM, Browning GF, Coppo MJC, et al
    Superinfection and recombination of infectious laryngotracheitis virus vaccines in the natural host.
    Vaccine. 2020 Oct 1. pii: S0264-410X(20)31235.
    PubMed     Abstract available

  717. NIANG M, Deming ME, Goudiaby D, Diop OM, et al
    Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: Results from a cluster-randomized trial.
    Vaccine. 2020 Oct 1. pii: S0264-410X(20)31230.
    PubMed     Abstract available

    September 2020
  718. HAIMOWITZ R, Torres R, Caleb S, Thompson D, et al
    Serogroup B meningococcal vaccination practice patterns on college campuses.
    Vaccine. 2020 Sep 30. pii: S0264-410X(20)31195.
    PubMed     Abstract available

  719. LAWTON B, Howe AS, Turner N, Filoche S, et al
    Retraction notice to "Association of prior HPV vaccination with reduced preterm birth: A population based study" [Vaccine 36 (2018) 134-140].
    Vaccine. 2020;38:6658.

  720. HATTORI F, Kozawa K, Miura H, Kawamura Y, et al
    Trend in varicella patients 4 years after implementation of universal two-dose varicella vaccination in Japan.
    Vaccine. 2020 Sep 29. pii: S0264-410X(20)31198.
    PubMed     Abstract available

  721. CHARANIA NA, Gaze N, Kung JY, Brooks S, et al
    Interventions to reduce the burden of vaccine-preventable diseases among migrants and refugees worldwide: A scoping review of published literature, 2006-2018.
    Vaccine. 2020 Sep 29. pii: S0264-410X(20)31225.
    PubMed     Abstract available

  722. IMRAN KHAN M, Aijaz S, Syed FF, Kaljee L, et al
    An optimal typhoid conjugate vaccine coverage complemented with WASH is imperative for the control of antimicrobial resistance in Pakistan.
    Vaccine. 2020 Sep 29. pii: S0264-410X(20)31221.

  723. MUNSERI P, Said J, Amour M, Magohe A, et al
    DAR-901 vaccine for the prevention of infection with Mycobacterium tuberculosis among BCG-immunized adolescents in Tanzania: A randomized controlled, double-blind phase 2b trial.
    Vaccine. 2020 Sep 28. pii: S0264-410X(20)31226.
    PubMed     Abstract available

  724. FALKENBERG SM, Dassanayake RP, Palmer MV, Silveira S, et al
    Changes in circulating lymphocytes and lymphoid tissue associated with vaccination of colostrum deprived calves.
    Vaccine. 2020 Sep 25. pii: S0264-410X(20)31206.
    PubMed     Abstract available

  725. VIDANAPATHIRANA G, Angulmaduwa S, Munasinghe T, Ekanayake A, et al
    Pneumococcal colonization among healthy and hospitalized vaccine-naive Sri Lankan children.
    Vaccine. 2020 Sep 24. pii: S0264-410X(20)31200.
    PubMed     Abstract available

  726. JIMBO SOTOMAYOR R, Toscano CM, Sanchez Choez X, Vilema Ortiz M, et al
    Impact of pneumococcal conjugate vaccine on pneumonia hospitalization and mortality in children and elderly in Ecuador: Time series analyses.
    Vaccine. 2020 Sep 24. pii: S0264-410X(20)31192.
    PubMed     Abstract available

  727. LEE CHJ, Sibley CG
    Ethnic disparities in vaccine safety attitudes and perceptions of family doctors/general practitioners.
    Vaccine. 2020 Sep 24. pii: S0264-410X(20)31190.
    PubMed     Abstract available

  728. VAN DER GRAAF R, Macklin R, Rid A, Bhan A, et al
    Integrating public health programs and research after the malaria vaccine implementation program (MVIP): Recommendations for next steps.
    Vaccine. 2020 Sep 24. pii: S0264-410X(20)31132.
    PubMed     Abstract available

  729. CHRISTIANSON B, Sharif-Mohamed F, Heath J, Roddy M, et al
    Parental attitudes and decisions regarding MMR vaccination during an outbreak of measles among an undervaccinated Somali community in Minnesota.
    Vaccine. 2020 Sep 24. pii: S0264-410X(20)31176.
    PubMed     Abstract available

  730. SUN J, Han Z, Zhao R, Ai H, et al
    Protection of chicks from Newcastle disease by combined vaccination with a plasmid DNA and the pre-fusion protein of the virulent genotype VII of Newcastle disease virus.
    Vaccine. 2020 Sep 24. pii: S0264-410X(20)31199.
    PubMed     Abstract available

  731. ASHKENAZI S, Livni G, Klein A, Kremer N, et al
    The relationship between parental source of information and knowledge about measles / measles vaccine and vaccine hesitancy.
    Vaccine. 2020 Sep 24. pii: S0264-410X(20)31204.
    PubMed     Abstract available

  732. MACIAS SAINT-GERONS D, Sola Arnau I, De Mucio B, Arevalo-Rodriguez I, et al
    Adverse events associated with the use of recommended vaccines during pregnancy: An overview of systematic reviews.
    Vaccine. 2020 Sep 21. pii: S0264-410X(20)30979.
    PubMed     Abstract available

  733. WILLIAMS JTB, Miller A, O'Leary ST
    Sacred or secular? Exploring religious Coloradans' questions about vaccines.
    Vaccine. 2020 Sep 21. pii: S0264-410X(20)31194.

  734. Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: A self-controlled case series analysis.
    Vaccine. 2020 Sep 21. pii: S0264-410X(20)31161.
    PubMed     Abstract available

  735. FAUZIA MALIK A, Belizan M, Gutierrez M, Vilajeliu A, et al
    Pregnant women's perspectives about maternal immunization in Latin America Journal: Vaccine.
    Vaccine. 2020 Sep 21. pii: S0264-410X(20)31151.
    PubMed     Abstract available

  736. FAIX DJ, Gordon DM, Perry LN, Raymond-Loher I, et al
    Prospective safety surveillance study of ACAM2000 smallpox vaccine in deploying military personnel.
    Vaccine. 2020 Sep 20. pii: S0264-410X(20)31197.
    PubMed     Abstract available

  737. ISTRATE A, Azoicai D, Almas A, Radulescu A, et al
    Variable anti-HBs antibody titers in vaccinated birth cohorts - A cross-sectional population-based study.
    Vaccine. 2020 Sep 19. pii: S0264-410X(20)31184.
    PubMed     Abstract available

  738. JENNINGS MC, Manchester C, Sauer M
    Navigating country decisions in response to a global rotavirus vaccine shortage.
    Vaccine. 2020 Sep 18. pii: S0264-410X(20)31131.

  739. ANDREW MK, McNeil SA
    Influenza vaccination and the evolution of evidence-based recommendations for older adults: A Canadian perspective.
    Vaccine. 2020 Sep 18. pii: S0264-410X(20)31153.
    PubMed     Abstract available

  740. LI Q, Ren J, Xian H, Yin C, et al
    rOmpF and OMVs as efficient subunit vaccines against Salmonella enterica serovar Enteritidis infections in poultry farms.
    Vaccine. 2020 Sep 17. pii: S0264-410X(20)31126.
    PubMed     Abstract available

  741. ROMANUTTI C, Keller L, Zanetti FA
    Current status of virus-vectored vaccines against pathogens that affect poultry.
    Vaccine. 2020 Sep 17. pii: S0264-410X(20)31155.
    PubMed     Abstract available

  742. LEE CHJ, Overall NC, Sibley CG
    Maternal and paternal confidence in vaccine safety: Whose attitudes are predictive of children's vaccination?
    Vaccine. 2020 Sep 17. pii: S0264-410X(20)31163.
    PubMed     Abstract available

  743. DETOC M, Bruel S, Frappe P, Tardy B, et al
    Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic.
    Vaccine. 2020 Sep 17. pii: S0264-410X(20)31201.
    PubMed     Abstract available

  744. HE Y, Wang M, Chen S, Cheng A, et al
    The role of capsid in the flaviviral life cycle and perspectives for vaccine development.
    Vaccine. 2020 Sep 16. pii: S0264-410X(20)31094.
    PubMed     Abstract available

  745. ALHALASEH L, Fayoumi H, Khalil B
    The Health Belief Model in predicting healthcare workers' intention for influenza vaccine uptake in Jordan.
    Vaccine. 2020 Sep 16. pii: S0264-410X(20)31128.
    PubMed     Abstract available

  746. DEAN NE, Pastore Y Piontti A, Madewell ZJ, Cummings DAT, et al
    Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials.
    Vaccine. 2020 Sep 15. pii: S0264-410X(20)31191.
    PubMed     Abstract available

  747. MCMAHON M, Strohmeier S, Rajendran M, Capuano C, et al
    Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice.
    Vaccine. 2020 Sep 15. pii: S0264-410X(20)31119.
    PubMed     Abstract available

  748. BAUER KA, Johnson K, Stephenson JJ, Visaria J, et al
    Rate of preventative vaccine use and vaccine beliefs among a commercially insured population.
    Vaccine. 2020 Sep 14. pii: S0264-410X(20)31127.
    PubMed     Abstract available

  749. DADARI I, Ssenyonjo J, Anga J
    Effective vaccine management through social behavior change communication: Exploring solutions using a participatory action research approach in the Solomon Islands.
    Vaccine. 2020 Sep 14. pii: S0264-410X(20)31109.
    PubMed     Abstract available

  750. SHOME R, Kilari S, Sahare A, Kalleshamurthy T, et al
    Evaluation of the immune responses against reduced doses of Brucella abortus S19 (calfhood) vaccine in water buffaloes (Bubalus bubalis), India.
    Vaccine. 2020 Sep 14. pii: S0264-410X(20)31152.
    PubMed     Abstract available

  751. HOSOMI K, Kunisawa J
    Impact of the intestinal environment on the immune responses to vaccination.
    Vaccine. 2020 Sep 12. pii: S0264-410X(20)31162.
    PubMed     Abstract available

  752. GUY B
    Combine two different dengue vaccines could efficiently target dengue-naive subjects. Comment to Macias A, Ruiz-Palacios G, Ramos-Castaneda J. Combine dengue vaccines to optimize effectiveness. Vaccine. 2020 Jun 26;38(31):4801-4804.
    Vaccine. 2020 Sep 11. pii: S0264-410X(20)31129.

  753. CONWAY JH, Davis JP, Eickhoff JC, Pool V, et al
    Brand-specific rates of pertussis disease among Wisconsin children given 1-4 doses of pertussis Vaccine, 2010-2014.
    Vaccine. 2020 Sep 10. pii: S0264-410X(20)31158.
    PubMed     Abstract available

  754. VAN RIJN PA, Maris-Veldhuis MA, Grobler M, Wright IM, et al
    Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants.
    Vaccine. 2020 Sep 10. pii: S0264-410X(20)31124.
    PubMed     Abstract available

  755. WANG K, Wong ELY, Ho KF, Cheung AWL, et al
    Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional survey.
    Vaccine. 2020 Sep 10. pii: S0264-410X(20)31175.
    PubMed     Abstract available

  756. ZANONI G, Migliorini M, Gallo T, Guidolin L, et al
    Recurrent injection site reactions to vaccines: Two clinical patterns of presentation.
    Vaccine. 2020 Sep 9. pii: S0264-410X(20)31125.
    PubMed     Abstract available

  757. HOLROYD TA, Sauer MA, Limaye RJ
    Vaccine decision-making among parents of children on Medicaid with and without autism spectrum disorder.
    Vaccine. 2020 Sep 8. pii: S0264-410X(20)31082.
    PubMed     Abstract available

  758. TU S, Sun FY, Chantler T, Zhang X, et al
    Caregiver and service provider vaccine confidence following the Changchun Changsheng vaccine incident in China: A cross-sectional mixed methods study.
    Vaccine. 2020 Sep 7. pii: S0264-410X(20)31115.
    PubMed     Abstract available

  759. CHAPMAN R, Sutton K, Dillon-Murphy D, Patel S, et al
    Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis.
    Vaccine. 2020 Sep 7. pii: S0264-410X(20)31120.
    PubMed     Abstract available

  760. CONDIT RC, Kim D, Robertson JS, Excler JL, et al
    The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines.
    Vaccine. 2020 Sep 6. pii: S0264-410X(20)31030.
    PubMed     Abstract available

  761. KROW-LUCAL ER, Laven J, Perry L, Biggerstaff BJ, et al
    Immune response at 12-23 months following a single dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine.
    Vaccine. 2020 Sep 6. pii: S0264-410X(20)31113.
    PubMed     Abstract available

  762. MOSA AI, Urbanowicz RA, AbouHaidar MG, Tavis JE, et al
    A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in mice.
    Vaccine. 2020 Sep 5. pii: S0264-410X(20)31118.
    PubMed     Abstract available

  763. GERARD AL, Goulenok T, Bahuaud M, Francois C, et al
    Serum IgG2 levels predict long-term protection following pneumococcal vaccination in systemic lupus erythematosus (SLE).
    Vaccine. 2020 Sep 4. pii: S0264-410X(20)31117.
    PubMed     Abstract available

  764. LEPILLER Q, Bouiller K, Slekovec C, Millot D, et al
    Perceptions of French healthcare students of vaccines and the impact of conducting an intervention in health promotion.
    Vaccine. 2020 Sep 4. pii: S0264-410X(20)31077.
    PubMed     Abstract available

  765. KAUCLEY L, Essoh TA, Ilboudo GP, Abdoulaye Alfa D, et al
    Decision making process, programmatic and logistic impact of the transition from a single-dose vial to a multi-dose vial of the 13-valent pneumococcal vaccine in Benin.
    Vaccine. 2020 Sep 3. pii: S0264-410X(20)31070.
    PubMed     Abstract available

  766. JAFFE E, Lyerly AD, Goldfarb IT
    Pregnant women's perceptions of risks and benefits when considering participation in vaccine trials.
    Vaccine. 2020 Sep 3. pii: S0264-410X(20)31111.
    PubMed     Abstract available

  767. OTIENO NA, Nyawanda B, Otiato F, Adero M, et al
    Knowledge and attitudes towards influenza and influenza vaccination among pregnant women in Kenya.
    Vaccine. 2020 Sep 3. pii: S0264-410X(20)31046.
    PubMed     Abstract available

  768. ENUJIOKE SC, Shedd-Steele R, Daggy J, Burney H, et al
    County-level correlates of missed opportunities for HPV vaccination in Indiana: An environmental scan.
    Vaccine. 2020 Sep 2. pii: S0264-410X(20)31089.
    PubMed     Abstract available

  769. LAU LHW, Lee SS, Wong NS
    The continuum of influenza vaccine hesitancy among nursing professionals in Hong Kong.
    Vaccine. 2020 Sep 2. pii: S0264-410X(20)31079.
    PubMed     Abstract available

  770. SLYKE GV, Ehrbar DJ, Doering J, Yates JL, et al
    Endpoint and epitope-specific antibody responses as correlates of vaccine-mediated protection of mice against ricin toxin.
    Vaccine. 2020 Sep 2. pii: S0264-410X(20)31088.
    PubMed     Abstract available

  771. HE Q, Wang H, Ma Y, Wang Z, et al
    Changes in parents' decisions pertaining to vaccination of their children after the Changchun Changsheng vaccine scandal in Guangzhou, China.
    Vaccine. 2020 Sep 2. pii: S0264-410X(20)31080.
    PubMed     Abstract available

  772. ZUO S, Zhang D, Mu Q, Dai L, et al
    Increasing vaccination coverage: The school entry vaccination record check program in Guizhou Province China, 2003-2018.
    Vaccine. 2020 Sep 2. pii: S0264-410X(20)31096.
    PubMed     Abstract available

  773. O'RYAN M, Calvo AE, Espinoza M, Vega N, et al
    Parent reported outcomes to measure satisfaction, acceptability, and daily life impact after vaccination with whole-cell and acellular pertussis vaccine in Chile.
    Vaccine. 2020 Sep 1. pii: S0264-410X(20)31087.
    PubMed     Abstract available

  774. BIANCHI-JASSIR F, Paul P, To KN, Carreras-Abad C, et al
    Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates.
    Vaccine. 2020 Sep 1. pii: S0264-410X(20)31093.
    PubMed     Abstract available

  775. WANLAPAKORN N, Maertens K, Thongmee T, Srimuan D, et al
    Levels of antibodies specific to diphtheria toxoid, tetanus toxoid, and Haemophilus influenzae type b in healthy children born to Tdap-vaccinated mothers.
    Vaccine. 2020 Sep 1. pii: S0264-410X(20)31110.
    PubMed     Abstract available

  776. CROUCH CF, Nell T, Reijnders M, Donkers T, et al
    Safety and efficacy of a novel inactivated trivalent Salmonella enterica vaccine in chickens.
    Vaccine. 2020 Sep 1. pii: S0264-410X(20)31074.
    PubMed     Abstract available

    Adjuvants for swine vaccines: Mechanisms of actions and adjuvant effects.
    Vaccine. 2020 Sep 1. pii: S0264-410X(20)31095.
    PubMed     Abstract available

    August 2020
  778. CALZETTA L, Pistocchini E, Ritondo BL, Roncada P, et al
    Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union.
    Vaccine. 2020 Aug 31. pii: S0264-410X(20)31092.
    PubMed     Abstract available

  779. SWAMY GK, Metz TD, Edwards KM, Soper DE, et al
    Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: Results from a randomized placebo-controlled phase II trial.
    Vaccine. 2020 Aug 31. pii: S0264-410X(20)31108.
    PubMed     Abstract available

  780. FINDLOW J, Bayliss CD, Beernink PT, Borrow R, et al
    Broad vaccine protection against Neisseria meningitidis using factor H binding protein.
    Vaccine. 2020 Aug 30. pii: S0264-410X(20)31072.
    PubMed     Abstract available

  781. MARCHETTI RL, Gallucci-Neto J, Kurcgant D, Proenca ICGF, et al
    Immunization stress-related responses presenting as psychogenic non-epileptic seizures following HPV vaccination in Rio Branco, Brazil.
    Vaccine. 2020 Aug 30. pii: S0264-410X(20)31085.
    PubMed     Abstract available

  782. SHERWOOD J, Mendelman PM, Lloyd E, Liu M, et al
    Efficacy of an intramuscular bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate in healthy US adults.
    Vaccine. 2020 Aug 30. pii: S0264-410X(20)31013.
    PubMed     Abstract available

  783. KASE T, Inoue M, Morikawa S, Kumashiro H, et al
    Comparison of immunogenicity between candidate influenza A(H3N2) virus vaccine strains in Japan: A randomized controlled trial using a monovalent vaccine of A/Saitama/103/2014 (CEXP-002) and A/Hong Kong/4801/2014 (X-263).
    Vaccine. 2020 Aug 29. pii: S0264-410X(20)31066.
    PubMed     Abstract available

  784. MCCOLLUM ED, Ahmed S, Roy AD, Chowdhury NH, et al
    Effectiveness of the 10-valent pneumococcal conjugate vaccine against radiographic pneumonia among children in rural Bangladesh: A case-control study.
    Vaccine. 2020 Aug 29. pii: S0264-410X(20)31076.
    PubMed     Abstract available

  785. TALAYEV V, Zaichenko I, Svetlova M, Matveichev A, et al
    Low-dose influenza vaccine Grippol Quadrivalent with adjuvant Polyoxidonium induces a T helper-2 mediated humoral immune response and increases NK cell activity.
    Vaccine. 2020 Aug 29. pii: S0264-410X(20)30984.
    PubMed     Abstract available

  786. AMIN AB, Nunes MC, Tapia MD, Madhi SA, et al
    Immunogenicity of influenza vaccines administered to pregnant women in randomized clinical trials in Mali and South Africa.
    Vaccine. 2020 Aug 28. pii: S0264-410X(20)30933.
    PubMed     Abstract available

  787. HOWE AS, Pointon L, Gauld N, Paynter J, et al
    Pertussis and influenza immunisation coverage of pregnant women in New Zealand.
    Vaccine. 2020 Aug 28. pii: S0264-410X(20)31071.
    PubMed     Abstract available

  788. HARAPAN H, Wagner AL, Yufika A, Setiawan AM, et al
    Acceptance and willingness to pay for a hypothetical vaccine against monkeypox viral infection among frontline physicians: A cross-sectional study in Indonesia.
    Vaccine. 2020 Aug 26. pii: S0264-410X(20)31075.
    PubMed     Abstract available

  789. GIUFRE M, Lindh E, Cardines R, Pezzotti P, et al
    Invasive Haemophilus influenzae type b (Hib) disease in children in Italy, after 20 years of routine use of conjugate Hib vaccines.
    Vaccine. 2020 Aug 25. pii: S0264-410X(20)31061.
    PubMed     Abstract available

  790. GERHARDT CMB, Castro APBM, Pastorino AC, Dorna MB, et al
    Safety of yellow fever vaccine administration in confirmed egg-allergic patients.
    Vaccine. 2020 Aug 20. pii: S0264-410X(20)31051.
    PubMed     Abstract available

  791. VU M, Berg CJ, Escoffery C, Jang HM, et al
    A systematic review of practice-, provider-, and patient-level determinants impacting Asian-Americans' human papillomavirus vaccine intention and uptake.
    Vaccine. 2020 Aug 20. pii: S0264-410X(20)30990.
    PubMed     Abstract available

  792. TOMITA Y, Sato R, Ikeda T, Sakagami T, et al
    BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
    Vaccine. 2020 Aug 20. pii: S0264-410X(20)31086.
    PubMed     Abstract available

  793. REITER PL, Pennell ML, Katz ML
    Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?
    Vaccine. 2020 Aug 20. pii: S0264-410X(20)31084.
    PubMed     Abstract available

  794. LELEUX JA, Albershardt TC, Parsons AJ, Ter Meulen J, et al
    ZVex, a dendritic-cell-tropic lentivector, primes protective antitumor T cell responses that are significantly boosted using heterologous vaccine modalities.
    Vaccine. 2020 Aug 19. pii: S0264-410X(20)31023.
    PubMed     Abstract available

  795. PAGET J, Caini S, Cowling B, Esposito S, et al
    The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies.
    Vaccine. 2020 Aug 19. pii: S0264-410X(20)31065.

  796. GALILI U
    Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present alpha-gal epitopes.
    Vaccine. 2020 Aug 19. pii: S0264-410X(20)31073.
    PubMed     Abstract available

  797. ZHOU F, Lindley MC
    Variability in influenza vaccination opportunities and coverage among privately insured children.
    Vaccine. 2020 Aug 18. pii: S0264-410X(20)30992.
    PubMed     Abstract available

  798. HUNG MC, Lu PJ, Srivastav A, Cheng YJ, et al
    Influenza vaccination coverage among adults with diabetes, United States, 2007-08 through 2017-18 seasons.
    Vaccine. 2020 Aug 17. pii: S0264-410X(20)31029.
    PubMed     Abstract available

  799. NEWMAN KL, Stewart LM, Scott EM, Tielsch JM, et al
    Assessment of indirect protection from maternal influenza immunization among non-vaccinated household family members in a randomized controlled trial in Sarlahi, Nepal.
    Vaccine. 2020 Aug 17. pii: S0264-410X(20)31045.
    PubMed     Abstract available

  800. BRUCE MG, Meites E, Bulkow L, Panicker G, et al
    A prospective cohort study of immunogenicity of quadrivalent human papillomavirus vaccination among Alaska Native Children, Alaska, United States.
    Vaccine. 2020 Aug 16. pii: S0264-410X(20)31026.
    PubMed     Abstract available

  801. BECK E, Klint J, Garcia S, Abbing V, et al
    Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: An application to England.
    Vaccine. 2020 Aug 14. pii: S0264-410X(20)31028.
    PubMed     Abstract available

  802. VON LINSTOW ML, Nordmann Winther T, Eltvedt A, Bybeck Nielsen A, et al
    Self-reported immunity and opinions on vaccination of hospital personnel among paediatric healthcare workers in Denmark.
    Vaccine. 2020 Aug 12. pii: S0264-410X(20)31031.
    PubMed     Abstract available

  803. BENNETT N, Crouch S, Hoskins A, Malloy MJ, et al
    'Closing the gap': Evaluating the success of non-mandatory strategies for influenza vaccination of Victorian healthcare workers.
    Vaccine. 2020 Aug 12. pii: S0264-410X(20)31044.
    PubMed     Abstract available

  804. BALASUBRAMANI GK, Choi WS, Nowalk MP, Zimmerman RK, et al
    Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19.
    Vaccine. 2020 Aug 12. pii: S0264-410X(20)31032.
    PubMed     Abstract available

  805. WOLDEYOHANNES SM, Perkins NR, Baker P, Gilks CF, et al
    Q fever vaccine efficacy and occupational exposure risk in Queensland, Australia: A retrospective cohort study.
    Vaccine. 2020 Aug 11. pii: S0264-410X(20)31027.
    PubMed     Abstract available

  806. CONTRERAS M, San Jose C, Estrada-Pena A, Talavera V, et al
    Control of tick infestations in wild roe deer (Capreolus capreolus) vaccinated with the Q38 Subolesin/Akirin chimera.
    Vaccine. 2020 Aug 11. pii: S0264-410X(20)31004.
    PubMed     Abstract available

  807. GRADY C, Shah S, Miller F, Danis M, et al
    So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development.
    Vaccine. 2020 Aug 11. pii: S0264-410X(20)31048.
    PubMed     Abstract available

  808. KASSIANOS G, MacDonald P, Aloysius I, Reynolds A, et al
    Implementation of the United Kingdom's childhood influenza national vaccination programme: A review of clinical impact and lessons learned over six influenza seasons.
    Vaccine. 2020;38:5747-5758.
    PubMed     Abstract available

  809. MONSLOW MA, Elbashir S, Sullivan NL, Thiriot DS, et al
    Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates.
    Vaccine. 2020;38:5793-5802.
    PubMed     Abstract available

  810. FREW PM, Paine MB, Rouphael N, Schamel J, et al
    Acceptability of an inactivated influenza vaccine delivered by microneedle patch: Results from a phase I clinical trial of safety, reactogenicity, and immunogenicity.
    Vaccine. 2020 Aug 10. pii: S0264-410X(20)31006.
    PubMed     Abstract available

  811. YITBAREK K, Abraham G, Girma T, Tilahun T, et al
    The effect of Bacillus Calmette-Guerin (BCG) vaccination in preventing sever infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
    Vaccine. 2020 Aug 10. pii: S0264-410X(20)31049.
    PubMed     Abstract available

  812. KAWAKATSU Y, Oyeniyi Adesina A, Kadoi N, Aiga H, et al
    Cost-effectiveness of SMS appointment reminders in increasing vaccination uptake in Lagos, Nigeria: A multi-centered randomized controlled trial.
    Vaccine. 2020 Aug 9. pii: S0264-410X(20)31019.
    PubMed     Abstract available

  813. CADEDDU C, Daugbjerg S, Ricciardi W, Rosano A, et al
    Beliefs towards vaccination and trust in the scientific community in Italy.
    Vaccine. 2020 Aug 9. pii: S0264-410X(20)31020.
    PubMed     Abstract available

  814. GESUALDO F, Marino F, Mantero J, Spadoni A, et al
    The use of web analytics combined with other data streams for tailoring online vaccine safety information at global level: The Vaccine Safety Net's web analytics project.
    Vaccine. 2020 Aug 9. pii: S0264-410X(20)31014.
    PubMed     Abstract available

  815. MARTIN S, Kilich E, Dada S, Kummervold PE, et al
    "Vaccines for pregnant women...?! Absurd" - Mapping maternal vaccination discourse and stance on social media over six months.
    Vaccine. 2020 Aug 9. pii: S0264-410X(20)31016.
    PubMed     Abstract available

  816. PRADHAN R, Sharma Gautam J, Tinkari BS, Adhikari N, et al
    Vaccine safety surveillance informs public health policy beyond immunization: A case-series on bleeding following vaccination, Nepal, 2016-2018.
    Vaccine. 2020 Aug 9. pii: S0264-410X(20)30953.
    PubMed     Abstract available

  817. RACINE E, Gilca V, Amini R, Tunis M, et al
    A systematic literature review of the recombinant subunit herpes zoster vaccine use in immunocompromised 18-49 year old patients.
    Vaccine. 2020 Aug 9. pii: S0264-410X(20)30980.
    PubMed     Abstract available

  818. ANRAAD C, Lehmann BA, Visser O, van Empelen P, et al
    Social-psychological determinants of maternal pertussis vaccination acceptance during pregnancy among women in the Netherlands.
    Vaccine. 2020 Aug 8. pii: S0264-410X(20)30978.
    PubMed     Abstract available

  819. STUURMAN AL, Bollaerts K, Alexandridou M, Biccler J, et al
    Vaccine effectiveness against laboratory-confirmed influenza in Europe - Results from the DRIVE network during season 2018/19.
    Vaccine. 2020 Aug 7. pii: S0264-410X(20)31005.
    PubMed     Abstract available

  820. SOWE A, Gariboldi MI
    An assessment of the quality of vaccination data produced through smart paper technology in The Gambia.
    Vaccine. 2020 Aug 7. pii: S0264-410X(20)31018.
    PubMed     Abstract available

  821. CHAN MS, Jamieson KH, Albarracin D
    Prospective associations of regional social media messages with attitudes and actual vaccination: A big data and survey study of the influenza vaccine in the United States.
    Vaccine. 2020 Aug 6. pii: S0264-410X(20)30985.
    PubMed     Abstract available

  822. KLEIN BY
    Newborn BCG vaccination complemented by boosting correlates better with reduced juvenile diabetes in females, than vaccination alone.
    Vaccine. 2020 Aug 6. pii: S0264-410X(20)31008.
    PubMed     Abstract available

  823. HUANG YC, Wu FT, Huang YC, Liu CC, et al
    Long-term effectiveness of pentavalent and monovalent rotavirus vaccines against hospitalization in Taiwan children.
    Vaccine. 2020 Aug 4. pii: S0264-410X(20)31011.
    PubMed     Abstract available

  824. JENTSCHKE M, Kampers J, Becker J, Sibbertsen P, et al
    Prophylactic HPV vaccination after conization: A systematic review and meta-analysis.
    Vaccine. 2020 Aug 4. pii: S0264-410X(20)30986.
    PubMed     Abstract available

  825. MOTTA M
    Could concern about climate change increase demand for a Lyme disease vaccine in the U.S.?
    Vaccine. 2020 Aug 3. pii: S0264-410X(20)30991.

  826. SZILAGYI PG, Albertin CS, Gurfinkel D, Saville AW, et al
    Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US.
    Vaccine. 2020 Aug 2. pii: S0264-410X(20)30877.
    PubMed     Abstract available

  827. MARELLAPUDI A, King AR, Bednarczyk RA
    Presentation of caregiver-specific vaccine-related information on National Cancer Institute designated cancer center websites.
    Vaccine. 2020 Aug 1. pii: S0264-410X(20)30983.
    PubMed     Abstract available

    July 2020
  828. REN W, Sun H, Gao GF, Chen J, et al
    Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates.
    Vaccine. 2020;38:5653-5658.
    PubMed     Abstract available

  829. YAN S, Chen H, Zhang Z, Chang S, et al
    Immunogenicity and safety of different sequential schedules of Sabin strain-based inactivated poliovirus vaccination: A randomized, controlled, open-label, phase IV clinical trial in China.
    Vaccine. 2020 Jul 31. pii: S0264-410X(20)30971.
    PubMed     Abstract available

  830. MYERS TR, McNeil MM, Ng CS, Li R, et al
    Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra(R)) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016.
    Vaccine. 2020 Jul 31. pii: S0264-410X(20)30957.
    PubMed     Abstract available

  831. KOCHHAR S, Excler JL, Kim D, Robertson JS, et al
    The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines.
    Vaccine. 2020 Jul 31. pii: S0264-410X(20)30944.
    PubMed     Abstract available

  832. WANG S, Zheng Y, Jin X, Gan Z, et al
    Efficacy and safety of a live attenuated influenza vaccine in Chinese healthy children aged 3-17 years in one study center of a randomized, double-blind, placebo-controlled phase 3 clinical trial, 2016/17 season.
    Vaccine. 2020 Jul 31. pii: S0264-410X(20)30932.
    PubMed     Abstract available

  833. FORMAN R, Anderson M, Jit M, Mossialos E, et al
    Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines.
    Vaccine. 2020 Jul 31. pii: S0264-410X(20)31012.

  834. CELZO F, Buyse H, Welby S, Ibrahimi A, et al
    Safety evaluation of adverse events following vaccination with Havrix, Engerix-B or Twinrix during pregnancy.
    Vaccine. 2020 Jul 30. pii: S0264-410X(20)30970.
    PubMed     Abstract available

  835. MONALISA MENDES DANTAS SALES N, Azevedo J, Teles Bastos Ribeiro M, Fonseca de Freitas H, et al
    Long-term impacts of MenC vaccination campaign in the Salvador, Brazil metropolitan region: A comparison of pre- and post-vaccine periods.
    Vaccine. 2020 Jul 30. pii: S0264-410X(20)30974.
    PubMed     Abstract available

  836. XIAO Y, Zeng Y, Schante C, Joshi SB, et al
    Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus.
    Vaccine. 2020 Jul 30. pii: S0264-410X(20)30931.
    PubMed     Abstract available

  837. YEOLEKAR LR, Guilfoyle K, Ganguly M, Tyagi P, et al
    Immunogenicity and efficacy comparison of MDCK cell-based and egg-based live attenuated influenza vaccines of H5 and H7 subtypes in ferrets.
    Vaccine. 2020 Jul 30. pii: S0264-410X(20)30972.
    PubMed     Abstract available

  838. ZHANG T, Liu Y, Chen Y, Wang A, et al
    A single dose glycoprotein D-based subunit vaccine against pseudorabies virus infection.
    Vaccine. 2020 Jul 30. pii: S0264-410X(20)30941.
    PubMed     Abstract available

  839. MAZAGATOS C, Godoy P, Munoz Almagro C, Pozo F, et al
    Effectiveness of influenza vaccination during pregnancy to prevent severe infection in children under 6 months of age, Spain, 2017-2019.
    Vaccine. 2020 Jul 30. pii: S0264-410X(20)30914.
    PubMed     Abstract available

  840. ELLISON TJ, Talbott GC, Henderson DR
    VaxiPatch, a novel vaccination system comprised of subunit antigens, adjuvants and microneedle skin delivery: An application to influenza B/Colorado/06/2017.
    Vaccine. 2020 Jul 30. pii: S0264-410X(20)30958.
    PubMed     Abstract available

  841. DIVINO V, Krishnarajah G, Pelton SI, Mould-Quevedo J, et al
    A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season.
    Vaccine. 2020 Jul 29. pii: S0264-410X(20)30936.
    PubMed     Abstract available

  842. KIM YH, Bang YJ, Park HJ, Li Ko H, et al
    Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection.
    Vaccine. 2020 Jul 29. pii: S0264-410X(20)30935.
    PubMed     Abstract available

  843. MALTEZOU HC, Theodoridou K, Poland G
    Influenza immunization and COVID-19.
    Vaccine. 2020 Jul 29. pii: S0264-410X(20)30989.

  844. HUANG WT, Juan YC, Liu CH, Yang YY, et al
    Intussusception and Kawasaki disease after rotavirus vaccination in Taiwanese infants.
    Vaccine. 2020 Jul 28. pii: S0264-410X(20)30956.
    PubMed     Abstract available

  845. CORNALL AM, Saville M, Pyman J, Callegari ET, et al
    HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.
    Vaccine. 2020 Jul 28. pii: S0264-410X(20)30955.
    PubMed     Abstract available

  846. HARPAZ R
    Teach your parents well: Pediatric recipients of varicella vaccines yield insights for adults regarding herpes zoster.
    Vaccine. 2020 Jul 27. pii: S0264-410X(20)30973.

  847. GOIN-KOCHEL RP, Fombonne E, Mire SS, Minard CG, et al
    Beliefs about causes of autism and vaccine hesitancy among parents of children with autism spectrum disorder.
    Vaccine. 2020 Jul 27. pii: S0264-410X(20)30952.
    PubMed     Abstract available

  848. KIM HM, Kim DY, Kang YM, Cho HK, et al
    Immunogenicity and protective efficacy of clade and clade H5Nx avian influenza antigen bank vaccines in mice, Korea.
    Vaccine. 2020 Jul 27. pii: S0264-410X(20)30951.

  849. CHU K, Xu K, Tang R, Tian X, et al
    Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: A randomized, double-blind, controlled phase III study in healthy population aged >/=3 years.
    Vaccine. 2020 Jul 27. pii: S0264-410X(20)30872.
    PubMed     Abstract available

  850. DIB F, Mayaud P, Launay O, Chauvin P, et al
    Design and content validation of a survey questionnaire assessing the determinants of human papillomavirus (HPV) vaccine hesitancy in France: A reactive Delphi study.
    Vaccine. 2020 Jul 25. pii: S0264-410X(20)30943.
    PubMed     Abstract available

  851. VERDIJK P, van der Plas JL, van Brummelen EMJ, Jeeninga RE, et al
    First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial.
    Vaccine. 2020 Jul 25. pii: S0264-410X(20)30947.
    PubMed     Abstract available

  852. KAVIAN N, Hachim A, Poon LLM, Valkenburg SA, et al
    Vaccination with ADCC activating HA peptide epitopes provides 1 partial protection from influenza infection.
    Vaccine. 2020 Jul 24. pii: S0264-410X(20)30908.
    PubMed     Abstract available

  853. CHEN Q, Zhao H, Yao X, Lin Z, et al
    Comparing immunogenicity of the Escherichia coli-produced bivalent human papillomavirus vaccine in females of different ages.
    Vaccine. 2020 Jul 24. pii: S0264-410X(20)30948.
    PubMed     Abstract available

  854. WEI J, Li Z, Yang Y, Ma X, et al
    A biomimetic VLP influenza vaccine with interior NP/exterior M2e antigens constructed through a temperature shift-based encapsulation strategy.
    Vaccine. 2020 Jul 23. pii: S0264-410X(20)30915.
    PubMed     Abstract available

  855. LEBRUN-HARRIS LA, Mendel Van Alstyne JA, Sripipatana A
    Influenza vaccination among U.S. pediatric patients receiving care from federally funded health centers.
    Vaccine. 2020 Jul 23. pii: S0264-410X(20)30934.
    PubMed     Abstract available

  856. MACLAUGHLIN KL, Jacobson RM, Sauver JLS, Jacobson DJ, et al
    An innovative housing-related measure for individual socioeconomic status and human papillomavirus vaccination coverage: A population-based cross-sectional study.
    Vaccine. 2020 Jul 23. pii: S0264-410X(20)30942.
    PubMed     Abstract available

  857. TSANG SH, Basu P, Bender N, Herrero R, et al
    Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines.
    Vaccine. 2020 Jul 23. pii: S0264-410X(20)30917.
    PubMed     Abstract available

  858. MARSHALL HS, Koehler AP, Wang B, A'Houre M, et al
    Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia.
    Vaccine. 2020 Jul 22. pii: S0264-410X(20)30909.
    PubMed     Abstract available

  859. BUKOWINSKI AT, Hall C, Chang RN, Gumbs GR, et al
    Maternal and infant outcomes following exposure to quadrivalent human papillomavirus vaccine during pregnancy.
    Vaccine. 2020 Jul 22. pii: S0264-410X(20)30876.
    PubMed     Abstract available

  860. MORO PL, Woo EJ, Marquez P, Cano M, et al
    Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011 - 2019.
    Vaccine. 2020 Jul 21. pii: S0264-410X(20)30907.
    PubMed     Abstract available

  861. HEALY CM, Rench MA, Swaim LS, Timmins A, et al
    Kinetics of maternal pertussis-specific antibodies in infants of mothers vaccinated with tetanus, diphtheria and acellular pertussis (Tdap) during pregnancy.
    Vaccine. 2020 Jul 21. pii: S0264-410X(20)30836.
    PubMed     Abstract available

  862. PHILLIPS A, Hickie M, Totterdell J, Brotherton J, et al
    Adverse events following HPV vaccination: 11 years of surveillance in Australia.
    Vaccine. 2020 Jul 21. pii: S0264-410X(20)30825.
    PubMed     Abstract available

  863. HOFF BM, Livingston MD 3rd, Thompson EL
    The association between state Medicaid expansion and human papillomavirus vaccination.
    Vaccine. 2020 Jul 21. pii: S0264-410X(20)30937.
    PubMed     Abstract available

  864. DEL SIGNORE C, Hemmendinger A, Khanafer N, Thierry J, et al
    Acceptability and perception of the herpes zoster vaccine in the 65 and over population: A French observational study.
    Vaccine. 2020 Jul 20. pii: S0264-410X(20)30904.
    PubMed     Abstract available

  865. KRUDWIG K, Knittel B, Karim A, Kanagat N, et al
    The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia.
    Vaccine. 2020 Jul 20. pii: S0264-410X(20)30912.
    PubMed     Abstract available

  866. TOTH DJA, Keegan LT, Samore MH, Khader K, et al
    Modeling the potential impact of administering vaccines against Clostridioides difficile infection to individuals in healthcare facilities.
    Vaccine. 2020 Jul 20. pii: S0264-410X(20)30884.
    PubMed     Abstract available

  867. MOSENA ACS, Falkenberg SM, Ma H, Casas E, et al
    Multivariate analysis as a method to evaluate antigenic relationships between BVDV vaccine and field strains.
    Vaccine. 2020 Jul 17. pii: S0264-410X(20)30910.
    PubMed     Abstract available

  868. SAUNIER F, Berthelot P, Mottet-Auselo B, Pelissier C, et al
    Impact of a decision-aid tool on influenza vaccine coverage among HCW in two French hospitals: A cluster-randomized trial.
    Vaccine. 2020 Jul 16. pii: S0264-410X(20)30911.
    PubMed     Abstract available

  869. PHELPS CC, Vadia S, Boyaka PN, Varikuti S, et al
    A listeriolysin O subunit vaccine is protective against Listeria monocytogenes.
    Vaccine. 2020 Jul 16. pii: S0264-410X(20)30835.
    PubMed     Abstract available

  870. LAHOUATI M, De Coucy A, Sarlangue J, Cazanave C, et al
    Spread of vaccine hesitancy in France: What about YouTube?
    Vaccine. 2020 Jul 15. pii: S0264-410X(20)30902.
    PubMed     Abstract available

  871. SKARLUPKA AL, Handel A, Ross TM
    Influenza hemagglutinin antigenic distance measures capture trends in HAI differences and infection outcomes, but are not suitable predictive tools.
    Vaccine. 2020 Jul 15. pii: S0264-410X(20)30828.
    PubMed     Abstract available

  872. REZZA G, Ricciardi W
    No jab, no pay and vaccine mandates: Do compulsory policies increase vaccination coverage? The Italian experience.
    Vaccine. 2020;38:5089.

  873. CURLIN ME, Shao J, Diaz G, Edlefsen PT, et al
    Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine.
    Vaccine. 2020 Jul 14. pii: S0264-410X(20)30829.
    PubMed     Abstract available

  874. JUNG YJ, Kim KH, Ko EJ, Lee Y, et al
    Adjuvant effects of killed Lactobacillus casei DK128 on enhancing T helper type 1 immune responses and the efficacy of influenza vaccination in normal and CD4-deficient mice.
    Vaccine. 2020 Jul 13. pii: S0264-410X(20)30878.
    PubMed     Abstract available

  875. RHODA DA, Wagai JN, Beshanski-Pedersen BR, Yusafari Y, et al
    Combining cluster surveys to estimate vaccination coverage: Experiences from Nigeria's multiple indicator cluster survey / national immunization coverage survey (MICS/NICS), 2016-17.
    Vaccine. 2020 Jul 11. pii: S0264-410X(20)30703.
    PubMed     Abstract available

  876. HASHEMZADEH A, Avan A, Ferns GA, Khazaei M, et al
    Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus.
    Vaccine. 2020 Jul 11. pii: S0264-410X(20)30903.
    PubMed     Abstract available

  877. KOCHHAR S, Salmon DA
    Planning for COVID-19 vaccines safety surveillance.
    Vaccine. 2020 Jul 10. pii: S0264-410X(20)30913.

  878. MCGEOCH LJ, Finn A, Marlow RD
    Impact of rotavirus vaccination on intussusception hospital admissions in England.
    Vaccine. 2020 Jul 9. pii: S0264-410X(20)30881.
    PubMed     Abstract available

  879. SASIENI P, Castanon A
    Evidence of HPV vaccination efficacy comes from more than clinical trials.
    Vaccine. 2020 Jul 9. pii: S0264-410X(20)30883.

  880. KUNZE U, Schweinzer H
    Self-reported vaccination status and attitudes towards mandatory vaccinations for health care workers among medical students.
    Vaccine. 2020 Jul 9. pii: S0264-410X(20)30832.
    PubMed     Abstract available

  881. GATWOOD J, Shuvo S, Hohmeier KC, Hagemann T, et al
    Pneumococcal vaccination in older adults: An initial analysis of social determinants of health and vaccine uptake.
    Vaccine. 2020 Jul 9. pii: S0264-410X(20)30880.
    PubMed     Abstract available

  882. OLIVER JL, Sadorge C, Boisnard F, Snape MD, et al
    Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant series.
    Vaccine. 2020 Jul 9. pii: S0264-410X(20)30787.
    PubMed     Abstract available

  883. SAITOH A, Nirei J, Tanaka T, Haniu H, et al
    Skin thickness in neonates: Implications for intradermal vaccination.
    Vaccine. 2020 Jul 9. pii: S0264-410X(20)30847.
    PubMed     Abstract available

  884. AMODIO E, Casuccio A, Tramuto F, Costantino C, et al
    Varicella vaccination as useful strategy for reducing the risk of varicella-related hospitalizations in both vaccinated and unvaccinated cohorts (Italy, 2003-2018).
    Vaccine. 2020 Jul 9. pii: S0264-410X(20)30879.
    PubMed     Abstract available

  885. HALSTEAD SB, Katzelnick LC, Russell PK, Markoff L, et al
    Ethics of a partially effective dengue vaccine: Lessons from the Philippines.
    Vaccine. 2020 Jul 9. pii: S0264-410X(20)30882.
    PubMed     Abstract available

  886. KOCHHAR S, Kim D, Excler JL, Condit RC, et al
    The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.
    Vaccine. 2020 Jul 8. pii: S0264-410X(20)30830.
    PubMed     Abstract available

  887. YAZDANI M, Gholizadeh Z, Nikpoor AR, Hatamipour M, et al
    Vaccination with dendritic cells pulsed ex vivo with gp100 peptide-decorated liposomes enhances the efficacy of anti PD-1 therapy in a mouse model of melanoma.
    Vaccine. 2020 Jul 8. pii: S0264-410X(20)30841.
    PubMed     Abstract available

  888. ASHWELL D, Murray N
    When being positive might be negative: An analysis of Australian and New Zealand newspaper framing of vaccination post Australia's No Jab No Pay legislation.
    Vaccine. 2020 Jul 8. pii: S0264-410X(20)30856.
    PubMed     Abstract available

  889. BIBERA GL, Chen J, Pereira P, Benninghoff B, et al
    Dynamics of G2P[4] strain evolution and rotavirus vaccination: A review of evidence for Rotarix.
    Vaccine. 2020 Jul 7. pii: S0264-410X(20)30845.
    PubMed     Abstract available

  890. WIEDINGER K, McCauley J, Bitsaktsis C
    Isotype-specific outcomes in Fc gamma receptor targeting of PspA using fusion proteins as a vaccination strategy against Streptococcus pneumoniae infection.
    Vaccine. 2020 Jul 6. pii: S0264-410X(20)30853.
    PubMed     Abstract available

  891. SU QD, Yi Y, Zou YN, Jia ZY, et al
    The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650.
    Vaccine. 2020;38:5071-5075.
    PubMed     Abstract available

  892. OSAMA EL-GENDY A, Saeed H, Ali AMA, Zawbaa HM, et al
    Bacillus Calmette-Guerin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality.
    Vaccine. 2020 Jul 3. pii: S0264-410X(20)30886.
    PubMed     Abstract available

  893. POLAND GA
    Expression of concern: "Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?" and "Bactericidal antibody against a representative epidemiological meningococcal serogro
    Vaccine. 2020 Jul 2. pii: S0264-410X(20)30834.

  894. CHEN Y, Hu Y, Chen H, Li X, et al
    A ferritin nanoparticle vaccine for foot-and-mouth disease virus elicited partial protection in mice.
    Vaccine. 2020 Jul 2. pii: S0264-410X(20)30849.
    PubMed     Abstract available

  895. NISKANEN M, Myllymaki H, Ramet M
    DNA vaccination with the Mycobacterium marinum MMAR_4110 antigen inhibits reactivation of a latent mycobacterial infection in the adult Zebrafish.
    Vaccine. 2020 Jul 2. pii: S0264-410X(20)30839.
    PubMed     Abstract available

  896. KROGSGAARD LW, Helmuth IG, Bech BH, Plana-Ripoll O, et al
    Are unexplained adverse health events following HPV vaccination associated with infectious mononucleosis? - A Danish nationwide matched case-control study.
    Vaccine. 2020 Jul 2. pii: S0264-410X(20)30843.
    PubMed     Abstract available

  897. MELIDOU A, Hungnes O, Pereyaslov D, Adlhoch C, et al
    Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019.
    Vaccine. 2020 Jul 2. pii: S0264-410X(20)30804.
    PubMed     Abstract available

    June 2020
  898. BALZARINI F, Frascella B, Oradini-Alacreu A, Gaetti G, et al
    Does the use of personal electronic health records increase vaccine uptake? A systematic review.
    Vaccine. 2020 Jun 30. pii: S0264-410X(20)30738.
    PubMed     Abstract available

  899. YU W, Cao L, Liu Y, Li K, et al
    Two media-reported vaccine events in China from 2013 to 2016: Impact on confidence and vaccine utilization.
    Vaccine. 2020 Jun 30. pii: S0264-410X(20)30632.
    PubMed     Abstract available

  900. ABU-RAYA B, Giles ML, Kollmann TR, Sadarangani M, et al
    Profiling avidity of antibodies elicited by vaccination using enzyme-linked immunosorbent assay-based elution - Insights into a novel experimental and analytical approach.
    Vaccine. 2020 Jun 30. pii: S0264-410X(20)30846.

  901. UNDURRAGA EA, Millien MF, Allel K, Etheart MD, et al
    Costs and effectiveness of alternative dog vaccination strategies to improve dog population coverage in rural and urban settings during a rabies outbreak.
    Vaccine. 2020 Jun 29. pii: S0264-410X(20)30767.
    PubMed     Abstract available

  902. TAN SHS, Wang D, Tan WJ, Allameen NA, et al
    Facilitators and barriers of Hepatitis B screening and vaccination.
    Vaccine. 2020 Jun 29. pii: S0264-410X(20)30831.
    PubMed     Abstract available

  903. SIIRA L, Vestrheim DF, Winje BA, Caugant DA, et al
    Antimicrobial susceptibility and clonality of Streptococcus pneumoniae isolates recovered from invasive disease cases during a period with changes in pneumococcal childhood vaccination, Norway, 2004-2016.
    Vaccine. 2020 Jun 29. pii: S0264-410X(20)30826.
    PubMed     Abstract available

  904. RAJARAM S, Wojcik R, Moore C, Ortiz de Lejarazu R, et al
    The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus.
    Vaccine. 2020 Jun 26. pii: S0264-410X(20)30794.
    PubMed     Abstract available

  905. SCARIA PV, Chen BB, Rowe CG, Alani N, et al
    Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230.
    Vaccine. 2020 Jun 26. pii: S0264-410X(20)30790.
    PubMed     Abstract available

  906. LEE H, Kim HJ, Choe YJ, Shin JY, et al
    Signals and trends of Guillain-Barre syndrome after the introduction of live-attenuated vaccines for influenza in the US and South Korean adverse event reporting systems.
    Vaccine. 2020 Jun 26. pii: S0264-410X(20)30824.
    PubMed     Abstract available

  907. GARCIA LY, Cerda AA
    Contingent assessment of the COVID-19 vaccine.
    Vaccine. 2020 Jun 25. pii: S0264-410X(20)30854.
    PubMed     Abstract available

  908. PAGUIO JA, Yao JS, Dee EC
    Silver lining of COVID-19: Heightened global interest in pneumococcal and influenza vaccines, an infodemiology study.
    Vaccine. 2020 Jun 25. pii: S0264-410X(20)30855.
    PubMed     Abstract available

  909. GUIDRY JPD, Coman IA, Vraga EK, O'Donnell NH, et al
    (S)pin the flu vaccine: Recipes for concern.
    Vaccine. 2020 Jun 24. pii: S0264-410X(20)30773.
    PubMed     Abstract available

  910. DE OLIVEIRA BRESSANE LIMA P, van Lier A, de Melker H, Ferreira JA, et al
    MenACWY vaccination campaign for adolescents in the Netherlands: Uptake and its determinants.
    Vaccine. 2020 Jun 24. pii: S0264-410X(20)30754.
    PubMed     Abstract available

  911. KARTOGLU UH, Moore KL, Lloyd JS
    Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers.
    Vaccine. 2020 Jun 23. pii: S0264-410X(20)30842.

  912. HENN W
    Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity.
    Vaccine. 2020 Jun 23. pii: S0264-410X(20)30844.

  913. SOETERS HM, Kambire D, Sawadogo G, Ouedraogo-Traore R, et al
    Evaluation of pneumococcal meningitis clusters in Burkina Faso and implications for potential reactive vaccination.
    Vaccine. 2020 Jun 23. pii: S0264-410X(20)30763.
    PubMed     Abstract available

  914. HARTMANN K, Pagliusi S, Precioso A
    Landscape analysis of pharmacovigilance and related practices among 34 vaccine manufacturers' from emerging countries.
    Vaccine. 2020 Jun 23. pii: S0264-410X(20)30788.
    PubMed     Abstract available

  915. FERREIRA HL, Reilley AM, Goldenberg D, Ortiz IRA, et al
    Protection conferred by commercial NDV live attenuated and double recombinant HVT vaccines against virulent California 2018 Newcastle disease virus (NDV) in chickens.
    Vaccine. 2020 Jun 23. pii: S0264-410X(20)30765.
    PubMed     Abstract available

  916. MARTINELLI D, Fortunato F, Del Matto G, Iannelli G, et al
    Post-marketing surveillance study of the DTaP2-IPV-HB-Hib (Hexyon) vaccine administered in preterm infants in the Apulia region, Italy, in 2017.
    Vaccine. 2020 Jun 22. pii: S0264-410X(20)30806.
    PubMed     Abstract available

  917. GILES ML, Mantel C, Munoz FM, Moran A, et al
    Vaccine implementation factors affecting maternal tetanus immunization in low- and middle-income countries: Results of the Maternal Immunization and Antenatal Care Situational Analysis (MIACSA) project.
    Vaccine. 2020 Jun 22. pii: S0264-410X(20)30739.
    PubMed     Abstract available

  918. FALCON VC, Porras YVV, Altamirano CMG, Kartoglu U, et al
    A vaccine cold chain temperature monitoring study in the United Mexican States.
    Vaccine. 2020 Jun 22. pii: S0264-410X(20)30775.
    PubMed     Abstract available

  919. BARAL R, Li X, Willem L, Antillon M, et al
    The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models.
    Vaccine. 2020 Jun 22. pii: S0264-410X(20)30822.
    PubMed     Abstract available

  920. PARIZE P, Poujol P, Morineau Le Houssine P, Goesch J, et al
    Immune response to rabies post-exposure prophylaxis in patients with non-HIV secondary immunodeficiencies.
    Vaccine. 2020 Jun 22. pii: S0264-410X(20)30823.
    PubMed     Abstract available

  921. MOEHLING KK, Zimmerman RK, Nowalk MP, Jeng Lin C, et al
    A randomized controlled trial of antibody response to 2018-19 cell-based vs. egg-based quadrivalent inactivated influenza vaccine in children.
    Vaccine. 2020 Jun 21. pii: S0264-410X(20)30796.
    PubMed     Abstract available

  922. LINDHOLM DE, Licciardi PV, Ratu FT, Kim Mulholland E, et al
    Predictors of antibody persistence to the 7-valent pneumococcal conjugate vaccine in healthy Fijian infants at 12 months of age.
    Vaccine. 2020 Jun 21. pii: S0264-410X(20)30798.
    PubMed     Abstract available

  923. GILBERT NL, Rotondo J, Shapiro J, Sherrard L, et al
    Corrigendum to "Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada, 2008-2011" [Vaccine 35 (2017) 3050-3055].
    Vaccine. 2020 Jun 20. pii: S0264-410X(20)30766.

  924. VAN AALST R, Russo EM, Neupane N, Mahmud SM, et al
    Comparing the impact of high-dose versus standard dose influenza vaccines on hospitalization cost for cardiovascular and respiratory diseases: Economic assessment in the US Veteran population during 5 respiratory seasons using an instrumental variable
    Vaccine. 2020 Jun 20. pii: S0264-410X(20)30735.
    PubMed     Abstract available

    Economic evaluation and budget impact analysis of dengue vaccination following pre-vaccination serological screening in India.
    Vaccine. 2020 Jun 20. pii: S0264-410X(20)30801.
    PubMed     Abstract available

  926. GRIECO L, Panovska-Griffiths J, van Leeuwen E, Grove P, et al
    Exploring the role of mass immunisation in influenza pandemic preparedness: A modelling study for the UK context.
    Vaccine. 2020 Jun 20. pii: S0264-410X(20)30805.
    PubMed     Abstract available

  927. YUAN L, Wang Y, Ma X, Cui X, et al
    Sunflower seed oil combined with ginseng stem-leaf saponins as an adjuvant to enhance the immune response elicited by Newcastle disease vaccine in chickens.
    Vaccine. 2020 Jun 19. pii: S0264-410X(20)30708.
    PubMed     Abstract available

  928. ULYTE A, Wei W, Gruebner O, Bahler C, et al
    Insights into the protective effects of influenza vaccination: More hospitalizations but lower follow-up mortality during the 2014/15 influenza season in a Swiss cohort.
    Vaccine. 2020 Jun 19. pii: S0264-410X(20)30791.
    PubMed     Abstract available

  929. OUATTARA A, Niangaly A, Adams M, Coulibaly D, et al
    Epitope-based sieve analysis of Plasmodium falciparum sequences from a FMP2.1/AS02A vaccine trial is consistent with differential vaccine efficacy against immunologically relevant AMA1 variants.
    Vaccine. 2020 Jun 19. pii: S0264-410X(20)30821.
    PubMed     Abstract available

  930. MUNOZ FM, Patel SM, Jackson LA, Swamy GK, et al
    Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants.
    Vaccine. 2020 Jun 19. pii: S0264-410X(20)30704.
    PubMed     Abstract available

  931. KIM D, Robertson JS, Excler JL, Condit RC, et al
    The Brighton collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines.
    Vaccine. 2020 Jun 19. pii: S0264-410X(20)30789.
    PubMed     Abstract available

  932. THINDWA D, Garcia Quesada M, Liu Y, Bennett J, et al
    Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality.
    Vaccine. 2020 Jun 19. pii: S0264-410X(20)30833.

  933. LAYTON JB, McGrath LJ, Sahrmann JM, Ma Y, et al
    Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease.
    Vaccine. 2020 Jun 18. pii: S0264-410X(20)30793.
    PubMed     Abstract available

  934. WIENER RC, Findley PA, Shen C, Dwibedi N, et al
    Human papillomavirus (HPV) vaccine utilization among adults (18-29 years), BRFSS 2015.
    Vaccine. 2020 Jun 18. pii: S0264-410X(20)30701.
    PubMed     Abstract available

  935. DHINGRA MS, Peterson J, Hedrick J, Pan J, et al
    Immunogenicity, safety and inter-lot consistency of a meningococcal conjugate vaccine (MenACYW-TT) in adolescents and adults: A Phase III randomized study.
    Vaccine. 2020 Jun 18. pii: S0264-410X(20)30774.
    PubMed     Abstract available

  936. LU Y, Clark-Deener S, Gillam F, Heffron CL, et al
    Virus-like particle vaccine with B-cell epitope from porcine epidemic diarrhea virus (PEDV) incorporated into hepatitis B virus core capsid provides clinical alleviation against PEDV in neonatal piglets through lactogenic immunity.
    Vaccine. 2020 Jun 18. pii: S0264-410X(20)30770.
    PubMed     Abstract available

    What can vaccines learn from aviation?
    Vaccine. 2020 Jun 18. pii: S0264-410X(20)30800.

  938. CRAMER JP, Jimeno J, Han HH, Lin S, et al
    Safety and immunogenicity of experimental stand-alone trivalent, inactivated Sabin-strain polio vaccine formulations in healthy infants: A randomized, observer-blind, controlled phase 1/2 trial.
    Vaccine. 2020 Jun 17. pii: S0264-410X(20)30736.
    PubMed     Abstract available

  939. TREANOR J, Sherwood J, Cramer JP, Le Cam Bouveret N, et al
    A phase 2 study of the bivalent VLP norovirus vaccine candidate in older adults; impact of MPL adjuvant or a second dose.
    Vaccine. 2020 Jun 17. pii: S0264-410X(20)30772.
    PubMed     Abstract available

  940. LLAMAS A, Amirthalingam G, Andrews N, Edelstein M, et al
    Delivering prenatal pertussis vaccine through maternity services in England: What is the impact on vaccine coverage?
    Vaccine. 2020 Jun 17. pii: S0264-410X(20)30723.
    PubMed     Abstract available

  941. ARMIENTO R, Hoq M, Kua E, Crawford N, et al
    Impact of Australian mandatory 'No Jab, No Pay' and 'No Jab, No Play' immunisation policies on immunisation services, parental attitudes to vaccination and vaccine uptake, in a tertiary paediatric hospital, the Royal Children's Hospital, Melbourne.
    Vaccine. 2020 Jun 16. pii: S0264-410X(20)30761.
    PubMed     Abstract available

  942. LEO S, Lazarevic V, Girard M, Getaz-Jimenez Velasco GC, et al
    Strain coverage of Bexsero vaccine assessed by whole-genome sequencing over a cohort of invasive meningococci of serogroups B and W isolated in Switzerland.
    Vaccine. 2020 Jun 16. pii: S0264-410X(20)30726.
    PubMed     Abstract available

  943. EDELSTEIN M, Muller M, Ladhani S, Yarwood J, et al
    Keep calm and carry on vaccinating: Is anti-vaccination sentiment contributing to declining vaccine coverage in England?
    Vaccine. 2020 Jun 16. pii: S0264-410X(20)30737.
    PubMed     Abstract available

  944. Assessment of risk of intussusception after pilot rollout of rotavirus vaccine in the Indian public health system.
    Vaccine. 2020 Jun 15. pii: S0264-410X(20)30760.
    PubMed     Abstract available

  945. MA HY, Lai CC, Chiu NC, Lee PI, et al
    Adverse events following immunization with the live-attenuated recombinant Japanese encephalitis vaccine (IMOJEV(R)) in Taiwan, 2017-18.
    Vaccine. 2020 Jun 13. pii: S0264-410X(20)30769.
    PubMed     Abstract available

  946. HUBER A, Gazder J, Dobay O, Meszner Z, et al
    Attitudes towards varicella vaccination in parents and paediatric healthcare providers in Hungary.
    Vaccine. 2020 Jun 13. pii: S0264-410X(20)30758.
    PubMed     Abstract available

  947. KELLY MK, Grundmeier RW, Stephens-Shields AJ, Localio R, et al
    Missed opportunities for human papillomavirus vaccination at office visits during which influenza vaccine was administered: An AAP pediatric research in office settings (PROS) national primary care research network study.
    Vaccine. 2020 Jun 12. pii: S0264-410X(20)30757.
    PubMed     Abstract available

  948. COOKENHAM T, Lanzer KG, Gage E, Lorenzo EC, et al
    Vaccination of aged mice with adjuvanted recombinant influenza nucleoprotein enhances protective immunity.
    Vaccine. 2020 Jun 12. pii: S0264-410X(20)30752.
    PubMed     Abstract available

  949. YANG TU, Jung CW, Kim D, Park HA, et al
    Impact of the National Perinatal Hepatitis B Prevention Programme in the Republic of Korea: A retrospective registry-based cohort study.
    Vaccine. 2020 Jun 12. pii: S0264-410X(20)30689.
    PubMed     Abstract available

  950. AIDOUD A, Marlet J, Angoulvant D, Debacq C, et al
    Influenza vaccination as a novel means of preventing coronary heart disease: Effectiveness in older adults.
    Vaccine. 2020 Jun 11. pii: S0264-410X(20)30725.
    PubMed     Abstract available

    Vaccine handling and administration errors should be addressed to improve vaccine program safety.
    Vaccine. 2020 Jun 11. pii: S0264-410X(20)30759.

  952. TAMIYA S, Yoshikawa E, Ogura M, Kuroda E, et al
    Vaccination using inactivated Mycoplasma pneumoniae induces detrimental infiltration of neutrophils after subsequent infection in mice.
    Vaccine. 2020 Jun 11. pii: S0264-410X(20)30729.
    PubMed     Abstract available

  953. WOLFF E, Storsaeter J, Ortqvist A, Naucler P, et al
    Cost-effectiveness of pneumococcal vaccination for elderly in Sweden.
    Vaccine. 2020 Jun 11. pii: S0264-410X(20)30727.
    PubMed     Abstract available

  954. CHEUNG YB, Ma X, Lam KF, Milligan P, et al
    Estimation of the primary, secondary and composite effects of malaria vaccines using data on multiple clinical malaria episodes.
    Vaccine. 2020 Jun 11. pii: S0264-410X(20)30753.
    PubMed     Abstract available

  955. REITER PL, Bustamante G, McRee AL
    HPV vaccine coverage and acceptability among a national sample of sexual minority women ages 18-45.
    Vaccine. 2020 Jun 11. pii: S0264-410X(20)30762.
    PubMed     Abstract available

  956. STOWE J, Andrews NJ, Turner PJ, Miller E, et al
    The risk of Kawasaki disease after pneumococcal conjugate & meningococcal B vaccine in England: A self-controlled case-series analysis.
    Vaccine. 2020 Jun 11. pii: S0264-410X(20)30756.
    PubMed     Abstract available

  957. PAGLIUSI S, Jarrett S, Hayman B, Kreysa U, et al
    Emerging manufacturers engagements in the COVID -19 vaccine research, development and supply.
    Vaccine. 2020 Jun 11. pii: S0264-410X(20)30795.
    PubMed     Abstract available

  958. MOSITES E, Seeman S, Negus S, Homan C, et al
    Immunogenicity of the hepatitis A vaccine 20 years after infant immunization.
    Vaccine. 2020 Jun 10. pii: S0264-410X(20)30724.
    PubMed     Abstract available

  959. PAGLIUSI S, Dennehy M, Homma A
    Two decades of vaccine innovations for global public good: Report of the Developing Countries' Vaccine Manufacturers Network 20th meeting, 21-23 october 2019, Rio de Janeiro, Brazil.
    Vaccine. 2020 Jun 10. pii: S0264-410X(20)30707.
    PubMed     Abstract available

  960. AL AMIN M, Ali MR, Islam MR, Alam ASMRU, et al
    Development and serology based efficacy assessment of a trivalent foot-and-mouth disease vaccine.
    Vaccine. 2020 Jun 10. pii: S0264-410X(20)30734.
    PubMed     Abstract available

  961. TIZARD IR
    Vaccination against coronaviruses in domestic animals.
    Vaccine. 2020 Jun 10. pii: S0264-410X(20)30799.
    PubMed     Abstract available

  962. DONNISON T, von Delft A, Brown A, Swadling L, et al
    Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes.
    Vaccine. 2020 Jun 9. pii: S0264-410X(20)30687.
    PubMed     Abstract available

  963. ISMAIL SJ, Hardy K, Tunis MC, Young K, et al
    A framework for the systematic consideration of ethics, equity, feasibility, and acceptability in vaccine program recommendations.
    Vaccine. 2020 Jun 9. pii: S0264-410X(20)30696.
    PubMed     Abstract available

  964. CHOI EJ, Park JH, Chun BC
    Cost effectiveness of trivalent and quadrivalent influenza vaccines in 50- to 64-year-old adults in Korea.
    Vaccine. 2020 Jun 9. pii: S0264-410X(20)30710.
    PubMed     Abstract available

  965. DONG TQ, Rhoda DA, Mercer LD
    Impact of state weights on national vaccination coverage estimates from household surveys in Nigeria.
    Vaccine. 2020 Jun 9. pii: S0264-410X(20)30645.
    PubMed     Abstract available

  966. GILES ML, Mason E, Munoz FM, Moran AC, et al
    Antenatal care service delivery and factors affecting effective tetanus vaccine coverage in low- and middle-income countries: Results of the Maternal Immunisation and Antenatal Care Situational analysis (MIACSA) project.
    Vaccine. 2020 Jun 8. pii: S0264-410X(20)30644.
    PubMed     Abstract available

  967. PEMPA, Luz ACG, Luangasanatip N, Kingkaew P, et al
    Economic evaluation of rotavirus vaccination in children of Bhutan.
    Vaccine. 2020 Jun 7. pii: S0264-410X(20)30666.
    PubMed     Abstract available

  968. ANGSUWATCHARAKON P, Ratananpinit N, Yoksan S, Saengseesom W, et al
    Immunogenicity and safety of two-visit, intradermal pre-exposure rabies prophylaxis simultaneously administrated with chimeric live-attenuated Japanese encephalitis vaccine in children living in rabies and Japanese encephalitis endemic country.
    Vaccine. 2020 Jun 7. pii: S0264-410X(20)30699.
    PubMed     Abstract available

  969. VERMA SK, Joseph SK, Verma R, Kushwaha V, et al
    Corrigendum to 'Protection against filarial infection by 45-49kDa molecules of Brugia malayi via IFN-gamma-mediated iNOS induction' [Vaccine 33 (2015) 527-534].
    Vaccine. 2020 Jun 7. pii: S0264-410X(20)30674.

  970. ASARE EO, Al-Mamun MA, Armah GE, Lopman BA, et al
    Modeling of rotavirus transmission dynamics and impact of vaccination in Ghana.
    Vaccine. 2020 Jun 5. pii: S0264-410X(20)30702.
    PubMed     Abstract available

  971. BONWITT J, Bonaparte S, Blanton J, Gibson AD, et al
    Oral bait preferences and feasibility of oral rabies vaccination in Bangladeshi dogs.
    Vaccine. 2020 Jun 5. pii: S0264-410X(20)30692.
    PubMed     Abstract available

  972. MACIAS A, Ruiz-Palacios G, Ramos-Castaneda J
    Combine dengue vaccines to optimize effectiveness.
    Vaccine. 2020 Jun 4. pii: S0264-410X(20)30755.
    PubMed     Abstract available

  973. SCHAEFER GO, Tam CC, Savulescu J, Voo TC, et al
    COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?
    Vaccine. 2020 Jun 4. pii: S0264-410X(20)30768.
    PubMed     Abstract available

  974. BOONE AC, Kaser T, Cortes AL, Kulkarni RR, et al
    In ovo vaccination with herpesvirus of turkey enhances innate and cellular responses in meat-type chickens: Effect of vaccine dose and strain.
    Vaccine. 2020 Jun 3. pii: S0264-410X(20)30695.
    PubMed     Abstract available

  975. HWANG A, Veira C, Malvolti S, Cherian T, et al
    Global Vaccine Action Plan Lessons Learned II: Stakeholder Perspectives.
    Vaccine. 2020 Jun 3. pii: S0264-410X(20)30693.
    PubMed     Abstract available

  976. ROBINSON C, Waller AS, Frykberg L, Flock M, et al
    Intramuscular vaccination with Strangvac is safe and induces protection against equine strangles caused by Streptococcus equi.
    Vaccine. 2020 Jun 2. pii: S0264-410X(20)30691.
    PubMed     Abstract available

  977. MORALES KF, Menning L, Lambach P
    The faces of influenza vaccine recommendation: A Literature review of the determinants and barriers to health providers' recommendation of influenza vaccine in pregnancy.
    Vaccine. 2020 Jun 2. pii: S0264-410X(20)30513.
    PubMed     Abstract available

  978. GLOVER C, Crawford N, Leeb A, Wood N, et al
    Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety.
    Vaccine. 2020 Jun 1. pii: S0264-410X(20)30560.
    PubMed     Abstract available

  979. BOUM Y, Juan-Giner A, Hitchings M, Soumah A, et al
    Humoral and cellular immune response induced by rVSVDeltaG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea.
    Vaccine. 2020 Jun 1. pii: S0264-410X(20)30583.
    PubMed     Abstract available

  980. ANTONELLO J, Grant-Klein RJ, Nichols R, Kennedy SB, et al
    Serostatus cutoff levels and fold increase to define seroresponse to recombinant vesicular stomatitis virus - Zaire Ebola virus envelope glycoprotein vaccine: An evidence-based analysis.
    Vaccine. 2020 Jun 1. pii: S0264-410X(20)30565.
    PubMed     Abstract available

    May 2020
  981. BRIGGS KT, Taraban MB, Yu YB
    Quality assurance at the point-of-care: Noninvasively detecting vaccine freezing variability using water proton NMR.
    Vaccine. 2020 May 29. pii: S0264-410X(20)30694.
    PubMed     Abstract available

  982. PEDERSEN EA, Loft LH, Jacobsen SU, Soborg B, et al
    Strategic health communication on social media: Insights from a Danish social media campaign to address HPV vaccination hesitancy.
    Vaccine. 2020 May 29. pii: S0264-410X(20)30706.
    PubMed     Abstract available

  983. POST AL, Li SH, Berry M, Itell H, et al
    Efficiency of placental transfer of vaccine-elicited antibodies relative to prenatal Tdap vaccination status.
    Vaccine. 2020 May 29. pii: S0264-410X(20)30667.
    PubMed     Abstract available

  984. ANDREWS N, Stowe J, Miller E
    Nephrotic syndrome in infants and toddlers before and after introduction of the meningococcal B vaccine programme in England: An ecological study.
    Vaccine. 2020 May 29. pii: S0264-410X(20)30700.
    PubMed     Abstract available

  985. ASTURIAS EJ, Duclos P, MacDonald NE, Nohynek H, et al
    Advanced vaccinology education: Landscaping its growth and global footprint.
    Vaccine. 2020 May 28. pii: S0264-410X(20)30669.
    PubMed     Abstract available

  986. ESPARZA J, Lederman S, Nitsche A, Damaso CR, et al
    Early smallpox vaccine manufacturing in the United States: Introduction of the "animal vaccine" in 1870, establishment of "vaccine farms", and the beginnings of the vaccine industry.
    Vaccine. 2020 May 27. pii: S0264-410X(20)30668.
    PubMed     Abstract available

  987. POWELL AM, Luo Z, Martin L, Wan Z, et al
    Corrigendum to "The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals
    Vaccine. 2020 May 27. pii: S0264-410X(20)30673.

  988. NOGAREDA F, Gunregjav N, Sarankhuu A, Munkhbat E, et al
    Measles and rubella IgG seroprevalence in persons 6 month-35 years of age, Mongolia, 2016.
    Vaccine. 2020;38:4200-4208.
    PubMed     Abstract available

  989. ANDRE GO, Assoni L, Rodriguez D, Leite LCC, et al
    Immunization with PhtD truncated fragments reduces nasopharyngeal colonization by Streptococcus pneumoniae.
    Vaccine. 2020;38:4146-4153.
    PubMed     Abstract available

  990. BREAKWELL L, Anga J, Cooley G, Ropiti L, et al
    Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6-7 years old in the Solomon Islands, 2016.
    Vaccine. 2020 May 27. pii: S0264-410X(20)30648.
    PubMed     Abstract available

  991. QIN S, Fu JX, Chen MZ, Meng YT, et al
    Acceptability of vaccination against human papillomavirus among women aged 20 to 45 in rural Hunan Province, China: A cross-sectional study.
    Vaccine. 2020 May 26. pii: S0264-410X(20)30635.
    PubMed     Abstract available

  992. JAMAL D, Zaidi S, Husain S, Orr DW, et al
    Low vaccination in rural Sindh, Pakistan: A case of refusal, ignorance or access?
    Vaccine. 2020 May 25. pii: S0264-410X(20)30636.
    PubMed     Abstract available

  993. LAMBERT PH, Ambrosino DM, Andersen SR, Baric RS, et al
    Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Vaccine. 2020 May 25. pii: S0264-410X(20)30709.
    PubMed     Abstract available

  994. JONES OS, Vassie C, Emanuel O, Lechner M, et al
    Targeting key groups using a low-cost strategy to increase HPV awareness and vaccine uptake.
    Vaccine. 2020;38:4059.

  995. XIA S, Du J, Su J, Zhou X, et al
    Efficacy, immunogenicity and safety of a trivalent live human-lamb reassortant rotavirus vaccine (LLR3) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial.
    Vaccine. 2020 May 22. pii: S0264-410X(20)30531.
    PubMed     Abstract available

  996. SIMONS JJM, Vida N, Westra TA, Postma MJ, et al
    Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands.
    Vaccine. 2020 May 22. pii: S0264-410X(20)30661.
    PubMed     Abstract available

  997. JANUSZ CB, Wagner AL, Masters NB, Ding Y, et al
    Measles vaccination of young infants in China: A cost-effectiveness analysis.
    Vaccine. 2020 May 22. pii: S0264-410X(20)30607.
    PubMed     Abstract available

  998. CIVELLO AN, Spiropoulos J, Sanchez-Cordon PJ, Hicks DJ, et al
    The effect of BCG vaccination on macrophage phenotype in a mouse model of intranasal Mycobacterium bovis challenge.
    Vaccine. 2020 May 22. pii: S0264-410X(20)30663.
    PubMed     Abstract available

  999. BARUG D, Berbers GAM, van Houten MA, Kuijer M, et al
    Infant antibody levels following 10-valent pneumococcal-protein D conjugate and DTaP-Hib vaccinations in the first year of life after maternal Tdap vaccination: An open-label, parallel, randomised controlled trial.
    Vaccine. 2020 May 21. pii: S0264-410X(20)30458.
    PubMed     Abstract available

  1000. PICKARD GE, Brodersen B, Sollars PJ, Smith GA, et al
    The pseudorabies virus R2 non-neuroinvasive vaccine: A proof-of-concept study in pigs.
    Vaccine. 2020 May 21. pii: S0264-410X(20)30608.
    PubMed     Abstract available

  1001. LEE SH, Kang HJ, Lee DH, Kang SM, et al
    Corrigendum to "Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection" [Vaccine 36 (2018) 5692-5700].
    Vaccine. 2020 May 21. pii: S0264-410X(20)30665.

  1002. STEENS A, Stefanoff P, Daae A, Vestrheim DF, et al
    High overall confidence in childhood vaccination in Norway, slightly lower among the unemployed and those with a lower level of education.
    Vaccine. 2020 May 21. pii: S0264-410X(20)30629.
    PubMed     Abstract available

  1003. AGOPIAN A, Young H, Quinlan S, Rice MM, et al
    Timeliness of childhood vaccinations in Armenia, 2015-2016.
    Vaccine. 2020 May 21. pii: S0264-410X(20)30662.
    PubMed     Abstract available

  1004. SILVERBERG MJ, Leyden WA, Lam JO, Chao CR, et al
    Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women.
    Vaccine. 2020 May 20. pii: S0264-410X(20)30610.
    PubMed     Abstract available

  1005. PAUDEL M, Mahmud S, Buikema A, Korrer S, et al
    Relative vaccine efficacy of high-dose versus standard-dose influenza vaccines in preventing probable influenza in a Medicare Fee-for-Service population.
    Vaccine. 2020 May 20. pii: S0264-410X(20)30638.
    PubMed     Abstract available

  1006. WU F, Lu F, Fan X, Pan Q, et al
    Development of a live attenuated duck hepatitis a virus type 3 vaccine (strain SD70).
    Vaccine. 2020 May 20. pii: S0264-410X(20)30649.
    PubMed     Abstract available

  1007. RODRIGUES MX, Yang Y, de Souza Meira EB Jr, do Carmo Silva J, et al
    Development and evaluation of a new recombinant protein vaccine (YidR) against Klebsiella pneumoniae infection.
    Vaccine. 2020 May 19. pii: S0264-410X(20)30446.
    PubMed     Abstract available

  1008. WEINMANN S, Irving SA, Koppolu P, Naleway AL, et al
    Incidence of herpes zoster among varicella-vaccinated children, by number of vaccine doses and simultaneous administration of measles, mumps, and rubella vaccine.
    Vaccine. 2020 May 19. pii: S0264-410X(20)30612.
    PubMed     Abstract available

  1009. ONEKO M, Cherop YR, Sang T, Gutman JR, et al
    Feasibility of direct venous inoculation of the radiation-attenuated Plasmodium falciparum whole sporozoite vaccine in children and infants in Siaya, western Kenya.
    Vaccine. 2020 May 19. pii: S0264-410X(20)30614.
    PubMed     Abstract available

  1010. GRADINATI V, Baruffaldi F, Abbaraju S, Laudenbach M, et al
    Polymer-mediated delivery of vaccines to treat opioid use disorders and to reduce opioid-induced toxicity.
    Vaccine. 2020 May 19. pii: S0264-410X(20)30646.
    PubMed     Abstract available

  1011. PLOTKIN SA, Caplan A
    Extraordinary diseases require extraordinary solutions.
    Vaccine. 2020;38:3987-3988.

  1012. CHERIAN T, Hwang A, Mantel C, Veira C, et al
    Global Vaccine Action Plan lessons learned III: Monitoring and evaluation/accountability framework.
    Vaccine. 2020 May 16. pii: S0264-410X(20)30647.
    PubMed     Abstract available

  1013. KOPSIDAS I, Tsopela GC, Maroudi-Manta S, Kourkouni E, et al
    Increasing healthcare workers' uptake of seasonal influenza vaccination in a tertiary-care pediatric hospital in Greece with a low-cost, tailor-made, multifaceted strategy.
    Vaccine. 2020 May 16. pii: S0264-410X(20)30639.
    PubMed     Abstract available

  1014. KHODR ZG, Hall C, Chang RN, Bukowinski AT, et al
    Japanese encephalitis vaccination in pregnancy among U.S. active duty military women.
    Vaccine. 2020 May 15. pii: S0264-410X(20)30641.
    PubMed     Abstract available

  1015. GORTZ M, Brewer NT, Hansen PR, Ejrnaes M, et al
    The contagious nature of a vaccine scare: How the introduction of HPV vaccination lifted and eroded MMR vaccination in Denmark.
    Vaccine. 2020 May 14. pii: S0264-410X(20)30549.
    PubMed     Abstract available

  1016. KURA K, Collyer BS, Toor J, Truscott JE, et al
    Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration.
    Vaccine. 2020 May 14. pii: S0264-410X(20)30605.
    PubMed     Abstract available

  1017. BUTLER AM, Grabinski VF, Boloker GD, Newland JG, et al
    A qualitative study examining pediatric clinicians' perceptions of delayed vaccine schedules.
    Vaccine. 2020 May 14. pii: S0264-410X(20)30633.
    PubMed     Abstract available

  1018. BONNETON M, Antona D, Danis K, Ait-Belghiti F, et al
    Are vaccinated measles cases protected against severe disease?
    Vaccine. 2020 May 14. pii: S0264-410X(20)30611.
    PubMed     Abstract available

  1019. STOMA I, Karpov I, Iskrov I, Lendina I, et al
    Clinical efficacy of pneumococcal vaccination in multiple myeloma patients on novel agents: Results of a prospective clinical study.
    Vaccine. 2020 May 14. pii: S0264-410X(20)30643.
    PubMed     Abstract available

  1020. BERCE PC, Bernstein RS, MacKinnon GE, Sorum S, et al
    Immunizations at Wisconsin Pharmacies: Results of a statewide vaccine registry analysis and pharmacist survey.
    Vaccine. 2020 May 13. pii: S0264-410X(20)30537.
    PubMed     Abstract available

  1021. DUMONTEIL E, Herrera C, Tu W, Goff K, et al
    Safety and immunogenicity of a recombinant vaccine against Trypanosoma cruzi in Rhesus macaques.
    Vaccine. 2020 May 13. pii: S0264-410X(20)30628.
    PubMed     Abstract available

  1022. LUISI MLR
    From bad to worse: The representation of the HPV vaccine Facebook.
    Vaccine. 2020 May 13. pii: S0264-410X(20)30634.
    PubMed     Abstract available

  1023. SHEEL M, Tippins A, Glass K, Kirk M, et al
    Electronic immunization registers - A tool for mitigating outbreaks of vaccine-preventable diseases in the Pacific.
    Vaccine. 2020 May 12. pii: S0264-410X(20)30588.

  1024. SALL O, Olofsson E, Jacobsson S
    High genomic-based predicted strain coverage among invasive meningococcal isolates when combining Bexsero and Trumenba vaccines.
    Vaccine. 2020 May 12. pii: S0264-410X(20)30591.
    PubMed     Abstract available

  1025. NEUFEIND J, Betsch C, Habersaat KB, Eckardt M, et al
    Barriers and drivers to adult vaccination among family physicians - Insights for tailoring the immunization program in Germany.
    Vaccine. 2020 May 11. pii: S0264-410X(20)30546.
    PubMed     Abstract available

  1026. XIAO X, Wong RM
    Vaccine hesitancy and perceived behavioral control: A meta-analysis.
    Vaccine. 2020 May 11. pii: S0264-410X(20)30593.
    PubMed     Abstract available

  1027. ORTA OR, Hatch EE, Regan AK, Perkins R, et al
    A prospective study of influenza vaccination and time to pregnancy.
    Vaccine. 2020 May 11. pii: S0264-410X(20)30548.
    PubMed     Abstract available

  1028. ECKERT LO, Jones CE, Kachikis A, Bardaji A, et al
    Obstetrics risk Assessment: Evaluation of selection criteria for vaccine research studies in pregnant women.
    Vaccine. 2020 May 11. pii: S0264-410X(20)30640.
    PubMed     Abstract available

  1029. DEAN TC, Gilliland AE, Cameron JE
    Parents' receptiveness to oral health clinic-based vaccination.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30535.
    PubMed     Abstract available

  1030. SREEVATSAVA M, Burman AL, Wahdan A, Safdar RM, et al
    Routine immunization coverage in Pakistan: a survey of children under 1 year of age in community-based vaccination areas.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30585.
    PubMed     Abstract available

  1031. MORGENROTH A, Jakel V, Hanke-Robinson H, Muller T, et al
    A novel electrophoretic immunoblot as antigen desorption and quantification method for alum-adjuvanted veterinary rabies vaccines.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30561.
    PubMed     Abstract available

  1032. KAUR R, Pichichero M
    Comparison of anti-capsular antibody quantity and functionality in children after different primary dose and booster schedules of 13 valent-pneumococcal conjugate vaccine.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30580.
    PubMed     Abstract available

  1033. MALTEZOU HC, Asimakopoulos G, Stavrou S, Daskalakis G, et al
    Effectiveness of quadrivalent influenza vaccine in pregnant women and infants, 2018-2019.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30564.
    PubMed     Abstract available

  1034. WON G, Senevirathne A, Lee JH
    Salmonella Enteritidis ghost vaccine carrying the hemagglutinin globular head (HA1) domain from H1N1 virus protects against salmonellosis and influenza in chickens.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30594.
    PubMed     Abstract available

  1035. CUI A, Zhang Y, Zhu Z, Wang H, et al
    Classification of measles cases from 2014 to 2018: Implications for progress towards measles elimination in China.
    Vaccine. 2020;38:3832-3838.
    PubMed     Abstract available

  1036. WEBBER C, Peyrani P, Balmer P, Serra L, et al
    Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studies.
    Vaccine. 2020 May 7. pii: S0264-410X(20)30260.
    PubMed     Abstract available

  1037. LI J, Li X, Ma H, Ren X, et al
    Efficient mucosal vaccination of a novel classical swine fever virus E2-Fc fusion protein mediated by neonatal Fc receptor.
    Vaccine. 2020 May 7. pii: S0264-410X(20)30631.
    PubMed     Abstract available

  1038. LIAO Q, Ng TWY, Cowling BJ
    What influenza vaccination programmes are preferred by healthcare personnel? A discrete choice experiment.
    Vaccine. 2020 May 7. pii: S0264-410X(20)30630.
    PubMed     Abstract available

  1039. WRAITH S, Nachbagauer R, Balmaseda A, Stadlbauer D, et al
    Antibody responses to influenza A(H1N1)pdm infection.
    Vaccine. 2020 May 7. pii: S0264-410X(20)30586.
    PubMed     Abstract available

  1040. MAURELLI M, Bellinato F, Gisondi P, Girolomoni G, et al
    Persistent localized hypertrichosis in a Caucasian child at sites of DTPa and chickenpox vaccination.
    Vaccine. 2020;38:3808-3809.

  1041. QUIAMBAO BP, Ambas C, Diego S, Bosch Castells V, et al
    Single-visit, 4-site intradermal (ID) rabies vaccination induces robust immune responses 5 years after 1-week, 4-site ID primary post-exposure prophylaxis in the Philippines.
    Vaccine. 2020;38:3740-3746.
    PubMed     Abstract available

  1042. SOLASTIE A, Leino T, Ollgren J
    Success ofrotavirus vaccination in Finland, a register based study measuring impact beyond overall effectiveness.
    Vaccine. 2020;38:3766-3772.
    PubMed     Abstract available

  1043. WAGNER AL, Gordon A, Tallo VL, Simaku A, et al
    Intent to obtain pediatric influenza vaccine among mothers in four middle income countries.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30508.
    PubMed     Abstract available

  1044. ESTEVES-JARAMILLO A, Koehler T, Jeanfreau R, Neveu D, et al
    Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in >/=56-year-olds: A Phase III randomized study.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30584.
    PubMed     Abstract available

  1045. PALLIKKUTH S, Bolivar H, Fletcher MA, Babic DZ, et al
    A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30485.
    PubMed     Abstract available

  1046. BATMUNKH T, Dalmau MT, Munkhsaikhan ME, Khorolsuren T, et al
    A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30534.
    PubMed     Abstract available

  1047. STRONSKY SM, Cooper CL, Steffens J, Van Tongeren S, et al
    Adjuvant selection impacts the correlates of vaccine protection against Ebola infection.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30627.
    PubMed     Abstract available

  1048. FRANCIS MJ
    A Veterinary Vaccine Development Process Map to assist in the development of new vaccines.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30613.
    PubMed     Abstract available

  1049. YASUDA I, Suzuki M, Dhoubhadel BG, Terada M, et al
    The low carriage prevalence of pneumococcus among community-dwelling older people: A cross-sectional study in Japan.
    Vaccine. 2020;38:3752-3758.
    PubMed     Abstract available

  1050. NOUATIN O, Ateba Ngoa U, Ibanez J, Dejon-Agobe JC, et al
    Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults.
    Vaccine. 2020 May 5. pii: S0264-410X(20)30540.
    PubMed     Abstract available

  1051. SMITH LE, Amlot R, Weinman J, Yiend J, et al
    Why do parents not re-vaccinate their child for influenza? A prospective cohort study.
    Vaccine. 2020 May 5. pii: S0264-410X(20)30509.
    PubMed     Abstract available

  1052. MACDONALD N, Mohsni E, Al-Mazrou Y, Kim Andrus J, et al
    Global vaccine action plan lessons learned I: Recommendations for the next decade.
    Vaccine. 2020 May 5. pii: S0264-410X(20)30609.
    PubMed     Abstract available

  1053. CHERIAN T, Arora N, MacDonald NE
    The global vaccine action plan monitoring and evaluation/accountability framework: Perspective.
    Vaccine. 2020 May 4. pii: S0264-410X(20)30529.

  1054. BELL S, Chantler T, Paterson P, Mounier-Jack S, et al
    Is flu vaccination opt-out feasible? Evidence from vaccination programme implementers and managers in the English National Health Service.
    Vaccine. 2020 May 4. pii: S0264-410X(20)30506.
    PubMed     Abstract available

  1055. LEI D, Griffiths E, Martin J
    WHO working group meeting to develop WHO Recommendations to assure the quality, safety and efficacy of enterovirus 71 vaccines.
    Vaccine. 2020 May 4. pii: S0264-410X(20)30606.
    PubMed     Abstract available

  1056. HAWKSWORTH A, Lockhart R, Crowe J, Maeso R, et al
    Replication of live attenuated influenza vaccine viruses in human nasal epithelial cells is associated with H1N1 vaccine effectiveness.
    Vaccine. 2020 May 3. pii: S0264-410X(20)30462.
    PubMed     Abstract available

  1057. NAKASONE M, Lopes MH, Sartori AMC, Sandoval EPN, et al
    Immunogenicity, long term protection and safety of subcutaneous administration of hepatitis A vaccine in patients with hemophilia and other bleeding disorders: A randomized study.
    Vaccine. 2020 May 3. pii: S0264-410X(20)30533.
    PubMed     Abstract available

  1058. STOJANOV M, Besancon H, Snaka T, Nardelli-Haefliger D, et al
    Differentially regulated promoters for antigen expression in Salmonella vaccine strains.
    Vaccine. 2020 May 3. pii: S0264-410X(20)30541.
    PubMed     Abstract available

  1059. OBI-JEFF C, Rakhshani NS, Bello-Malabu JI, Nwangwu C, et al
    Vaccine indicator and reminder band to improve demand for vaccination in Northern Nigeria: A qualitative evaluation of implementation outcomes.
    Vaccine. 2020 May 3. pii: S0264-410X(20)30505.
    PubMed     Abstract available

  1060. POLAND GA
    Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development.
    Vaccine. 2020 May 1. pii: S0264-410X(20)30590.

    April 2020
  1061. LOFT LH, Pedersen EA, Jacobsen SU, Soborg B, et al
    Using Facebook to increase coverage of HPV vaccination among Danish girls: An assessment of a Danish social media campaign.
    Vaccine. 2020 Apr 30. pii: S0264-410X(20)30512.
    PubMed     Abstract available

  1062. BELL GJ, Loop M, Topazian HM, Hudgens M, et al
    Case reduction and cost-effectiveness of the RTS,S/AS01 malaria vaccine alongside bed nets in Lilongwe, Malawi.
    Vaccine. 2020 Apr 30. pii: S0264-410X(20)30511.
    PubMed     Abstract available

  1063. IWU CJ, Ngcobo N, McCaul M, Mangqalaza H, et al
    Vaccine stock management in primary health care facilities in OR Tambo District, Eastern Cape, South Africa.
    Vaccine. 2020 Apr 30. pii: S0264-410X(20)30489.
    PubMed     Abstract available

  1064. KHAN N, Saggurti N
    Socioeconomic inequality trends in childhood vaccination coverage in India: Findings from multiple rounds of National Family Health Survey.
    Vaccine. 2020 Apr 30. pii: S0264-410X(20)30503.
    PubMed     Abstract available

  1065. GEWENIGER A, Abbas KM
    Childhood vaccination coverage and equity impact in Ethiopia by socioeconomic, geographic, maternal, and child characteristics.
    Vaccine. 2020;38:3627-3638.
    PubMed     Abstract available

  1066. NGUYEN VH, Vizzotti C, Uruena A, Giglio N, et al
    Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina.
    Vaccine. 2020;38:3682-3689.
    PubMed     Abstract available

  1067. BERRIE DM, Waters RC, Montoya C, Chatel A, et al
    Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor.
    Vaccine. 2020;38:3639-3645.
    PubMed     Abstract available

  1068. DENG H, Yu S, Guo Y, Gu L, et al
    Development of a multivalent enterovirus subunit vaccine based on immunoinformatic design principles for the prevention of HFMD.
    Vaccine. 2020;38:3671-3681.
    PubMed     Abstract available

  1069. ZHANG X, Liu CR, Wang ZZ, Ren ZF, et al
    Effect of a school-based educational intervention on HPV and HPV vaccine knowledge and willingness to be vaccinated among Chinese adolescents : a multi-center intervention follow-up study.
    Vaccine. 2020;38:3665-3670.
    PubMed     Abstract available

  1070. LIN J, Wood JG, Bernardo C, Stocks NP, et al
    Herpes zoster vaccine coverage in Australia before and after introduction of a national vaccination program.
    Vaccine. 2020;38:3646-3652.
    PubMed     Abstract available

  1071. SANGHA P, McCullough JM
    Trends in school-level vaccination coverage from 2015 to 2018: Increases in exemption rates and declines in herd immunity in Arizona.
    Vaccine. 2020 Apr 29. pii: S0264-410X(20)30510.
    PubMed     Abstract available

  1072. GOTTLIEB SL, Ndowa F, Hook EW 3rd, Deal C, et al
    Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019.
    Vaccine. 2020 Apr 28. pii: S0264-410X(20)30317.
    PubMed     Abstract available

  1073. CHRAPKOWSKA C, Galanis I, Kark M, Lepp T, et al
    Validation of the new Swedish vaccination register - Accuracy and completeness of register data.
    Vaccine. 2020 Apr 28. pii: S0264-410X(20)30490.
    PubMed     Abstract available

  1074. HERST CV, Burkholz S, Sidney J, Sette A, et al
    An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design.
    Vaccine. 2020 Apr 28. pii: S0264-410X(20)30518.
    PubMed     Abstract available

  1075. SCARINCI IC, Hansen B, Kim YI
    HPV vaccine uptake among daughters of Latinx immigrant mothers: Findings from a cluster randomized controlled trial of a community-based, culturally relevant intervention.
    Vaccine. 2020 Apr 27. pii: S0264-410X(20)30441.
    PubMed     Abstract available

  1076. CONREY R, Valencia V, Cioletti A, Williams-Brown MY, et al
    Regional variation in human papillomavirus vaccination uptake and completion among adolescents 13-17 in the state of Texas.
    Vaccine. 2020 Apr 26. pii: S0264-410X(20)30448.
    PubMed     Abstract available

    Homeopathic nosodes are not vaccines.
    Vaccine. 2020;38:3517.

  1078. WANG SH, Chen J, Smith D, Cao Z, et al
    A novel combination of intramuscular vaccine adjuvants, nanoemulsion and CpG produces an effective immune response against influenza A virus.
    Vaccine. 2020;38:3537-3544.
    PubMed     Abstract available

  1079. FULTON RW, Cook BJ, Payton ME, Burge LJ, et al
    Immune response to bovine viral diarrhea virus (BVDV) vaccines detecting antibodies to BVDV subtypes 1a, 1b, 2a, and 2c.
    Vaccine. 2020 Apr 23. pii: S0264-410X(20)30447.
    PubMed     Abstract available

  1080. SAYINZOGA F, Umulisa MC, Sibomana H, Tenet V, et al
    Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort.
    Vaccine. 2020 Apr 23. pii: S0264-410X(20)30491.
    PubMed     Abstract available

  1081. LEE JH, Hong S, Im JH, Lee JS, et al
    Systematic review and meta-analysis of immune response of double dose of hepatitis B vaccination in HIV-infected patients.
    Vaccine. 2020 Apr 22. pii: S0264-410X(20)30492.
    PubMed     Abstract available

  1082. WANLAPAKORN N, Puenpa J, Thongmee T, Srimuan D, et al
    Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: A longitudinal study.
    Vaccine. 2020 Apr 21. pii: S0264-410X(20)30483.
    PubMed     Abstract available

  1083. THOMPSON KM, Orenstein WA, Hinman AR
    An opportunity to incentivize innovation to increase vaccine safety in the United States by improving vaccine delivery using vaccine patches.
    Vaccine. 2020 Apr 21. pii: S0264-410X(20)30538.
    PubMed     Abstract available

  1084. OUSMANE S, Kobayashi M, Seidou I, Issaka B, et al
    Characterization of pneumococcal meningitis before and after introduction of 13-valent pneumococcal conjugate vaccine in Niger, 2010-2018.
    Vaccine. 2020 Apr 20. pii: S0264-410X(20)30468.
    PubMed     Abstract available

  1085. HOSANGADI D, Warmbrod KL, Martin EK, Adalja A, et al
    Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic.
    Vaccine. 2020 Apr 20. pii: S0264-410X(20)30530.

  1086. LAL M
    Freeze-dried tablets for oral vaccine delivery: Ease of administration and potential for production in existing facilities.
    Vaccine. 2020 Apr 19. pii: S0264-410X(20)30488.

  1087. LI YT, Luo XQ, Zhong XB, Cai LM, et al
    Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: A cross-sectional study in children following vaccination procedure in Guangzhou, China.
    Vaccine. 2020 Apr 19. pii: S0264-410X(20)30445.
    PubMed     Abstract available

  1088. KAUFMAN J, Attwell K, Tuckerman J, O'Sullivan J, et al
    Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study.
    Vaccine. 2020 Apr 19. pii: S0264-410X(20)30469.
    PubMed     Abstract available

  1089. LAZARUS DD, Peta F, Blight D, Van Heerden J, et al
    Efficacy of a foot-and-mouth disease vaccine against a heterologous SAT1 virus challenge in goats.
    Vaccine. 2020 Apr 17. pii: S0264-410X(20)30484.
    PubMed     Abstract available

  1090. MUTSAERTS EAML, Nunes MC, Bhikha S, Ikulinda BT, et al
    Short-term immunogenicity and safety of hepatitis-A and varicella vaccines in HIV-exposed uninfected and HIV-unexposed South African children.
    Vaccine. 2020 Apr 16. pii: S0264-410X(20)30433.
    PubMed     Abstract available

  1091. JUN JW, Kang JW, Giri SS, Yun S, et al
    Immunostimulation by starch hydrogel-based oral vaccine using formalin-killed cells against edwardsiellosis in Japanese eel, Anguilla japonica.
    Vaccine. 2020 Apr 16. pii: S0264-410X(20)30435.
    PubMed     Abstract available

  1092. AVENDANO C, Celis-Giraldo C, Ordonez D, Diaz-Arevalo D, et al
    Evaluating the immunogenicity of chemically-synthesised peptides derived from foot-and-mouth disease VP1, VP2 and VP3 proteins as vaccine candidates.
    Vaccine. 2020 Apr 16. pii: S0264-410X(20)30464.
    PubMed     Abstract available

  1093. HOQUE SA, Khandoker N, Thongprachum A, Khamrin P, et al
    Distribution of rotavirus genotypes in Japan from 2015 to 2018: Diversity in genotypes before and after introduction of rotavirus vaccines.
    Vaccine. 2020 Apr 16. pii: S0264-410X(20)30465.
    PubMed     Abstract available

  1094. DIB F, le Sage FV, Cohen R, Launay O, et al
    Recommendation of HPV vaccination to boys in France - An unhappy coincidence with the WHO call to pause the implementation of this vaccination in boys.
    Vaccine. 2020 Apr 15. pii: S0264-410X(20)30487.

  1095. MORICONI A, Onnis V, Aggravi M, Parlati C, et al
    A new strategy for preparing a tailored meningococcal ACWY conjugate vaccine for clinical testing.
    Vaccine. 2020 Apr 13. pii: S0264-410X(20)30463.

  1096. CROSS JW, Joy M, McGee C, Akinyemi O, et al
    Adverse events of interest vary by influenza vaccine type and brand: Sentinel network study of eight seasons (2010-2018).
    Vaccine. 2020 Apr 13. pii: S0264-410X(20)30402.
    PubMed     Abstract available

  1097. STAPLETON JT, Wagner N, Tuetken R, Bellamy AR, et al
    High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial.
    Vaccine. 2020 Apr 12. pii: S0264-410X(20)30459.
    PubMed     Abstract available

  1098. JALLOH MF, Wallace AS, Bunnell RE, Carter RJ, et al
    Ebola vaccine? Family first! Evidence from using a brief measure on Ebola vaccine demand in a national household survey during the outbreak in Sierra Leone.
    Vaccine. 2020 Apr 11. pii: S0264-410X(20)30423.
    PubMed     Abstract available

  1099. VESIKARI T, Forsten A, Laudat F, Li P, et al
    Long-term antibody persistence after a booster dose of quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in healthy 5-year-old children.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30227.
    PubMed     Abstract available

  1100. CHANG CY, Cho CY, Lai CC, Lu CY, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in healthy subjects aged 3 to 17 years old: A phase III, open label, single-arm study.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30437.
    PubMed     Abstract available

  1101. TOTTERDELL J, Phillips A, Glover C, Chidwick K, et al
    Safety of live attenuated herpes zoster vaccine in adults 70-79 years: A self-controlled case series analysis using primary care data from Australia's MedicineInsight program.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30443.
    PubMed     Abstract available

  1102. LI Y, Lin Y, Xin G, Zhou X, et al
    Comparative evaluation of ELPylated virus-like particle vaccine with two commercial PCV2 vaccines by experimental challenge.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30460.
    PubMed     Abstract available

  1103. TAPIA MD, Doumbia M, Dembele R, Ball K, et al
    Arranging good clinical practices training and trial monitoring for a vaccine efficacy study during a public health emergency of international concern.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30359.
    PubMed     Abstract available

  1104. JOE CCD, Chatterjee S, Lovrecz G, Adams TE, et al
    Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30350.
    PubMed     Abstract available

  1105. STIFTER K, Dekhtiarenko I, Krieger J, Tissot AC, et al
    A tumor-specific neoepitope expressed in homologous/self or heterologous/viral antigens induced comparable effector CD8(+) T-cell responses by DNA vaccination.
    Vaccine. 2020 Apr 9. pii: S0264-410X(20)30461.
    PubMed     Abstract available

  1106. KIM JH, Lee H, Shin JY
    Bacillus Calmette-Guerin (BCG) vaccine safety surveillance in the Korea Adverse Event Reporting System using the tree-based scan statistic and conventional disproportionality-based algorithms.
    Vaccine. 2020 Apr 9. pii: S0264-410X(20)30466.
    PubMed     Abstract available

  1107. JI YS, Park SK, Ryu S
    Whole leukemia cell vaccines: Past progress and future directions.
    Vaccine. 2020 Apr 9. pii: S0264-410X(20)30421.
    PubMed     Abstract available

  1108. GARY E, O'Connor M, Chakhtoura M, Tardif V, et al
    Adenosine deaminase-1 enhances germinal center formation and functional antibody responses to HIV-1 Envelope DNA and protein vaccines.
    Vaccine. 2020 Apr 9. pii: S0264-410X(20)30436.
    PubMed     Abstract available

  1109. DODD C, de Ridder M, Weibel D, Mahaux O, et al
    ADVANCE system testing: Estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data.
    Vaccine. 2020 Apr 9. pii: S0264-410X(20)30439.
    PubMed     Abstract available

  1110. WANG S, Yang G, Nie J, Yang R, et al
    Recombinant E(rns)-E2 protein vaccine formulated with MF59 and CPG-ODN promotes T cell immunity against bovine viral diarrhea virus infection.
    Vaccine. 2020 Apr 9. pii: S0264-410X(20)30373.
    PubMed     Abstract available

  1111. HIRSCH J, Faber BW, Crowe JE Jr, Verstrepen B, et al
    E. coli production process yields stable dengue 1 virus-sized particles (VSPs).
    Vaccine. 2020;38:3305-3312.
    PubMed     Abstract available

  1112. SINGH AK, Wang X, Sun W
    Oral vaccination with live attenuated Yersinia pseudotuberculosis strains delivering a FliC180-LcrV fusion antigen confers protection against pulmonary Y. Pestis infection.
    Vaccine. 2020 Apr 8. pii: S0264-410X(20)30444.
    PubMed     Abstract available

  1113. CHEBLOUNE Y, Moussa M, Arrode-Bruses G, Ronfort C, et al
    A single lentivector DNA based immunization contains a late heterologous SIVmac251 mucosal challenge infection.
    Vaccine. 2020 Apr 8. pii: S0264-410X(20)30442.
    PubMed     Abstract available

  1114. MEITES E, Markowitz LE, Kempe A, O'Leary ST, et al
    Primary care physician support for harmonizing HPV vaccination recommendations across genders - United States, 2018.
    Vaccine. 2020 Apr 7. pii: S0264-410X(20)30417.
    PubMed     Abstract available

  1115. SUGISHITA Y, Nakayama T, Sugawara T, Ohkusa Y, et al
    Negative effect on immune response of repeated influenza vaccination and waning effectiveness in interseason for elderly people.
    Vaccine. 2020 Apr 7. pii: S0264-410X(20)30378.
    PubMed     Abstract available

  1116. SURAGH TA, Hibbs B, Marquez P, McNeil MM, et al
    Age inappropriate influenza vaccination in infants less than 6 months old, 2010-2018.
    Vaccine. 2020 Apr 6. pii: S0264-410X(20)30418.
    PubMed     Abstract available

  1117. SAEZ-LLORENS X, Thierry-Carstensen B, Stoey LS, Sorensen C, et al
    Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, following vaccination in children at 2, 4, 6 and at 15-18 months.
    Vaccine. 2020 Apr 6. pii: S0264-410X(20)30295.
    PubMed     Abstract available

  1118. SCHMUHL NB, Mooney KE, Zhang X, Cooney LG, et al
    No association between HPV vaccination and infertility in U.S. females 18-33 years old.
    Vaccine. 2020 Apr 3. pii: S0264-410X(20)30414.
    PubMed     Abstract available

  1119. GUTIERREZ RL, Porter CK, Jarell A, Alcala A, et al
    A grading system for local skin reactions developed for clinical trials of an intradermal and transcutaneous ETEC vaccine.
    Vaccine. 2020 Apr 3. pii: S0264-410X(20)30323.
    PubMed     Abstract available

    March 2020
  1120. JIANG Y, Cheng X, Zhao X, Yu Y, et al
    Recombinant infectious bronchitis coronavirus H120 with the spike protein S1 gene of the nephropathogenic IBYZ strain remains attenuated but induces protective immunity.
    Vaccine. 2020;38:3157-3168.
    PubMed     Abstract available

  1121. AHMED MA, Naus M, Singer J, Valiquette L, et al
    Investigating the association of receipt of seasonal influenza vaccine with occurrence of anesthesia/paresthesia and severe headaches, Canada 2012/13-2016/17, the Canadian Vaccine Safety Network.
    Vaccine. 2020 Mar 27. pii: S0264-410X(20)30371.
    PubMed     Abstract available

  1122. STEPANEK L, Nakladalova M, Borikova A, Horakova D, et al
    Measles immunity in a Czech tertiary care hospital.
    Vaccine. 2020;38:2889-2892.
    PubMed     Abstract available

  1123. HOANG HH, Wang PC, Chen SC
    The protective efficacy of recombinant hypoxic response protein 1 of Nocardia seriolae in largemouth bass (Micropterus salmoides).
    Vaccine. 2020;38:2925-2936.
    PubMed     Abstract available

  1124. LIU FJ, Shi DY, Mao YY, Xiong XH, et al
    Immunological characterisation and immunoprotective efficacy of functional domain antigens of botulinum neurotoxin serotype A.
    Vaccine. 2020;38:2978-2983.
    PubMed     Abstract available

  1125. CHANG LJ, Hedrick J, Christensen S, Pan J, et al
    A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States.
    Vaccine. 2020 Mar 21. pii: S0264-410X(20)30370.
    PubMed     Abstract available

  1126. O'LEARY ST, Cataldi JR, Lindley MC, Hurley LP, et al
    Impact of media reports regarding influenza vaccine on obstetricians' vaccination practices.
    Vaccine. 2020 Mar 21. pii: S0264-410X(20)30263.
    PubMed     Abstract available

  1127. DAYAN GH, Langevin E, Gilbert PB, Wu Y, et al
    Assessment of the long-term efficacy of a dengue vaccine against symptomatic, virologically-confirmed dengue disease by baseline dengue serostatus.
    Vaccine. 2020 Mar 20. pii: S0264-410X(20)30384.
    PubMed     Abstract available

  1128. SUO L, Lu L, Zhao D, Pang X, et al
    Impact of a 2-dose voluntary vaccination strategy on varicella epidemiology in Beijing, 2011-2017.
    Vaccine. 2020 Mar 20. pii: S0264-410X(20)30140.
    PubMed     Abstract available

  1129. WILSON-WELDER JH, Boggiatto P, Nally JE, Wafa EI, et al
    Bovine immune response to leptospira antigen in different novel adjuvants and vaccine delivery platforms.
    Vaccine. 2020 Mar 20. pii: S0264-410X(20)30333.
    PubMed     Abstract available

  1130. IKILEZI G, Augusto OJ, Sbarra A, Sherr K, et al
    Determinants of geographical inequalities for DTP3 vaccine coverage in sub-Saharan Africa.
    Vaccine. 2020 Mar 20. pii: S0264-410X(20)30338.
    PubMed     Abstract available

  1131. WOESTENBERG PJ, van Benthem BHB, Bogaards JA, King AJ, et al
    HPV infections among young MSM visiting sexual health centers in the Netherlands: Opportunities for targeted HPV vaccination.
    Vaccine. 2020 Mar 19. pii: S0264-410X(20)30330.
    PubMed     Abstract available

  1132. SANDO E, Suzuki M, Furumoto A, Asoh N, et al
    Corrigendum to "Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE)" [Vaccine 37 (2019)
    Vaccine. 2020 Mar 19. pii: S0264-410X(20)30397.

  1133. QAMAR FN, Yousafzai MT, Khaliq A, Karim S, et al
    Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan.
    Vaccine. 2020 Mar 19. pii: S0264-410X(20)30383.
    PubMed     Abstract available

  1134. SHI S, Liang Z, Sun B
    Response to comment on: Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity.
    Vaccine. 2020;38:2759.

    Reply to Shuting Shi et al., Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity (Vaccine 2019;37 (24):3167-3178).
    Vaccine. 2020;38:2758.

  1136. LANE MC, Gordon JL, Jiang C, Leitner WW, et al
    Workshop report: Optimization of animal models to better predict influenza vaccine efficacy.
    Vaccine. 2020;38:2751-2757.
    PubMed     Abstract available

  1137. NEUMANN G, Kawaoka Y
    Optimization of animal models to better predict influenza vaccine efficacy (VA).
    Vaccine. 2020;38:2749-2750.

  1138. MURAKAMI K, Fujii Y, Someya Y
    Effects of the thermal denaturation of Sabin-derived inactivated polio vaccines on the D-antigenicity and the immunogenicity in rats.
    Vaccine. 2020 Mar 17. pii: S0264-410X(20)30380.
    PubMed     Abstract available

  1139. CHOE YJ, Jee Y, Takashima Y, Lee JK, et al
    Japanese encephalitis in the Western Pacific Region: Implication from the Republic of Korea.
    Vaccine. 2020;38:2760-2763.
    PubMed     Abstract available

  1140. COULBORN RM, Nackers F, Bachy C, Porten K, et al
    Field challenges to measles elimination in the Democratic Republic of the Congo.
    Vaccine. 2020;38:2800-2807.
    PubMed     Abstract available

  1141. HVASS AMF, Norredam M, Sodemann M, Thomsen MK, et al
    Are refugees arriving in Denmark an under-immunised group for measles? A cross-sectional serology study.
    Vaccine. 2020;38:2788-2794.
    PubMed     Abstract available

  1142. VOS RA, Pasmans H, Tymchenko L, Janga-Jansen AVA, et al
    High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands.
    Vaccine. 2020;38:2816-2826.
    PubMed     Abstract available

  1143. ASANTE KP, Ansong D, Kaali S, Adjei S, et al
    Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial.
    Vaccine. 2020 Mar 16. pii: S0264-410X(20)30358.
    PubMed     Abstract available

  1144. LAI JI, Eszterhas SK, Brooks SA, Guo C, et al
    Induction of cross-reactive HIV-1 specific antibody responses by engineered V1V2 immunogens with reduced conformational plasticity.
    Vaccine. 2020 Mar 16. pii: S0264-410X(20)30354.
    PubMed     Abstract available

  1145. BENZAKEN CL, Miller JD, Onono M, Young SL, et al
    Development of a cumulative metric of vaccination adherence behavior and its application among a cohort of 12-month-olds in western Kenya.
    Vaccine. 2020 Mar 14. pii: S0264-410X(20)30355.
    PubMed     Abstract available

  1146. RUANSIT W, Charerntantanakul W
    Oral supplementation of quercetin in PRRSV-1 modified-live virus vaccinated pigs in response to HP-PRRSV-2 challenge.
    Vaccine. 2020 Mar 14. pii: S0264-410X(20)30372.
    PubMed     Abstract available

  1147. FEYSSAGUET M, Berthold V, Helle L, Povey M, et al
    Comparison of a glycoprotein E-based ELISA with a varicella-zoster whole-virus ELISA for the quantification of varicella vaccine immune responses in young children.
    Vaccine. 2020 Mar 14. pii: S0264-410X(20)30352.
    PubMed     Abstract available

  1148. SUNDARAM AK, Ewing D, Blevins M, Liang Z, et al
    Comparison of purified psoralen-inactivated and formalin-inactivated dengue vaccines in mice and nonhuman primates.
    Vaccine. 2020 Mar 14. pii: S0264-410X(20)30351.
    PubMed     Abstract available

  1149. HUANG K, Tao S, Zhou X, Mo J, et al
    Incidence rates of health outcomes of interest among Chinese children exposed to selected vaccines in Yinzhou Electronic Health Records: A population-based retrospective cohort study.
    Vaccine. 2020 Mar 13. pii: S0264-410X(20)30357.
    PubMed     Abstract available

  1150. YANG YT, Pendo E, Reiss DR
    The Americans with disabilities act and healthcare employer-mandated vaccinations.
    Vaccine. 2020 Mar 13. pii: S0264-410X(20)30356.

  1151. OESTERREICH S, Lindemann M, Goldblatt D, Horn PA, et al
    Humoral response to a 13-valent pneumococcal conjugate vaccine in kidney transplant recipients.
    Vaccine. 2020 Mar 13. pii: S0264-410X(20)30335.
    PubMed     Abstract available

  1152. ASTON-DEAVILLE S, Carlsson E, Saleem M, Thistlethwaite A, et al
    An assessment of the use of Hepatitis B Virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis.
    Vaccine. 2020 Mar 13. pii: S0264-410X(20)30327.
    PubMed     Abstract available

  1153. DIAMOS AG, Pardhe MD, Sun H, Hunter JGL, et al
    Codelivery of improved immune complex and virus-like particle vaccines containing Zika virus envelope domain III synergistically enhances immunogenicity.
    Vaccine. 2020 Mar 12. pii: S0264-410X(20)30337.
    PubMed     Abstract available

  1154. COLRAIN P, Chang Blanc D, Grundy J, Kone S, et al
    The binomial nature of immunization session size distributions and the implications for vaccine wastage.
    Vaccine. 2020 Mar 11. pii: S0264-410X(20)30292.
    PubMed     Abstract available

  1155. RUSCIO B, Bolster A, Bresee J
    Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness.
    Vaccine. 2020 Mar 11. pii: S0264-410X(20)30247.
    PubMed     Abstract available

  1156. BARTSCH SM, Stokes-Cawley OJ, Buekens P, Asti L, et al
    The potential economic value of a therapeutic Chagas disease vaccine for pregnant women to prevent congenital transmission.
    Vaccine. 2020 Mar 11. pii: S0264-410X(20)30322.
    PubMed     Abstract available

  1157. KUTER BJ, Offit P
    Celebrating the Centennial of the Birth of the World's Greatest Vaccinologist, Maurice R. Hilleman, 1919-2005.
    Vaccine. 2020 Mar 11. pii: S0264-410X(20)30303.

  1158. BRAEYE T, Emborg HD, Llorente-Garcia A, Huerta C, et al
    Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project.
    Vaccine. 2020 Mar 11. pii: S0264-410X(20)30326.
    PubMed     Abstract available

  1159. LACOUR M, Davis T
    Vaccine skepticism reflects basic cognitive differences in mortality-related event frequency estimation.
    Vaccine. 2020 Mar 10. pii: S0264-410X(20)30264.
    PubMed     Abstract available

  1160. CHO HK, Kang YM, Kim HM, Lee CH, et al
    Sales and immunogenicity of commercial vaccines to H9N2 low pathogenic avian influenza virus in Korea from 2007 to 2017.
    Vaccine. 2020 Mar 10. pii: S0264-410X(20)30328.
    PubMed     Abstract available

  1161. CARIAS C, Hills SL, Kahn EB, Adhikari BB, et al
    Comparative economic analysis of strategies for Japanese encephalitis vaccination of U.S. travelers.
    Vaccine. 2020 Mar 10. pii: S0264-410X(20)30229.
    PubMed     Abstract available

  1162. BERAN J, Leroux-Roels G, Van Damme P, de Hoon J, et al
    Safety and immunogenicity of fully liquid and lyophilized formulations of an investigational trivalent group B streptococcus vaccine in healthy non-pregnant women: Results from a randomized comparative phase II trial.
    Vaccine. 2020 Mar 10. pii: S0264-410X(20)30331.
    PubMed     Abstract available

  1163. BARTHOLOMEUS E, De Neuter N, Suls A, Elias G, et al
    Transcriptomic profiling of different responder types in adults after a Priorix(R) vaccination.
    Vaccine. 2020 Mar 9. pii: S0264-410X(20)30336.
    PubMed     Abstract available

  1164. DANCHIN MH, Bines JE, Watts E, Cowley D, et al
    Rotavirus specific maternal antibodies and immune response to RV3-BB rotavirus vaccine in central java and yogyakarta, Indonesia.
    Vaccine. 2020 Mar 9. pii: S0264-410X(20)30334.
    PubMed     Abstract available

  1165. YU H, Karunakaran KP, Jiang X, Chan Q, et al
    Comparison of Chlamydia outer membrane complex to recombinant outer membrane proteins as vaccine.
    Vaccine. 2020 Mar 6. pii: S0264-410X(20)30282.
    PubMed     Abstract available

  1166. MCCLYMONT E, Ogilvie G, Albert A, Johnston A, et al
    Impact of quadrivalent HPV vaccine dose spacing on immunologic response in women living with HIV.
    Vaccine. 2020 Mar 5. pii: S0264-410X(20)30319.
    PubMed     Abstract available

  1167. AHMED N, Giorgakoudi K, Usuf E, Okomo U, et al
    Potential cost-effectiveness of a maternal Group B streptococcal vaccine in The Gambia.
    Vaccine. 2020 Mar 5. pii: S0264-410X(20)30302.
    PubMed     Abstract available

  1168. MENZIES R, Heron L, Lampard J, McMillan M, et al
    A randomised controlled trial of SMS messaging and calendar reminders to improve vaccination timeliness in infants.
    Vaccine. 2020 Mar 5. pii: S0264-410X(20)30257.
    PubMed     Abstract available

  1169. MOUNIER-JACK S, Bell S, Chantler T, Edwards A, et al
    Organisational factors affecting performance in delivering influenza vaccination to staff in NHS Acute Hospital Trusts in England: A qualitative study.
    Vaccine. 2020 Mar 5. pii: S0264-410X(20)30321.
    PubMed     Abstract available

  1170. BELONGIA EA, Levine MZ, Olaiya O, Gross FL, et al
    Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018.
    Vaccine. 2020 Mar 4. pii: S0264-410X(20)30278.
    PubMed     Abstract available

  1171. BASU R, Zhai L, Rosso B, Tumban E, et al
    Bacteriophage Qbeta virus-like particles displaying Chikungunya virus B-cell epitopes elicit high-titer E2 protein antibodies but fail to neutralize a Thailand strain of Chikungunya virus.
    Vaccine. 2020;38:2542-2550.
    PubMed     Abstract available

  1172. LIU M, Zhong Y, Chen J, Liu Y, et al
    Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.
    Vaccine. 2020 Mar 2. pii: S0264-410X(20)30245.
    PubMed     Abstract available

  1173. MORAN EB, Wagner AL, Asiedu-Bekoe F, Abdul-Karim A, et al
    Socioeconomic characteristics associated with the introduction of new vaccines and full childhood vaccination in Ghana, 2014.
    Vaccine. 2020 Mar 2. pii: S0264-410X(20)30293.
    PubMed     Abstract available

    February 2020
  1174. SONG Y, Yang Y, Lin X, Li X, et al
    In-situ and sensitive stability study of emulsion and aluminum adjuvanted inactivated foot-and-mouth disease virus vaccine by differential scanning fluorimetry analysis.
    Vaccine. 2020 Feb 29. pii: S0264-410X(20)30297.
    PubMed     Abstract available

  1175. LIN Y, Lin Z, He F, Chen H, et al
    HPV vaccination intent and willingness to pay for 2-,4-, and 9-valent HPV vaccines: A study of adult women aged 27-45 years in China.
    Vaccine. 2020 Feb 29. pii: S0264-410X(20)30254.
    PubMed     Abstract available

  1176. SHU J, Shen W, Liu H, Zhou Y, et al
    The immunologic dominance of an epitope within a rationally designed poly-epitope vaccine is influenced by multiple factors.
    Vaccine. 2020 Feb 29. pii: S0264-410X(20)30298.
    PubMed     Abstract available

  1177. MOGASALE V, Kanungo S, Pati S, Lynch J, et al
    The history of OCV in India and barriers remaining to programmatic introduction.
    Vaccine. 2020;38 Suppl 1:A41-A45.
    PubMed     Abstract available

  1178. HOLMGREN J
    Vaccine. 2020;38 Suppl 1:A1-A3.

  1179. GUPTA SS, Gupta SK
    Social mobilization for cholera prevention & control in India: Building on the existing framework.
    Vaccine. 2020;38 Suppl 1:A181-A183.
    PubMed     Abstract available

  1180. HALDAR P
    Programmatic Preparations and challenges for OCV introduction in India.
    Vaccine. 2020;38 Suppl 1:A175-A177.
    PubMed     Abstract available

  1181. GUPTA SS, Ganguly NK
    Opportunities and challenges for cholera control in India.
    Vaccine. 2020;38 Suppl 1:A25-A27.
    PubMed     Abstract available

  1182. SEKHAR A, Kang G
    Pathways to a policy for cholera control in India.
    Vaccine. 2020;38 Suppl 1:A157-A159.
    PubMed     Abstract available

  1183. AZMAN AS, Moore SM, Lessler J
    Surveillance and the global fight against cholera: Setting priorities and tracking progress.
    Vaccine. 2020;38 Suppl 1:A28-A30.

  1184. CHASE-TOPPING M, Xie J, Pooley C, Trus I, et al
    New insights about vaccine effectiveness: Impact of attenuated PRRS-strain vaccination on heterologous strain transmission.
    Vaccine. 2020 Feb 28. pii: S0264-410X(20)30188.
    PubMed     Abstract available

  1185. UTAZI CE, Wagai J, Pannell O, Cutts FT, et al
    Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: Analysis of recent household surveys.
    Vaccine. 2020 Feb 28. pii: S0264-410X(20)30301.
    PubMed     Abstract available

  1186. POLAND GA
    Another coronavirus, another epidemic, another warning.
    Vaccine. 2020;38:v-vi.

  1187. ARIS E, Montourcy M, Esterberg E, Kurosky SK, et al
    The adult vaccination landscape in the United States during the Affordable Care Act era: Results from a large retrospective database analysis.
    Vaccine. 2020 Feb 27. pii: S0264-410X(20)30280.
    PubMed     Abstract available

  1188. NABER SK, Bruijning-Verhagen PCJL, de Hoog MLA, van Giessen A, et al
    Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands.
    Vaccine. 2020 Feb 27. pii: S0264-410X(20)30084.
    PubMed     Abstract available

  1189. SELVEY LA, Roux F, Burns S
    Potential process improvements to increase coverage of human papillomavirus vaccine in schools - A focus on schools with low vaccine uptake.
    Vaccine. 2020 Feb 27. pii: S0264-410X(20)30259.
    PubMed     Abstract available

  1190. FERREIRA VM, Ferreira IE, Chang HY, Nunes AMPB, et al
    Meningococcal carriage in young adults six years after meningococcal C conjugate (MCC) vaccine catch-up campaign in Salvador, Brazil.
    Vaccine. 2020 Feb 27. pii: S0264-410X(20)30262.
    PubMed     Abstract available

  1191. KALLIGEROS M, Shehadeh F, Mylona EK, Dapaah-Afriyie C, et al
    Influenza vaccine effectiveness against influenza-associated hospitalization in children: A systematic review and meta-analysis.
    Vaccine. 2020 Feb 27. pii: S0264-410X(20)30261.
    PubMed     Abstract available

  1192. ZAHN T, Akhras S, Spengler C, Murra RO, et al
    A new approach for therapeutic vaccination against chronic HBV infections.
    Vaccine. 2020 Feb 26. pii: S0264-410X(20)30291.
    PubMed     Abstract available

  1193. ELKIN LE, Pullon SRH, Stubbe MH
    'Should I vaccinate my child?' comparing the displayed stances of vaccine information retrieved from Google, Facebook and YouTube.
    Vaccine. 2020 Feb 25. pii: S0264-410X(20)30253.
    PubMed     Abstract available

  1194. HASAN AZ, Saha S, Saha SK, Sahakyan G, et al
    Corrigendum to "Using pneumococcal and rotavirus surveillance in vaccine decision-making: A series of case studies in Bangladesh, Armenia and the Gambia" [Vaccine 36 (2018) 4939-4943].
    Vaccine. 2020 Feb 25. pii: S0264-410X(20)30230.

  1195. LEIDNER AJ, Fisun H, Trimble S, Lucas P, et al
    Evaluation of temperature stability among different types and grades of vaccine storage units: Data from continuous temperature monitoring devices.
    Vaccine. 2020 Feb 25. pii: S0264-410X(20)30255.
    PubMed     Abstract available

  1196. JOHNSON DM, Jokinen JD, Wang M, Pfeffer T, et al
    Bivalent Junin & Machupo experimental vaccine based on alphavirus RNA replicon vector.
    Vaccine. 2020 Feb 25. pii: S0264-410X(20)30265.
    PubMed     Abstract available

  1197. WHITBY PW, Morton DJ, Mussa HJ, Mirea L, et al
    A bacterial vaccine polypeptide protective against nontypable Haemophilus influenzae.
    Vaccine. 2020 Feb 25. pii: S0264-410X(20)30277.
    PubMed     Abstract available

  1198. ASHBAUGH HR, Cherry JD, Hoff NA, Doshi RH, et al
    Measles antibody levels among vaccinated and unvaccinated children 6-59months of age in the Democratic Republic of the Congo, 2013-2014.
    Vaccine. 2020;38:2258-2265.
    PubMed     Abstract available

  1199. ANDREWS N, Stowe J, Walker J, Thomas S, et al
    Response to Letter to the editor by Signe Sorup re: The risk of non-specific hospitalised infections following MMR vaccination given with and without inactivated vaccines in the second year of life. Comparative self-controlled case-series study in Eng
    Vaccine. 2020;38:2116.

  1200. SORUP S
    Careful consideration of hypotheses and model assumptions in study of non-specific effects of vaccines.
    Vaccine. 2020;38:2115.

  1201. BLYTH CC, Cheng AC, Crawford NW, Clark JE, et al
    The impact of new universal child influenza programs in Australia: Vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018.
    Vaccine. 2020 Feb 24. pii: S0264-410X(20)30228.
    PubMed     Abstract available

  1202. MUELLER S, Stauft CB, Kalkeri R, Koidei F, et al
    A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates.
    Vaccine. 2020 Feb 24. pii: S0264-410X(20)30279.
    PubMed     Abstract available

  1203. HUNEYCUTT B, Lurie N, Rotenberg S, Wilder R, et al
    Finding equipoise: CEPI revises its equitable access policy.
    Vaccine. 2020;38:2144-2148.
    PubMed     Abstract available

  1204. ANGELIDOU A, Conti MG, Diray-Arce J, Benn CS, et al
    Licensed Bacille Calmette-Guerin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation.
    Vaccine. 2020;38:2229-2240.
    PubMed     Abstract available

  1205. DUDLEY MZ, Limaye RJ, Omer SB, O'Leary ST, et al
    Factors associated with referring close contacts to an app with individually-tailored vaccine information.
    Vaccine. 2020 Feb 22. pii: S0264-410X(20)30206.
    PubMed     Abstract available

  1206. COLEY KC, Gessler C, McGivney M, Richardson R, et al
    Increasing adult vaccinations at a regional supermarket chain pharmacy: A multi-site demonstration project.
    Vaccine. 2020 Feb 21. pii: S0264-410X(20)30252.
    PubMed     Abstract available

  1207. KASEREKA MC, Ericson AD, Conroy AL, Tumba L, et al
    Prior vaccination with recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus vaccine is associated with improved survival among patients with Ebolavirus infection.
    Vaccine. 2020 Feb 21. pii: S0264-410X(20)30256.
    PubMed     Abstract available

  1208. QIU Y, Zhao Y, Liu F, Ye B, et al
    Evaluation of Plasmodium vivax HAP2 as a transmission-blocking vaccine candidate.
    Vaccine. 2020 Feb 21. pii: S0264-410X(20)30184.
    PubMed     Abstract available

  1209. HU D, Martin C, Dredze M, Broniatowski DA, et al
    Chinese social media suggest decreased vaccine acceptance in China: An observational study on Weibo following the 2018 Changchun Changsheng vaccine incident.
    Vaccine. 2020 Feb 21. pii: S0264-410X(20)30224.
    PubMed     Abstract available

  1210. LOCKYER K, Gao F, Francis RJ, Eastwood D, et al
    Higher mass meningococcal group C-tetanus toxoid vaccines conjugated with carbodiimide correlate with greater immunogenicity.
    Vaccine. 2020 Feb 20. pii: S0264-410X(20)30185.
    PubMed     Abstract available

  1211. MCDONALD SL, Weldon WC, Wei L, Chen Q, et al
    Neutralization capacity of highly divergent type 2 vaccine-derived polioviruses from immunodeficient patients.
    Vaccine. 2020 Feb 20. pii: S0264-410X(20)30244.
    PubMed     Abstract available

  1212. KABORE L, Meda CZ, Sawadogo F, Bengue MM, et al
    Quality and reliability of vaccination documentation in the routine childhood immunization program in Burkina Faso: Results from a cross-sectional survey.
    Vaccine. 2020 Feb 20. pii: S0264-410X(20)30220.
    PubMed     Abstract available

  1213. GORMAN DR, Bielecki K, Larson HJ, Willocks LJ, et al
    Comparing vaccination hesitancy in Polish migrant parents who accept or refuse nasal flu vaccination for their children.
    Vaccine. 2020 Feb 20. pii: S0264-410X(20)30225.
    PubMed     Abstract available

  1214. ALBERSHARDT TC, Parsons AJ, Reeves RS, Flynn PA, et al
    Therapeutic efficacy of PD1/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccine.
    Vaccine. 2020 Feb 19. pii: S0264-410X(20)30243.
    PubMed     Abstract available

  1215. CHURCH JA, Chasekwa B, Rukobo S, Govha M, et al
    Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants.
    Vaccine. 2020 Feb 19. pii: S0264-410X(20)30150.
    PubMed     Abstract available

  1216. ZHOU Y, Lin YF, Meng X, Duan Q, et al
    Anal human papillomavirus among men who have sex with men in three metropolitan cities in southern China: implications for HPV vaccination.
    Vaccine. 2020 Feb 19. pii: S0264-410X(20)30176.
    PubMed     Abstract available

  1217. VODICKA E, Zimmermann M, Lopez AL, Silva MW, et al
    Japanese encephalitis vaccination in the Philippines: A cost-effectiveness analysis comparing alternative delivery strategies.
    Vaccine. 2020 Feb 18. pii: S0264-410X(20)30205.
    PubMed     Abstract available

  1218. TRETYAKOVA I, Plante KS, Rossi SL, Lawrence HWS, et al
    Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge.
    Vaccine. 2020 Feb 18. pii: S0264-410X(20)30173.
    PubMed     Abstract available

  1219. DAVIS H, Dow T, Isopi L, Blue JT, et al
    Examination of the effect of agitation on the potency of the Ebola Zaire vaccine rVSVDeltaG-ZEBOV-GP.
    Vaccine. 2020 Feb 18. pii: S0264-410X(20)30155.
    PubMed     Abstract available

  1220. PERRETT KP, Halperin SA, Nolan T, Martinez Pancorbo C, et al
    Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial.
    Vaccine. 2020;38:2095-2104.
    PubMed     Abstract available

  1221. PERRETT KP, Halperin SA, Nolan T, Carmona Martinez A, et al
    Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial.
    Vaccine. 2020;38:2105-2114.
    PubMed     Abstract available

  1222. ADAMSON PJ, Wang JJ, Anosova NG, Colella AD, et al
    Proteomic profiling of precipitated Clostridioides difficile toxin A and B antibodies.
    Vaccine. 2020;38:2077-2087.
    PubMed     Abstract available

  1223. LANGSAM D, Anis E, Haas EJ, Gosinov R, et al
    Tdap vaccination during pregnancy interrupts a twenty-year increase in the incidence of pertussis.
    Vaccine. 2020 Feb 15. pii: S0264-410X(20)30148.
    PubMed     Abstract available

  1224. MADHI SA, Izu A, Violari A, Cotton MF, et al
    Effect of HIV-exposure and timing of antiretroviral treatment initiation in children living with HIV on antibody persistence and memory responses to Haemophilus influenzae type b and pneumococcal polysaccharide-protein conjugate vaccines.
    Vaccine. 2020 Feb 15. pii: S0264-410X(20)30223.
    PubMed     Abstract available

  1225. SOMPAGDEE N, Anuwutnavin S, Phongsamart W, Senawong S, et al
    Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women.
    Vaccine. 2020 Feb 15. pii: S0264-410X(20)30116.
    PubMed     Abstract available

  1226. HOSCHLER K, Maharjan S, Whitaker H, Southern J, et al
    Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.
    Vaccine. 2020 Feb 15. pii: S0264-410X(20)30221.
    PubMed     Abstract available

  1227. MOHAMMED H, Roberts CT, Grzeskowiak LE, Giles L, et al
    Psychosocial determinants of pertussis and influenza vaccine uptake in pregnant women: A prospective study.
    Vaccine. 2020 Feb 15. pii: S0264-410X(20)30217.
    PubMed     Abstract available

  1228. KOIVUMAGI K, Toompere K, Soeorg H, Kallas E, et al
    Acute gastroenteritis hospitalizations after implementation of universal mass vaccination against rotavirus.
    Vaccine. 2020 Feb 14. pii: S0264-410X(20)30151.
    PubMed     Abstract available

  1229. XU Q, Cao Q, Yang W, Liu X, et al
    Interchangeability of two Enterovirus 71 inactivated vaccines in Chinese children: A phase IV, open-label, and randomized controlled trial.
    Vaccine. 2020 Feb 14. pii: S0264-410X(20)30186.
    PubMed     Abstract available

  1230. SIGURDSSON S, Eythorsson E, Erlendsdottir H, Hrafnkelsson B, et al
    Impact of the 10-valent pneumococcal conjugate vaccine on hospital admissions in children under three years of age in Iceland.
    Vaccine. 2020 Feb 13. pii: S0264-410X(20)30147.
    PubMed     Abstract available

  1231. VAN DEN BOOGAARD J, Rots NY, van der Klis F, de Melker HE, et al
    Is there an association between socioeconomic status and immune response to infant and childhood vaccination in the Netherlands?
    Vaccine. 2020 Feb 13. pii: S0264-410X(20)30113.
    PubMed     Abstract available

  1232. STEINICHE MM, Thysen SM, Jensen AKG, Rodrigues A, et al
    The effect of early measles vaccination on morbidity and growth: A randomised trial from Guinea-Bissau.
    Vaccine. 2020 Feb 12. pii: S0264-410X(20)30149.
    PubMed     Abstract available

  1233. DI LELLO FA, Blejer J, Alter A, Bartoli S, et al
    Hepatitis B surface antibodies seroprevalence among people born before and after implementation of universal HBV vaccination.
    Vaccine. 2020 Feb 12. pii: S0264-410X(20)30187.
    PubMed     Abstract available

  1234. STURKENBOOM M, Braeye T, van der Aa L, Danieli G, et al
    ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinations.
    Vaccine. 2020 Feb 12. pii: S0264-410X(20)30153.
    PubMed     Abstract available

  1235. SHARON AJ, Yom-Tov E, Baram-Tsabari A
    Vaccine information seeking on social Q&A services.
    Vaccine. 2020 Feb 12. pii: S0264-410X(20)30177.
    PubMed     Abstract available

  1236. BRANDON D, Kimmel M, Kuriyakose SO, Kostanyan L, et al
    Corrigendum to 'Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults'. [Vaccine 36 (2018) 6325-6
    Vaccine. 2020 Feb 12. pii: S0264-410X(20)30134.

  1237. YU X, Zhang T, Cui L, Geng X, et al
    Corrigendum to "Epidemiology study of pediatric primary intussusception aged </=24 months in pre-rotavirus vaccine era of Jinan, China" [Vaccine 37(11) (2019) 1436-1442].
    Vaccine. 2020 Feb 11. pii: S0264-410X(20)30111.

  1238. BUTTENHEIM AM, Joyce CM, Ibarra J, Agas J, et al
    Vaccine exemption requirements and parental vaccine attitudes: an online experiment.
    Vaccine. 2020 Feb 11. pii: S0264-410X(20)30050.
    PubMed     Abstract available

  1239. SAMY N, Reichhardt D, Schmidt D, Chen LM, et al
    Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial.
    Vaccine. 2020 Feb 11. pii: S0264-410X(20)30081.
    PubMed     Abstract available

  1240. OVERTON ET, Lawrence SJ, Stapleton JT, Weidenthaler H, et al
    A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS.
    Vaccine. 2020 Feb 11. pii: S0264-410X(20)30085.
    PubMed     Abstract available

  1241. ESPARZA J
    Three different paths to introduce the smallpox vaccine in early 19th century United States.
    Vaccine. 2020 Feb 11. pii: S0264-410X(20)30119.
    PubMed     Abstract available

  1242. NATH B, Vandna, Saini HM, Prasad M, et al
    Evaluation of Japanese encephalitis virus E and NS1 proteins immunogenicity using a recombinant Newcastle disease virus in mice.
    Vaccine. 2020;38:1860-1868.
    PubMed     Abstract available

  1243. GORAIN C, Singh A, Bhattacharyya S, Kundu A, et al
    Mucosal delivery of live Lactococcus lactis expressing functionally active JlpA antigen induces potent local immune response and prevent enteric colonization of Campylobacter jejuni in chickens.
    Vaccine. 2020;38:1630-1642.
    PubMed     Abstract available

  1244. ANYIWE K, Richardson M, Brophy J, Sander B, et al
    Assessing adolescent immunization options for pertussis in Canada: A cost-utility analysis.
    Vaccine. 2020;38:1825-1833.
    PubMed     Abstract available

  1245. LI S, Yang Y, Lin X, Li Z, et al
    Biocompatible cationic solid lipid nanoparticles as adjuvants effectively improve humoral and T cell immune response of foot and mouth disease vaccines.
    Vaccine. 2020 Feb 10. pii: S0264-410X(20)30157.
    PubMed     Abstract available

  1246. GARY EN, Kathuria N, Makurumidze G, Curatola A, et al
    CCR10 expression is required for the adjuvant activity of the mucosal chemokine CCL28 when delivered in the context of an HIV-1 Env DNA vaccine.
    Vaccine. 2020 Feb 10. pii: S0264-410X(20)30038.
    PubMed     Abstract available

  1247. DE SCHRYVER A, Lambaerts T, Lammertyn N, Francois G, et al
    European survey of hepatitis B vaccination policies for healthcare workers: An updated overview.
    Vaccine. 2020 Feb 10. pii: S0264-410X(20)30156.
    PubMed     Abstract available

  1248. JENSEN SK, Jensen TM, Birk NM, Stensballe LG, et al
    Bacille Calmette-Guerin vaccination at birth and differential white blood cell count in infancy. A randomised clinical trial.
    Vaccine. 2020 Feb 10. pii: S0264-410X(20)30171.
    PubMed     Abstract available

  1249. BECERRA-CULQUI TA, Sy LS, Ackerson BK, Chen LH, et al
    Safety of MenACWY-CRM vaccine exposure during pregnancy.
    Vaccine. 2020 Feb 10. pii: S0264-410X(20)30175.
    PubMed     Abstract available

  1250. FAN J, Cong S, Wang N, Bao H, et al
    Influenza vaccination rate and its association with chronic diseases in China: Results of a national cross-sectional study.
    Vaccine. 2020 Feb 8. pii: S0264-410X(20)30146.
    PubMed     Abstract available

  1251. LIU CH, Yeh YC, Huang WT, Chie WC, et al
    Assessment of pre-specified adverse events following varicella vaccine: A population-based self-controlled risk interval study.
    Vaccine. 2020 Feb 8. pii: S0264-410X(20)30143.
    PubMed     Abstract available

  1252. JUAN-GINER A, Alsalhani A, Panunzi I, Lambert V, et al
    Evaluation of the stability of measles vaccine out of the cold chain under extended controlled temperature conditions.
    Vaccine. 2020 Feb 8. pii: S0264-410X(20)30158.
    PubMed     Abstract available

  1253. BEAL JL, Kadakia NN, Reed JB, Illingworth Plake KS, et al
    Pharmacists' impact on older adults' access to vaccines in the United States.
    Vaccine. 2020 Feb 8. pii: S0264-410X(20)30088.
    PubMed     Abstract available

  1254. EMERSON A, Allison M, Kelly PJ, Ramaswamy M, et al
    Barriers and facilitators of implementing a collaborative HPV vaccine program in an incarcerated population: A case study.
    Vaccine. 2020 Feb 8. pii: S0264-410X(20)30138.
    PubMed     Abstract available

  1255. YANG H, Fan F, Liu L, Liu J, et al
    A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain).
    Vaccine. 2020 Feb 7. pii: S0264-410X(20)30009.
    PubMed     Abstract available

  1256. SICCA F, Martinuzzi D, Montomoli E, Huckriede A, et al
    Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreement.
    Vaccine. 2020 Feb 7. pii: S0264-410X(20)30141.
    PubMed     Abstract available

  1257. KUBA Y, Kyan H, Iha Y, Kato T, et al
    Emergent measles-containing vaccination recommendation for aged 6-11 months and detection of vaccine-associated measles during a large measles outbreak in Okinawa, Japan, in 2018.
    Vaccine. 2020 Feb 6. pii: S0264-410X(20)30105.
    PubMed     Abstract available

  1258. MATTHIAS KA, Reveille A, Connolly KL, Jerse AE, et al
    Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains.
    Vaccine. 2020 Feb 6. pii: S0264-410X(20)30053.
    PubMed     Abstract available

  1259. HENDRY AJ, Beard FH, Dey A, Quinn H, et al
    Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine.
    Vaccine. 2020 Feb 6. pii: S0264-410X(20)30122.
    PubMed     Abstract available

  1260. PULLAGURA GR, Violette R, Houle SKD, Waite NM, et al
    Shades of gray in vaccination decisions - Understanding community pharmacists' perspectives of, and experiences with, influenza vaccine hesitancy in Ontario, Canada.
    Vaccine. 2020 Feb 6. pii: S0264-410X(20)30137.
    PubMed     Abstract available

  1261. MOREIRA C JR, Ferreira MRA, Finger PF, Magalhaes CG, et al
    Protective efficacy of recombinant bacterin vaccine against botulism in cattle.
    Vaccine. 2020 Feb 6. pii: S0264-410X(20)30142.
    PubMed     Abstract available

  1262. VANDERVEN HA, Barr I, Reynaldi A, Wheatley AK, et al
    Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults.
    Vaccine. 2020 Feb 5. pii: S0264-410X(20)30104.
    PubMed     Abstract available

    Measuring equitable delivery of vaccines.
    Vaccine. 2020 Feb 5. pii: S0264-410X(20)30152.

  1264. MADHI SA, Moreira M, Koen A, van Niekerk N, et al
    Impact of HIV status and vaccination schedule on bacterial nasopharyngeal carriage following infant immunisation with the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in South Africa.
    Vaccine. 2020 Feb 5. pii: S0264-410X(20)30100.
    PubMed     Abstract available

  1265. REISS DR, Offit PA
    Improving vaccine policy making: A dose of reality.
    Vaccine. 2020 Feb 5. pii: S0264-410X(20)30051.

  1266. HALES C, Jochems SP, Robinson R, Solorzano C, et al
    Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx.
    Vaccine. 2020 Feb 4. pii: S0264-410X(20)30112.
    PubMed     Abstract available

  1267. CAMARGOS P, Nascimento-Carvalho CM, Teixeira R, Franca E, et al
    Lower respiratory infections mortality among Brazilians under-five before and after national pneumococcal conjugate vaccine implementation.
    Vaccine. 2020 Feb 4. pii: S0264-410X(20)30136.
    PubMed     Abstract available

  1268. MOURATIDOU E, Lambrou A, Andreopoulou A, Gioula G, et al
    Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
    Vaccine. 2020 Feb 4. pii: S0264-410X(20)30135.
    PubMed     Abstract available

  1269. PERRY MR, Ionin B, Barnewall RE, Vassar ML, et al
    Development of a guinea pig inhalational anthrax model for evaluation of post-exposure prophylaxis efficacy of anthrax vaccines.
    Vaccine. 2020 Feb 3. pii: S0264-410X(20)30106.
    PubMed     Abstract available

  1270. MUHSEN K, Haklai Z, Applbaum Y, Gordon ES, et al
    Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis.
    Vaccine. 2020 Feb 3. pii: S0264-410X(20)30049.
    PubMed     Abstract available

  1271. THOMPSON EL, Wheldon CW, Rosen BL, Maness SB, et al
    Awareness and knowledge of HPV and HPV vaccination among adults ages 27-45 years.
    Vaccine. 2020 Feb 3. pii: S0264-410X(20)30079.
    PubMed     Abstract available

  1272. YUFIKA A, Wagner AL, Nawawi Y, Wahyuniati N, et al
    Parents' hesitancy towards vaccination in Indonesia: A cross-sectional study in Indonesia.
    Vaccine. 2020 Feb 1. pii: S0264-410X(20)30114.
    PubMed     Abstract available

  1273. BAKER MA, Jankosky C, Yih WK, Gruber S, et al
    The risk of febrile seizures following influenza and 13-valent pneumococcal conjugate vaccines.
    Vaccine. 2020 Feb 1. pii: S0264-410X(20)30072.
    PubMed     Abstract available

  1274. BALLARD SB, Tallant A, Guerra RG, Quigley D, et al
    Application of a cost-effectiveness analysis of pathogen-specific vaccines against gastroenteritis to a military population in a developing country setting.
    Vaccine. 2020 Feb 1. pii: S0264-410X(20)30117.
    PubMed     Abstract available

  1275. CHAMPREDON D, Shoukat A, Moghadas SM
    Effectiveness and cost-effectiveness of a Clostridium difficile vaccine candidate in a hospital setting.
    Vaccine. 2020 Feb 1. pii: S0264-410X(20)30115.
    PubMed     Abstract available

    January 2020
  1276. LU Y, Landreth S, Liu G, Brownlie R, et al
    Innate immunemodulator containing adjuvant formulated HA based vaccine protects mice from lethal infection of highly pathogenic avian influenza H5N1 virus.
    Vaccine. 2020 Jan 31. pii: S0264-410X(20)30077.
    PubMed     Abstract available

  1277. DA CUNHA GK, de Matos MB, Trettim JP, Rubin BB, et al
    Thimerosal-containing vaccines and deficit in child development: Population-based study in southern Brazil.
    Vaccine. 2020 Jan 31. pii: S0264-410X(19)31696.
    PubMed     Abstract available

  1278. CHOI KY, El-Hamdi NS, McGregor A
    Neutralizing antibodies to gB based CMV vaccine requires full length antigen but reduced virus neutralization on non-fibroblast cells limits vaccine efficacy in the guinea pig model.
    Vaccine. 2020 Jan 31. pii: S0264-410X(20)30101.
    PubMed     Abstract available

  1279. AKPALU Y, Sullivan SJ, Regan AK
    Association between health insurance coverage and uptake of seasonal influenza vaccine in Brazos County, Texas.
    Vaccine. 2020 Jan 31. pii: S0264-410X(20)30044.
    PubMed     Abstract available

  1280. LIU J, Clayton K, Gao W, Li Y, et al
    Trimeric HIV-1 gp140 fused with APRIL, BAFF, and CD40L on the mucosal gp140-specific antibody responses in mice.
    Vaccine. 2020 Jan 31. pii: S0264-410X(20)30076.
    PubMed     Abstract available

  1281. PETIT B, Epaulard O
    Men having sex with men and the HPV vaccine in France: A low vaccine coverage that may be due to its infrequent proposal by physicians.
    Vaccine. 2020 Jan 30. pii: S0264-410X(20)30075.
    PubMed     Abstract available

  1282. BOVAY A, Nassiri S, Maby-El Hajjami H, Marcos Mondejar P, et al
    Minimal immune response to booster vaccination against Yellow Fever associated with pre-existing antibodies.
    Vaccine. 2020 Jan 30. pii: S0264-410X(20)30071.
    PubMed     Abstract available

  1283. OKENWA UJ, Dairo MD, Bamgboye E, Ajumobi O, et al
    Maternal knowledge and infant uptake of valid hepatitis B vaccine birth dose at routine immunization clinics in Enugu State - Nigeria.
    Vaccine. 2020 Jan 29. pii: S0264-410X(20)30070.
    PubMed     Abstract available

  1284. PILAEV M, Shen Y, Carbonneau J, Venable MC, et al
    Evaluation of pre- and post-fusion Human metapneumovirus F proteins as subunit vaccine candidates in mice.
    Vaccine. 2020 Jan 29. pii: S0264-410X(20)30073.
    PubMed     Abstract available

  1285. AVALOS LA, Ferber J, Zerbo O, Naleway AL, et al
    Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development.
    Vaccine. 2020 Jan 29. pii: S0264-410X(20)30086.
    PubMed     Abstract available

  1286. CUTTS FT, Dansereau E, Ferrari MJ, Hanson M, et al
    Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications.
    Vaccine. 2020;38:979-992.
    PubMed     Abstract available

  1287. SHILLING H, Murray G, Brotherton JML, Hawkes D, et al
    Monitoring human papillomavirus prevalence among young Australian women undergoing routine chlamydia screening.
    Vaccine. 2020;38:1186-1193.
    PubMed     Abstract available

  1288. FORSTNER C, Kolditz M, Kesselmeier M, Ewig S, et al
    Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumonia.
    Vaccine. 2020;38:1129-1136.
    PubMed     Abstract available

  1289. WANTUCH PL, Sun L, LoPilato RK, Mousa JJ, et al
    Isolation and characterization of new human carrier peptides from two important vaccine immunogens.
    Vaccine. 2020 Jan 28. pii: S0264-410X(20)30103.
    PubMed     Abstract available

  1290. LASSETER G, Al-Janabi H, Trotter CL, Carroll FE, et al
    Understanding the role of peace of mind in childhood vaccination: A qualitative study with members of the general public.
    Vaccine. 2020 Jan 28. pii: S0264-410X(19)31651.
    PubMed     Abstract available

  1291. NGUYEN TTM, Lafond KE, Nguyen TX, Tran PD, et al
    Acceptability of seasonal influenza vaccines among health care workers in Vietnam in 2017.
    Vaccine. 2020 Jan 27. pii: S0264-410X(19)31699.
    PubMed     Abstract available

  1292. KALOK A, Loh SYE, Chew KT, Abdul Aziz NH, et al
    Vaccine hesitancy towards childhood immunisation amongst urban pregnant mothers in Malaysia.
    Vaccine. 2020 Jan 27. pii: S0264-410X(20)30069.
    PubMed     Abstract available

  1293. HILLS SL, Fischer M, Biggerstaff BJ
    Perceptions among the U.S. population of value of Japanese encephalitis (JE) vaccination for travel to JE-endemic countries.
    Vaccine. 2020 Jan 25. pii: S0264-410X(20)30074.
    PubMed     Abstract available

  1294. KING JP, Hanson KE, Donahue JG, Glanz JM, et al
    Survey of influenza vaccine knowledge, attitudes, and beliefs among pregnant women in the 2016-17 season.
    Vaccine. 2020 Jan 25. pii: S0264-410X(20)30054.
    PubMed     Abstract available

  1295. UZIEL Y, Moshe V, Onozo B, Kulcsar A, et al
    Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection.
    Vaccine. 2020 Jan 24. pii: S0264-410X(20)30052.
    PubMed     Abstract available

  1296. SUNTARATTIWONG P, Vandepitte WP, Singhamatr P, Chotpitayasunondh T, et al
    Seroprotection rate in adults after 1-dose, 2-dose, and 3-dose series of a reduced-diphtheria-tetanus toxoid vaccine (Td) during a diphtheria outbreak in Thailand.
    Vaccine. 2020 Jan 24. pii: S0264-410X(20)30055.
    PubMed     Abstract available

  1297. PLOTKIN SA, Offit PA, DeStefano F, Larson HJ, et al
    The science of vaccine safety: Summary of meeting at Wellcome Trust.
    Vaccine. 2020 Jan 24. pii: S0264-410X(20)30039.
    PubMed     Abstract available

  1298. KAZAKOVA A, Kakkola L, Ziegler T, Syrjanen R, et al
    Pandemic influenza A(H1N1pdm09) vaccine induced high levels of influenza-specific IgG and IgM antibodies as analyzed by enzyme immunoassay and dual-mode multiplex microarray immunoassay methods.
    Vaccine. 2020 Jan 24. pii: S0264-410X(20)30037.
    PubMed     Abstract available

  1299. BETTINGER JA, Liberator P, Halperin SA, Vaudry W, et al
    Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp).
    Vaccine. 2020 Jan 23. pii: S0264-410X(19)31703.
    PubMed     Abstract available

  1300. AZIZ AB, Ali M, Basunia AH, Yunus M, et al
    Impact of vaccination on the risk factors for acute rotavirus diarrhea: An analysis of the data of a cluster randomized trial conducted in a rural area of Bangladesh.
    Vaccine. 2020 Jan 23. pii: S0264-410X(20)30056.
    PubMed     Abstract available

  1301. DESAI S, Scobie HM, Cherian T, Goodman T, et al
    Use of tetanus-diphtheria (Td) vaccine in children 4-7 years of age: World Health Organization consultation of experts.
    Vaccine. 2020 Jan 23. pii: S0264-410X(20)30033.
    PubMed     Abstract available

  1302. SATO R, Belel A
    The effect of performance-based financing on child vaccinations in northern Nigeria.
    Vaccine. 2020 Jan 23. pii: S0264-410X(20)30048.
    PubMed     Abstract available

  1303. LAI E, Tan HY, Kunasekaran M, Chughtai AA, et al
    Influenza vaccine coverage and predictors of vaccination among aged care workers in Sydney Australia.
    Vaccine. 2020 Jan 23. pii: S0264-410X(20)30008.
    PubMed     Abstract available

  1304. DALY C, Molodecky NA, Sreevatsava M, Belayneh AD, et al
    Needle-free injectors for mass administration of fractional dose inactivated poliovirus vaccine in Karachi, Pakistan: A survey of caregiver and vaccinator acceptability.
    Vaccine. 2020 Jan 23. pii: S0264-410X(19)31723.
    PubMed     Abstract available

  1305. CASTILLA J, Portillo ME, Casado I, Pozo F, et al
    Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019.
    Vaccine. 2020 Jan 22. pii: S0264-410X(20)30043.
    PubMed     Abstract available

  1306. BATISTA ICA, Quinan BR, Rocha Alves EA, Jangola STG, et al
    Design and production of dengue virus chimeric proteins useful for developing tetravalent vaccines.
    Vaccine. 2020 Jan 22. pii: S0264-410X(20)30007.
    PubMed     Abstract available

  1307. FADLYANA E, Dhamayanti M, Tarigan R, Mulia Sari R, et al
    Immunogenicity and safety profile of a primary dose of bivalent oral polio vaccine given simultaneously with DTwP-Hb-Hib and inactivated poliovirus vaccine at the 4th visit in Indonesian infants.
    Vaccine. 2020 Jan 22. pii: S0264-410X(20)30011.
    PubMed     Abstract available

  1308. FAN S, Liao Y, Jiang G, Jiang L, et al
    Study of integrated protective immunity induced in rhesus macaques by the intradermal administration of a bivalent EV71-CA16 inactivated vaccine.
    Vaccine. 2020 Jan 22. pii: S0264-410X(19)31721.
    PubMed     Abstract available

  1309. THOMPSON KM, Orenstein WA, Hinman AR
    Performance of the United States Vaccine Injury Compensation Program (VICP): 1988-2019.
    Vaccine. 2020 Jan 22. pii: S0264-410X(20)30057.
    PubMed     Abstract available

  1310. MOHANTY S, Joyce CM, Delamater PL, Klein NP, et al
    Homeschooling parents in California: Attitudes, beliefs and behaviors associated with child's vaccination status.
    Vaccine. 2020 Jan 22. pii: S0264-410X(20)30041.
    PubMed     Abstract available

  1311. FEDERIZON J, Frye A, Huang WC, Hart TM, et al
    Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes.
    Vaccine. 2020;38:942-950.
    PubMed     Abstract available

  1312. ZHANG L, Sun M, Zhang Q, Wang J, et al
    Long-term passage of duck Tembusu virus in BHK-21 cells generates a completely attenuated and immunogenic population with increased genetic diversity.
    Vaccine. 2020;38:933-941.
    PubMed     Abstract available

  1313. INGUVA S, Barnard M, Ward LM, Yang Y, et al
    Factors influencing Human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid.
    Vaccine. 2020 Jan 21. pii: S0264-410X(19)31672.
    PubMed     Abstract available

  1314. PACHECO FC, Franca GVA, Elidio GA, Leal MB, et al
    Measles-containing vaccines in Brazil: Coverage, homogeneity of coverage and associations with contextual factors at municipal level.
    Vaccine. 2020 Jan 21. pii: S0264-410X(20)30045.
    PubMed     Abstract available

  1315. BRADSHAW AS, Treise D, Shelton SS, Cretul M, et al
    Propagandizing anti-vaccination: Analysis of Vaccines Revealed documentary series.
    Vaccine. 2020 Jan 21. pii: S0264-410X(19)31669.
    PubMed     Abstract available

  1316. LUBOGO M, Mohamed AM, Ali AH, Ali AH, et al
    Oral cholera vaccination coverage in an acute emergency setting in Somalia, 2017.
    Vaccine. 2020 Jan 21. pii: S0264-410X(20)30030.
    PubMed     Abstract available

  1317. TILEY K, Tessier E, White JM, Andrews N, et al
    School-based vaccination programmes: An evaluation of school immunisation delivery models in England in 2015/16.
    Vaccine. 2020 Jan 21. pii: S0264-410X(20)30046.
    PubMed     Abstract available

  1318. WASKO I, Golebiewska A, Kiedrowska M, Ronkiewicz P, et al
    Genetic variability of Polish serogroup B meningococci (2010-2016) including the 4CMenB vaccine component genes.
    Vaccine. 2020 Jan 21. pii: S0264-410X(20)30036.
    PubMed     Abstract available

  1319. MUSA S, Skrijelj V, Kulo A, Habersaat KB, et al
    Identifying barriers and drivers to vaccination: A qualitative interview study with health workers in the Federation of Bosnia and Herzegovina.
    Vaccine. 2020 Jan 21. pii: S0264-410X(20)30040.
    PubMed     Abstract available

  1320. YILDIRIM M, Keskinocak P, Pelton S, Pickering L, et al
    Who is at risk of 13-valent conjugated pneumococcal vaccine failure?
    Vaccine. 2020 Jan 20. pii: S0264-410X(19)31724.
    PubMed     Abstract available

  1321. OPRIESSNIG T, Karuppannan AK, Halbur PG, Calvert JG, et al
    Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge.
    Vaccine. 2020 Jan 20. pii: S0264-410X(20)30017.
    PubMed     Abstract available

  1322. DERBISE A, Guillas C, Gerke C, Carniel E, et al
    Subcutaneous vaccination with a live attenuated Yersinia pseudotuberculosis plague vaccine.
    Vaccine. 2020 Jan 18. pii: S0264-410X(20)30018.
    PubMed     Abstract available

  1323. ROY P, Ali AJ, Kobiyama K, Ghosheh Y, et al
    Opportunities for an atherosclerosis vaccine: From mice to humans.
    Vaccine. 2020 Jan 18. pii: S0264-410X(19)31681.
    PubMed     Abstract available

    Dear fears: Vaccines and ebiribiri.
    Vaccine. 2020 Jan 17. pii: S0264-410X(20)30034.

  1325. TOURTELOT E, Quataert S, Glantz JC, Perlis L, et al
    Women who received varicella vaccine versus natural infection have different long-term T cell immunity but similar antibody levels.
    Vaccine. 2020 Jan 17. pii: S0264-410X(20)30003.
    PubMed     Abstract available

  1326. IZAC JR, O'Bier NS, Oliver LD Jr, Camire AC, et al
    Development and optimization of OspC chimeritope vaccinogens for Lyme disease.
    Vaccine. 2020 Jan 17. pii: S0264-410X(20)30042.
    PubMed     Abstract available

  1327. STINSON JA, Palmer CR, Miller DP, Li AB, et al
    Thin silk fibroin films as a dried format for temperature stabilization of inactivated polio vaccine.
    Vaccine. 2020 Jan 17. pii: S0264-410X(19)31726.
    PubMed     Abstract available

  1328. GOETTLER D, Streng A, Kemmling D, Schoen C, et al
    Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany.
    Vaccine. 2020;38:570-577.
    PubMed     Abstract available

  1329. SISTERE-ORO M, Martinez-Pulgarin S, Solanes D, Veljkovic V, et al
    Conserved HA-peptides expressed along with flagellin in Trichoplusia ni larvae protects chicken against intranasal H7N1 HPAIV challenge.
    Vaccine. 2020;38:416-422.
    PubMed     Abstract available

  1330. MCENTEE CP, Moran HBT, Munoz-Wolf N, Liddicoat AM, et al
    Type I IFN signalling is required for cationic adjuvant formulation (CAF)01-induced cellular immunity and mucosal priming.
    Vaccine. 2020;38:635-643.
    PubMed     Abstract available

  1331. BERENSON AB, Hirth JM, Southerland JH
    Knowledge of human papillomavirus among dental providers: A mixed methods study.
    Vaccine. 2020;38:423-426.
    PubMed     Abstract available

  1332. HARRIS A, Lazzaro T, Crawford NW
    Blistering post 4-year old Infanrix(R) IPV.
    Vaccine. 2020;38:705-706.

  1333. BROUSSEAU N, Skowronski DM, Bellemare D, Amini R, et al
    Impact of the adolescent pertussis booster dose on the incidence of pertussis in British Columbia and Quebec, Canada.
    Vaccine. 2020;38:427-432.
    PubMed     Abstract available

  1334. RUSSO AT, Berhanu A, Bigger CB, Prigge J, et al
    Co-administration of tecovirimat and ACAM2000 in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
    Vaccine. 2020;38:644-654.
    PubMed     Abstract available

  1335. RITSCHER AM, LeClair-Netzel M, Friedlander NJ, Howard Stewart DN, et al
    Cross-sectional study of hepatitis B antibody status in health care workers immunized as children at an academic medical center in Wisconsin.
    Vaccine. 2020 Jan 16. pii: S0264-410X(19)31678.
    PubMed     Abstract available

  1336. SALAMI K, Gsell PS, Olayinka A, Maiga D, et al
    Meeting report: WHO consultation on accelerating Lassa fever vaccine development in endemic countries, Dakar, 10-11 September 2019.
    Vaccine. 2020 Jan 14. pii: S0264-410X(20)30032.
    PubMed     Abstract available

  1337. HALL C, Abramovitz LM, Bukowinski AT, Ricker AA, et al
    Safety of tetanus, diphtheria, and acellular pertussis vaccination among pregnant active duty U.S. military women.
    Vaccine. 2020 Jan 14. pii: S0264-410X(20)30013.
    PubMed     Abstract available

  1338. POSUWAN N, Wanlapakorn N, Vongpunsawad S, Sintusek P, et al
    Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth.
    Vaccine. 2020 Jan 14. pii: S0264-410X(19)31729.
    PubMed     Abstract available

  1339. MANDAL S, Edelstein M, Ramsay M
    Public health leadership in the UK's response to hepatitis A and hepatitis B vaccine shortages.
    Vaccine. 2020 Jan 13. pii: S0264-410X(20)30014.

  1340. MA P, Luo Z, Qian J, Yan Z, et al
    Decreased ratio of influenza-specific IgG versus IgM in response to influenza vaccination in antiretroviral-treated HIV-infected African Americans compared to Caucasians, and its direct correlation with the percentages of peripheral Tfh cells.
    Vaccine. 2020 Jan 13. pii: S0264-410X(20)30004.
    PubMed     Abstract available

  1341. HUANG C, Fu X, Zhou Y, Mi F, et al
    Comparison of the immunogenicity and safety of quadrivalent and tetravalent influenza vaccines in children and adolescents.
    Vaccine. 2020 Jan 13. pii: S0264-410X(19)31625.
    PubMed     Abstract available

  1342. TIAN KY, Guo HF, Li N, Zhang YH, et al
    Protection of chickens against hepatitis-hydropericardium syndrome and Newcastle disease with a recombinant Newcastle disease virus vaccine expressing the fowl adenovirus serotype 4 fiber-2 protein.
    Vaccine. 2020 Jan 13. pii: S0264-410X(20)30010.
    PubMed     Abstract available

  1343. XU L, Qin Z, Qiao L, Wen J, et al
    Characterization of thermostable Newcastle disease virus recombinants expressing the hemagglutinin of H5N1 avian influenza virus as bivalent vaccine candidates.
    Vaccine. 2020 Jan 11. pii: S0264-410X(19)31718.
    PubMed     Abstract available

  1344. JARVIS JR, Dorey RB, Warricker FDM, Alwan NA, et al
    The effectiveness of influenza vaccination in pregnancy in relation to child health outcomes: Systematic review and meta-analysis.
    Vaccine. 2020 Jan 10. pii: S0264-410X(19)31720.
    PubMed     Abstract available

  1345. VAN DER MEEREN O, Jongert E, Seaton KE, Koutsoukos M, et al
    Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01B vaccination.
    Vaccine. 2020 Jan 10. pii: S0264-410X(19)31722.
    PubMed     Abstract available

  1346. GALOR I, Perry Markovich M, Wolf D, Haber M, et al
    Population seroprotection against hepatitis a virus in Israel 18 years after introduction of inactivated vaccine into the routine childhood vaccination schedule.
    Vaccine. 2020 Jan 10. pii: S0264-410X(19)31693.
    PubMed     Abstract available

  1347. SANDHU SK, Hua W, MaCurdy TE, Franks RL, et al
    Comparison of alpha-spending plans for near real-time monitoring for Guillain-Barre after influenza vaccination during the 2010/11 influenza season.
    Vaccine. 2020 Jan 10. pii: S0264-410X(19)31674.
    PubMed     Abstract available

  1348. RAINISCH G, Adhikari B, Meltzer MI, Langley G, et al
    Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants.
    Vaccine. 2020;38:251-257.
    PubMed     Abstract available

  1349. HARBECKE R, Jensen NJ, Depledge DP, Johnson GR, et al
    Recurrent herpes zoster in the Shingles Prevention Study: Are second episodes caused by the same varicella-zoster virus strain?
    Vaccine. 2020;38:150-157.
    PubMed     Abstract available

  1350. CHUN JY, Park WB, Kim NJ, Choi EH, et al
    Estimating contact-adjusted immunity levels against measles in South Korea and prospects for maintaining elimination status.
    Vaccine. 2020;38:107-111.
    PubMed     Abstract available

  1351. DOWALL SD, Kempster S, Findlay-Wilson S, Mattiuzzo G, et al
    Towards quantification of protective antibody responses by passive transfer of the 1st WHO International Standard for Ebola virus antibody in a guinea pig model.
    Vaccine. 2020;38:345-349.
    PubMed     Abstract available

  1352. ZAHRAEI SM, Mokhtari-Azad T, Izadi S, Mohammadi M, et al
    Seroprevalence of anti-rubella and anti-measles antibodies in women at the verge of marriage in Iran.
    Vaccine. 2020;38:235-241.
    PubMed     Abstract available

  1353. NEAL EFG, Flasche S, Nguyen CD, Ratu FT, et al
    Associations between ethnicity, social contact, and pneumococcal carriage three years post-PCV10 in Fiji.
    Vaccine. 2020;38:202-211.
    PubMed     Abstract available

  1354. CAVALLI A, Desario C, Marinaro M, Losurdo M, et al
    Oral administration of modified live canine parvovirus type 2b induces systemic immune response.
    Vaccine. 2020;38:115-118.
    PubMed     Abstract available

  1355. ESPUL C, Cuello H, Lo Castro I, Bravo C, et al
    Statistical modeling alongside observational data predicts long-term immunogenicity of one dose and two doses of pediatric hepatitis A vaccine in the Mendoza province of Argentina.
    Vaccine. 2020 Jan 9. pii: S0264-410X(19)31701.
    PubMed     Abstract available

  1356. TRUCAS M
    The Falconi's needle against anti-vaccination: A minimally invasive tool in the nineteenth century.
    Vaccine. 2020 Jan 9. pii: S0264-410X(19)31727.
    PubMed     Abstract available

  1357. ORTEGA-SANCHEZ R, Camacho-Nuez M, Castaneda-Ortiz JE, Martinez-Benitez MB, et al
    Vaccine efficacy of recombinant BmVDAC on Rhipicephalus microplus fed on Babesia bigemina-infected and uninfected cattle.
    Vaccine. 2020 Jan 9. pii: S0264-410X(19)31692.
    PubMed     Abstract available

  1358. ULZIIBAT G, Maygmarsuren O, Khishgee B, Basan G, et al
    Immunogenicity of imported foot-and-mouth vaccines in different species in Mongolia.
    Vaccine. 2020 Jan 9. pii: S0264-410X(19)31717.
    PubMed     Abstract available

  1359. POH ZW, Wang Z, Kumar SR, Yong HY, et al
    Modification of neutralizing epitopes of hemagglutinin for the development of broadly protective H9N2 vaccine.
    Vaccine. 2020 Jan 7. pii: S0264-410X(19)31634.
    PubMed     Abstract available

  1360. FOMBONNE E, Goin-Kochel RP, O'Roak BJ
    Beliefs in vaccine as causes of autism among SPARK cohort caregivers.
    Vaccine. 2020 Jan 7. pii: S0264-410X(19)31668.
    PubMed     Abstract available

  1361. HANSEN PR, Schmidtblaicher M, Brewer NT
    Resilience of HPV vaccine uptake in Denmark: Decline and recovery.
    Vaccine. 2020 Jan 6. pii: S0264-410X(19)31661.
    PubMed     Abstract available

  1362. HAGEDORN BL, Gauld J, Feasey N, Hu H, et al
    Cost-effectiveness of using environmental surveillance to target the roll-out typhoid conjugate vaccine.
    Vaccine. 2020 Jan 6. pii: S0264-410X(19)31725.

  1363. JIA R, Yan L, Guo J
    Enhancing the immunogenicity of a DNA vaccine against Streptococcus mutans by attenuating the inhibition of endogenous miR-9.
    Vaccine. 2020 Jan 6. pii: S0264-410X(19)31637.
    PubMed     Abstract available

  1364. BURKHARD J, Ciurea A, Gabay C, Hasler P, et al
    Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals.
    Vaccine. 2020 Jan 3. pii: S0264-410X(19)31694.
    PubMed     Abstract available

  1365. PUENTE-MASSAGUER E, Lecina M, Godia F
    Application of advanced quantification techniques in nanoparticle-based vaccine development with the Sf9 cell baculovirus expression system.
    Vaccine. 2020 Jan 3. pii: S0264-410X(19)31647.
    PubMed     Abstract available

  1366. JO SK, Ahn BE, Choi EH, Kang JE, et al
    Evaluation of the protective efficacy of recombinant protective antigen vaccine (GC1109)-immunized human sera using passive immunization in a mouse model.
    Vaccine. 2020 Jan 3. pii: S0264-410X(19)31700.
    PubMed     Abstract available

  1367. STERRETT S, Peng BJ, Burton RL, LaFon DC, et al
    Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individuals.
    Vaccine. 2020 Jan 3. pii: S0264-410X(19)31665.
    PubMed     Abstract available

  1368. CHIU ML, Luo ST, Chen YY, Chung WY, et al
    Establishment of Asia-Pacific Network for Enterovirus Surveillance.
    Vaccine. 2020;38:1-9.
    PubMed     Abstract available

  1369. ABDELLRAZEQ GS, Fry LM, Elnaggar MM, Bannantine JP, et al
    Simultaneous cognate epitope recognition by bovine CD4 and CD8 T cells is essential for primary expansion of antigen-specific cytotoxic T-cells following ex vivo stimulation with a candidate Mycobacterium avium subsp. paratuberculosis peptide vaccine.
    Vaccine. 2020 Jan 2. pii: S0264-410X(19)31704.
    PubMed     Abstract available

    December 2019
  1370. DELACRUZ WP, Savona MR, Thornton JA, Danaher PJ, et al
    Evidence of vaccinia dissemination despite lack of major reaction following smallpox vaccination.
    Vaccine. 2019 Dec 31. pii: S0264-410X(19)31698.
    PubMed     Abstract available

  1371. DUTHIE MS, Frevol A, Day T, Coler RN, et al
    A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA-SE) in healthy adults.
    Vaccine. 2019 Dec 30. pii: S0264-410X(19)31702.
    PubMed     Abstract available

  1372. KIM J, Kim T, Hong JK, Lee HS, et al
    The interference effect of maternally-derived antibodies on the serological performance of pigs immunized with a foot-and-mouth disease oil emulsion vaccine.
    Vaccine. 2019 Dec 28. pii: S0264-410X(19)31695.
    PubMed     Abstract available

  1373. JIANG L, Wang J, Zhang C, He W, et al
    Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China.
    Vaccine. 2019 Dec 28. pii: S0264-410X(19)31667.
    PubMed     Abstract available

  1374. LUTZ CS, Fink RV, Cloud AJ, Stevenson J, et al
    Factors associated with perceptions of influenza vaccine safety and effectiveness among adults, United States, 2017-2018.
    Vaccine. 2019 Dec 27. pii: S0264-410X(19)31644.
    PubMed     Abstract available

  1375. STOECKER C, Kobayashi M, Matanock A, Cho BH, et al
    Cost-effectiveness of continuing pneumococcal conjugate vaccination at age 65 in the context of indirect effects from the childhood immunization program.
    Vaccine. 2019 Dec 27. pii: S0264-410X(19)31671.
    PubMed     Abstract available

  1376. MCILHONE KA, Best EJ, Petousis-Harris H, Howe AS, et al
    Impact of rotavirus vaccine on paediatric rotavirus hospitalisation and intussusception in New Zealand: A retrospective cohort study.
    Vaccine. 2019 Dec 27. pii: S0264-410X(19)31697.
    PubMed     Abstract available

  1377. HABER P, Moro PL, Ng C, Dores GM, et al
    Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged >/=65years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010-December 2018.
    Vaccine. 2019 Dec 26. pii: S0264-410X(19)31628.
    PubMed     Abstract available

  1378. NAKANO S, Fujisawa T, Ito Y, Chang B, et al
    Nationwide surveillance of paediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugated vaccine, 2015-2017.
    Vaccine. 2019 Dec 24. pii: S0264-410X(19)31664.
    PubMed     Abstract available

  1379. SHAIKH H, Lynch J, Kim J, Excler JL, et al
    Current and future cholera vaccines.
    Vaccine. 2019 Dec 24. pii: S0264-410X(19)31653.
    PubMed     Abstract available

  1380. COUDEVILLE L, Baurin N, Shepard DS
    The potential impact of dengue vaccination with, and without, pre-vaccination screening.
    Vaccine. 2019 Dec 23. pii: S0264-410X(19)31654.
    PubMed     Abstract available

  1381. CHOWDHURY F, Bhuiyan TR, Akter A, Bhuiyan MS, et al
    Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccine.
    Vaccine. 2019 Dec 23. pii: S0264-410X(19)31676.
    PubMed     Abstract available

  1382. LUANA C, Teresa S, Sarah E, Klara F, et al
    Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany.
    Vaccine. 2019 Dec 23. pii: S0264-410X(19)31666.
    PubMed     Abstract available

  1383. BEYER WEP, Palache AM, Reperant LA, Boulfich M, et al
    Association between vaccine adjuvant effect and pre-seasonal immunity. Systematic review and meta-analysis of randomised immunogenicity trials comparing squalene-adjuvanted and aqueous inactivated influenza vaccines.
    Vaccine. 2019 Dec 23. pii: S0264-410X(19)31679.
    PubMed     Abstract available

  1384. OLWAGEN CP, Adrian PV, Madhi SA
    Evaluation of the impact of HIV-1 infection and density of common nasopharyngeal bacterial colonizers in South African children immunized with 7-valent pneumococcal conjugate vaccine.
    Vaccine. 2019 Dec 21. pii: S0264-410X(19)31675.
    PubMed     Abstract available

  1385. BEREZIN EN, Jarovsky D, Cardoso MRA, Mantese OC, et al
    Invasive pneumococcal disease among hospitalized children in Brazil before and after the introduction of a pneumococcal conjugate vaccine.
    Vaccine. 2019 Dec 21. pii: S0264-410X(19)31680.
    PubMed     Abstract available

  1386. SU JR, Haber P, Ng CS, Marquez PL, et al
    Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017.
    Vaccine. 2019 Dec 20. pii: S0264-410X(19)31670.
    PubMed     Abstract available

  1387. WHITWORTH HS, Gallagher KE, Howard N, Mounier-Jack S, et al
    Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials.
    Vaccine. 2019 Dec 20. pii: S0264-410X(19)31659.
    PubMed     Abstract available

  1388. ANWARI P, Debellut F, Vodicka E, Clark A, et al
    Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan.
    Vaccine. 2019 Dec 20. pii: S0264-410X(19)31655.
    PubMed     Abstract available

  1389. ORUMAA M, Kjaer SK, Dehlendorff C, Munk C, et al
    The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity.
    Vaccine. 2019 Dec 20. pii: S0264-410X(19)31658.
    PubMed     Abstract available

  1390. LAI SW
    Effectiveness of the herpes zoster vaccine Zostavax.
    Vaccine. 2019 Dec 19. pii: S0264-410X(19)31677.

  1391. ACCROMBESSI M, Adetola CV, Bacharou S, Dossou Y, et al
    Assessment of the anti-HBs antibody response in Beninese infants following 4 doses of HBV vaccine, including administration at birth, compared to the standard 3 doses regime; a cross-sectional survey.
    Vaccine. 2019 Dec 19. pii: S0264-410X(19)31673.
    PubMed     Abstract available

  1392. GIESE H, Neth H, Moussaid M, Betsch C, et al
    The echo in flu-vaccination echo chambers: Selective attention trumps social influence.
    Vaccine. 2019 Dec 18. pii: S0264-410X(19)31563.
    PubMed     Abstract available

  1393. MARKKULA J, Hemming-Harlo M, Vesikari T
    Shedding of oral pentavalent bovine-human reassortant rotavirus vaccine indicates high uptake rate of vaccine and prominence of G-type G1.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31649.
    PubMed     Abstract available

  1394. MORSE-BRADY J, Marie Hart A
    Prevalence and types of vaccination errors from 2009 to 2018: A systematic review of the medical literature.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31632.
    PubMed     Abstract available

  1395. RAO S, Ziniel SI, Khan I, Dempsey A, et al
    Be inFLUential: Evaluation of a multifaceted intervention to increase influenza vaccination rates among pediatric inpatients.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31652.
    PubMed     Abstract available

  1396. BERTRAN K, Criado MF, Lee DH, Killmaster L, et al
    Protection of White Leghorn chickens by recombinant fowlpox vector vaccine with an updated H5 insert against Mexican H5N2 avian influenza viruses.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31626.
    PubMed     Abstract available

  1397. DHAMAYANTI M, Tarigan R, Fadlyana E, Prasetyo D, et al
    Immunogenicity and safety of Quadrivalent Influenza HA vaccine in Indonesian children: An open-labeled, bridging, clinical study.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31650.
    PubMed     Abstract available

  1398. LEVILLAIN F, Kim H, Woong Kwon K, Clark S, et al
    Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31639.
    PubMed     Abstract available

  1399. OFFEDDU V, Low MSF, Surendran S, Kembhavi G, et al
    Acceptance and feasibility of school-based seasonal influenza vaccination in Singapore: A qualitative study.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31662.
    PubMed     Abstract available

  1400. PECENKA C, Debellut F, Bar-Zeev N, Anwari P, et al
    Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?
    Vaccine. 2019 Dec 16. pii: S0264-410X(19)31656.

  1401. NNAJI CA, Shey MS, Adetokunboh OO, Wiysonge CS, et al
    Immunogenicity and safety of fractional dose yellow fever vaccination: A systematic review and meta-analysis.
    Vaccine. 2019 Dec 16. pii: S0264-410X(19)31660.
    PubMed     Abstract available

  1402. DE HOOG MLA, Venekamp RP, Meijer A, Sanders EAM, et al
    Inactivated influenza vaccine does not reduce all cause respiratory illness in children with pre-existing medical conditions.
    Vaccine. 2019 Dec 16. pii: S0264-410X(19)31640.
    PubMed     Abstract available

  1403. HADJIPANAYIS A, van Esso D, Del Torso S, Dornbusch HJ, et al
    Vaccine confidence among parents: Large scale study in eighteen European countries.
    Vaccine. 2019 Dec 14. pii: S0264-410X(19)31622.
    PubMed     Abstract available

  1404. ZAMAN K, Kingma R, Yunus M, van Straaten I, et al
    Corrigendum to "Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study" [Vaccine 37 (2019) 4275-4280].
    Vaccine. 2019 Dec 14. pii: S0264-410X(19)31646.

  1405. CONSTABLE C, Caplan A
    Comparison of the implementation of human papillomavirus and hepatitis B vaccination programs in the United States: Implications for future vaccines.
    Vaccine. 2019 Dec 13. pii: S0264-410X(19)31627.
    PubMed     Abstract available

  1406. PASTURAL E, McNeil SA, MacKinnon-Cameron D, Ye L, et al
    Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study.
    Vaccine. 2019 Dec 13. pii: S0264-410X(19)31645.
    PubMed     Abstract available

  1407. TRICOU V, Low JG, Oh HM, Leo YS, et al
    Safety and immunogenicity of a single dose of a tetravalent dengu